Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,A1BG,Alpha-1B-glycoprotein,19587,69,3.34 [0.84-13.30],0.0869141379156365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AAMDC,Mth938 domain-containing protein,19070,67,0.95 [0.60-1.48],0.8059222945122579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AARSD1,Alanyl-tRNA editing protein Aarsd1,22343,78,1.19 [0.84-1.69],0.3235879686200193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABCA2,ATP-binding cassette sub-family A member 2,18884,64,2.04 [1.19-3.49],0.0092032626267219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABHD14B,Protein ABHD14B,22197,80,1.27 [0.90-1.79],0.1712142249837328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABL1,Tyrosine-protein kinase ABL1,22343,78,1.06 [0.79-1.42],0.7151992677770068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABO,Histo-blood group ABO system transferase,19567,68,1.10 [0.94-1.29],0.2357377493326216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABRAXAS2,BRISC complex subunit Abraxas 2,18884,64,1.08 [0.75-1.55],0.6768971718994947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",21953,75,1.26 [0.99-1.60],0.0577118114971471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19201,67,0.88 [0.60-1.29],0.5100381063934747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19554,67,1.19 [0.93-1.53],0.1653709573798356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACAN,Aggrecan core protein,22224,81,1.24 [0.61-2.52],0.5588374188472276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE,Angiotensin-converting enzyme,19567,68,2.38 [1.14-5.00],0.0214535077671339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE2,Angiotensin-converting enzyme 2,22040,77,1.40 [1.00-1.97],0.051580692587404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACHE,Acetylcholinesterase,19150,68,1.55 [0.81-2.98],0.1890874793460528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACOT13,Acyl-coenzyme A thioesterase 13,19459,66,1.04 [0.84-1.28],0.7131808146401803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22453,81,1.15 [0.80-1.66],0.4558684220308943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP1,Low molecular weight phosphotyrosine protein phosphatase,18976,67,1.21 [0.74-1.96],0.4442592169909801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP5,Tartrate-resistant acid phosphatase type 5,22575,78,1.05 [0.56-1.95],0.889049743385993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP6,Lysophosphatidic acid phosphatase type 6,22595,81,0.76 [0.59-0.97],0.0281135297568766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACRBP,Acrosin-binding protein,19460,68,0.94 [0.52-1.72],0.8482969265031303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACRV1,Acrosomal protein SP-10,18976,67,1.25 [0.97-1.63],0.0899842967310134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACSL1,Long-chain-fatty-acid--CoA ligase 1,18884,64,1.57 [1.01-2.44],0.0457336179797471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTA2,"Actin, aortic smooth muscle",22040,77,1.67 [1.22-2.28],0.0012256256075629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTN2,Alpha-actinin-2,18884,64,1.32 [0.91-1.92],0.1382427372668708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTN4,Alpha-actinin-4,22021,77,0.78 [0.39-1.59],0.4998340737653449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACVRL1,Serine/threonine-protein kinase receptor R3,22223,80,1.72 [0.83-3.55],0.1418573304236471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY1,Aminoacylase-1,22453,81,1.45 [1.06-1.96],0.0181089298055181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,18884,64,1.54 [1.05-2.26],0.0262829086749845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACYP1,Acylphosphatase-1,19077,68,1.15 [0.81-1.63],0.4247410830157923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA,Adenosine deaminase,22669,80,1.76 [1.11-2.79],0.0161986562012453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA2,Adenosine deaminase 2,22343,80,2.22 [1.49-3.32],0.0001020531344463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,18976,67,1.03 [0.50-2.12],0.935121161073389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22040,77,1.78 [0.93-3.42],0.0811916615754666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22257,80,0.98 [0.57-1.68],0.9337384866099028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22669,80,1.01 [0.58-1.77],0.9702553862813892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22595,81,0.82 [0.42-1.59],0.5535839617411975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19459,66,1.39 [0.66-2.94],0.3881218794270141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,18976,67,1.20 [0.59-2.47],0.6137571328295781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22732,79,0.67 [0.29-1.52],0.3372067057353466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22343,78,1.28 [0.79-2.07],0.3220064110178198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22040,77,1.10 [0.59-2.05],0.7579498516469345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,18976,67,1.21 [0.63-2.32],0.5730251846483114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22542,79,1.26 [0.80-1.97],0.3186455938291083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL2,ADAMTS-like protein 2,19568,68,2.09 [1.13-3.85],0.0190518039610589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL4,ADAMTS-like protein 4,19070,67,1.07 [0.39-2.92],0.901771930063719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL5,ADAMTS-like protein 5,19554,67,0.64 [0.35-1.15],0.1346673077933936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,21953,75,1.23 [0.81-1.86],0.3271483842876008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADD1,Alpha-adducin,19150,68,1.10 [0.79-1.52],0.5828831643351584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRB3,Adhesion G protein-coupled receptor B3,22223,80,1.36 [0.76-2.44],0.2942709181567253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRD1,Adhesion G-protein coupled receptor D1,19150,68,1.37 [0.76-2.47],0.2966043932626021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE1,Adhesion G protein-coupled receptor E1,19459,66,1.56 [1.06-2.30],0.024296106120366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE2,Adhesion G protein-coupled receptor E2,22549,81,1.42 [0.72-2.82],0.3153096571793676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE5,Adhesion G protein-coupled receptor E5,22638,79,1.47 [0.80-2.70],0.2159536196302523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRF5,Adhesion G protein-coupled receptor F5,19554,67,2.41 [1.09-5.35],0.0305756924154886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRG1,Adhesion G-protein coupled receptor G1,22343,78,1.03 [0.81-1.31],0.8302634710743865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRG2,Adhesion G-protein coupled receptor G2,22453,81,0.71 [0.34-1.47],0.356973960775452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRV1,Adhesion G-protein coupled receptor V1,18910,64,1.02 [0.72-1.44],0.9209255802372652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH1B,All-trans-retinol dehydrogenase,19150,68,1.50 [1.14-1.96],0.0035482618076423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22040,77,1.30 [1.03-1.65],0.0287436965462825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADIPOQ,Adiponectin,19587,69,1.14 [0.82-1.59],0.4279843685020853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADM,Pro-adrenomedullin,22632,81,1.33 [0.63-2.78],0.4507645524397299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADRA2A,Alpha-2A adrenergic receptor,18884,64,0.59 [0.35-0.98],0.0409246023416972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFAP1,Actin filament-associated protein 1,19150,68,0.95 [0.71-1.28],0.7354990676206978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFM,Afamin,19587,69,1.24 [0.39-3.94],0.7123422358574172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFP,Alpha-fetoprotein,22181,80,1.17 [0.87-1.57],0.3078273955359394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGBL2,Cytosolic carboxypeptidase 2,18910,64,1.09 [0.83-1.43],0.5356915471662473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGER,Advanced glycosylation end product-specific receptor,22410,81,0.94 [0.59-1.49],0.7782655264849216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGR2,Anterior gradient protein 2 homolog,21750,76,1.15 [0.95-1.40],0.1534072718200496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGR3,Anterior gradient protein 3,21906,74,1.26 [0.91-1.74],0.168498250103601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGRN,Agrin,22549,81,1.56 [0.94-2.60],0.0857683806354187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGRP,Agouti-related protein,22669,80,1.42 [0.97-2.07],0.0724143458578772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGT,Angiotensinogen,19567,68,1.50 [0.63-3.60],0.3640548528845252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGXT,Serine--pyruvate aminotransferase,22453,81,1.36 [1.08-1.73],0.0101504348560909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHCY,Adenosylhomocysteinase,22453,81,1.08 [0.81-1.44],0.5813263661206061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHNAK,Neuroblast differentiation-associated protein AHNAK,19070,67,1.01 [0.48-2.12],0.9738324841626615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHNAK2,Protein AHNAK2,19070,67,0.63 [0.27-1.48],0.287551574233822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19460,68,1.11 [0.81-1.52],0.5183102424296564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSG,Alpha-2-HS-glycoprotein,19567,68,2.19 [0.95-5.05],0.0644839737170352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSP,Alpha-hemoglobin-stabilizing protein,22438,80,1.08 [0.86-1.35],0.5243609283410251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIDA,"Axin interactor, dorsalization-associated protein",19029,66,0.86 [0.62-1.21],0.3899388404169007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIF1,Allograft inflammatory factor 1,21953,75,1.00 [0.67-1.48],0.9852918167728256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIF1L,Allograft inflammatory factor 1-like,19070,67,1.03 [0.67-1.57],0.8882436502756174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22310,78,1.18 [0.98-1.41],0.080355826911374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AK1,Adenylate kinase isoenzyme 1,22453,81,1.30 [0.97-1.73],0.0773379242619791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AK2,"Adenylate kinase 2, mitochondrial",19518,67,0.95 [0.76-1.19],0.6719506940772733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKAP12,A-kinase anchor protein 12,19150,68,1.57 [0.61-4.03],0.3485260038549774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1B1,Aldo-keto reductase family 1 member B1,21953,75,0.95 [0.72-1.25],0.707296151135545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1B10,Aldo-keto reductase family 1 member B10,19029,66,1.09 [0.75-1.58],0.6682610866919783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1C4,Aldo-keto reductase family 1 member C4,22040,77,1.03 [0.72-1.49],0.8571636883314067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR7L,Aflatoxin B1 aldehyde reductase member 4,18976,67,1.19 [0.87-1.64],0.2724110865492485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT1S1,Proline-rich AKT1 substrate 1,21936,76,1.28 [0.94-1.74],0.1228289554940473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT2,RAC-beta serine/threonine-protein kinase,19512,65,1.03 [0.86-1.25],0.7223485154438728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT3,RAC-gamma serine/threonine-protein kinase,21860,75,1.16 [0.81-1.66],0.4063441920073245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALCAM,CD166 antigen,22732,79,1.18 [0.43-3.26],0.74831692108264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH1A1,Retinal dehydrogenase 1,22481,80,1.50 [1.08-2.07],0.0144362791984402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH2,"Aldehyde dehydrogenase, mitochondrial",19460,68,0.92 [0.57-1.49],0.7476126458361365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22346,81,1.18 [0.92-1.52],0.1873938442860002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19512,65,1.50 [0.96-2.33],0.0757065055551265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALMS1,Alstrom syndrome protein 1,19201,67,0.94 [0.55-1.61],0.8249058636346647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALPI,Intestinal-type alkaline phosphatase,18976,67,0.98 [0.81-1.19],0.8393125184646124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALPP,"Alkaline phosphatase, placental type",22343,78,1.17 [0.97-1.41],0.1034461206001888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMBN,Ameloblastin,22021,77,0.45 [0.19-1.07],0.0716757764423074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMBP,Protein AMBP,22595,80,1.14 [0.44-2.97],0.7839454344744059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19568,68,1.38 [0.56-3.43],0.4880222194737111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMFR,E3 ubiquitin-protein ligase AMFR,21936,76,1.19 [0.89-1.59],0.2444043321614014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO1,Amphoterin-induced protein 1,19029,66,1.30 [0.89-1.90],0.1735005173224386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO2,Amphoterin-induced protein 2,22343,78,3.11 [1.35-7.17],0.007790790623077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMN,Protein amnionless,22021,77,0.87 [0.56-1.34],0.5156059542294957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMOT,Angiomotin,19150,68,1.69 [0.96-2.96],0.0668160368994046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMOTL2,Angiomotin-like protein 2,19378,68,0.85 [0.49-1.47],0.5625748776375364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMPD3,AMP deaminase 3,19518,67,1.04 [0.76-1.43],0.7990402620809395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18314,63,1.04 [0.66-1.63],0.8587281327198931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY2A,Pancreatic alpha-amylase,21568,75,1.02 [0.67-1.55],0.9346950268702052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY2B,Alpha-amylase 2B,20925,74,1.08 [0.71-1.65],0.7036155298355493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANG,Angiogenin,22425,80,1.73 [1.01-2.95],0.0444698301284522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPT1,Angiopoietin-1,22353,80,1.13 [0.89-1.43],0.3135644430171279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPT2,Angiopoietin-2,22632,81,1.67 [1.02-2.73],0.0406921950332547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL1,Angiopoietin-related protein 1,22135,76,2.09 [1.05-4.16],0.0354438733726936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL2,Angiopoietin-related protein 2,22477,81,1.64 [1.02-2.64],0.0418960488774241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL3,Angiopoietin-related protein 3,22491,80,1.12 [0.64-1.94],0.6909350942407009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL4,Angiopoietin-related protein 4,22511,81,2.08 [1.36-3.18],0.0007532545043909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL7,Angiopoietin-related protein 7,22632,81,1.29 [0.75-2.22],0.3599867563169402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANK2,Ankyrin-2,18884,64,1.06 [0.77-1.45],0.7330224454200667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,18976,67,1.01 [0.75-1.36],0.9460846592472668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKRA2,Ankyrin repeat family A protein 2,18853,65,1.14 [0.76-1.71],0.516894125704863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKRD54,Ankyrin repeat domain-containing protein 54,21953,75,1.16 [0.85-1.59],0.3482582626579206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19070,67,0.95 [0.50-1.79],0.8626707554747747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANPEP,Aminopeptidase N,22541,80,2.22 [1.18-4.18],0.0133404721696956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA1,Annexin A1,19044,67,0.92 [0.53-1.61],0.7765735796020459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA10,Annexin A10,21936,76,1.23 [1.00-1.52],0.0468135058850049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA11,Annexin A11,22361,81,1.11 [0.82-1.49],0.5162305920319193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA2,Annexin A2,18766,66,1.16 [0.86-1.57],0.3396189269392873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA3,Annexin A3,22595,81,1.08 [0.82-1.43],0.5767439770400637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA4,Annexin A4,22357,81,1.02 [0.78-1.33],0.9056697031071496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA5,Annexin A5,21868,76,0.84 [0.42-1.68],0.6242528343132505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AOC1,Amiloride-sensitive amine oxidase [copper-containing],22021,77,0.92 [0.63-1.35],0.6678990584140134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AOC3,Membrane primary amine oxidase,22574,80,1.76 [0.91-3.41],0.0954813491135575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP1G2,AP-1 complex subunit gamma-like 2,19460,68,1.11 [0.84-1.48],0.4529564375103145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP2B1,AP-2 complex subunit beta,19029,66,0.83 [0.49-1.41],0.4970478457491687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP3B1,AP-3 complex subunit beta-1,19459,66,0.99 [0.73-1.35],0.9709364078928624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP3S2,AP-3 complex subunit sigma-2,19518,67,1.00 [0.61-1.64],0.9964055645941784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22343,78,1.10 [0.72-1.69],0.6679452479325937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APCS,Serum amyloid P-component,19398,69,0.63 [0.32-1.21],0.1633033399990596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22551,81,1.27 [0.93-1.73],0.1320841292958964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APLP1,Amyloid-like protein 1,22453,81,0.86 [0.58-1.26],0.4358707738668872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA1,Apolipoprotein A-I,19587,69,0.57 [0.22-1.48],0.2477887832469189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA2,Apolipoprotein A-II,19567,68,1.25 [0.79-1.98],0.3443249666398199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA4,Apolipoprotein A-IV,19587,69,1.43 [0.81-2.52],0.2196272864686594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOB,Apolipoprotein B-100,19567,68,1.66 [0.58-4.74],0.3446422963084792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOBR,Apolipoprotein B receptor,19070,67,1.02 [0.59-1.78],0.9353364236414722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOC1,Apolipoprotein C-I,19555,69,0.82 [0.43-1.55],0.5385954174196115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOD,Apolipoprotein D,18751,67,1.17 [0.69-1.98],0.559229080030327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOE,Apolipoprotein E,19587,69,1.12 [0.85-1.49],0.4261963466906174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOF,Apolipoprotein F,19567,68,0.84 [0.41-1.71],0.6248090473984256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOH,Beta-2-glycoprotein 1,22481,80,0.92 [0.53-1.58],0.7557475271739015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOL1,Apolipoprotein L1,19567,68,0.92 [0.62-1.38],0.6997543528115227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOM,Apolipoprotein M,22527,80,0.97 [0.49-1.94],0.9372373375237878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APP,Amyloid-beta precursor protein,22454,80,1.31 [0.98-1.75],0.0679547855571785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APPL2,DCC-interacting protein 13-beta,19150,68,1.08 [0.88-1.34],0.4472370236059344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APRT,Adenine phosphoribosyltransferase,22207,80,1.05 [0.69-1.59],0.816755794954669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARAF,Serine/threonine-protein kinase A-Raf,19201,67,1.10 [0.80-1.52],0.5563258825892073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AREG,Amphiregulin,22343,78,1.36 [0.87-2.12],0.1720623759942281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARF6,ADP-ribosylation factor 6,19459,66,1.09 [0.87-1.36],0.4519553160891086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARFIP1,Arfaptin-1,19512,65,1.02 [0.72-1.44],0.9175490375989572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARG1,Arginase-1,22290,81,1.11 [0.77-1.60],0.5761751215746369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARG2,"Arginase-2, mitochondrial",19460,68,1.57 [1.08-2.29],0.0183809123105725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP1,Rho GTPase-activating protein 1,21953,75,1.12 [0.71-1.76],0.6292325776380185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP25,Rho GTPase-activating protein 25,21953,75,1.24 [0.90-1.70],0.1821761465502647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP30,Rho GTPase-activating protein 30,19201,67,0.72 [0.34-1.54],0.3971008989651075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP45,Rho GTPase-activating protein 45,19150,68,1.15 [0.86-1.52],0.3455362721507896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP5,Rho GTPase-activating protein 5,18853,65,1.10 [0.83-1.47],0.4927630463229485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF1,Rho guanine nucleotide exchange factor 1,19518,67,1.12 [0.86-1.45],0.4064142540977865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF10,Rho guanine nucleotide exchange factor 10,19512,65,1.04 [0.81-1.33],0.7719550012429688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF12,Rho guanine nucleotide exchange factor 12,22392,81,1.11 [0.92-1.35],0.2649921312303454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF5,Rho guanine nucleotide exchange factor 5,18910,64,1.43 [1.10-1.85],0.006833915435499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARID3A,AT-rich interactive domain-containing protein 3A,18910,64,0.88 [0.47-1.64],0.683143158973494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARID4B,AT-rich interactive domain-containing protein 4B,21936,76,1.06 [0.67-1.67],0.7956693218853973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARL13B,ADP-ribosylation factor-like protein 13B,18884,64,1.02 [0.72-1.44],0.923325631749017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,18884,64,1.03 [0.57-1.89],0.9110973117465516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARMCX2,Armadillo repeat-containing X-linked protein 2,18910,64,1.05 [0.72-1.53],0.8065889393907867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNT,Aryl hydrocarbon receptor nuclear translocator,22021,77,0.79 [0.43-1.45],0.4443314715616239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,18884,64,1.11 [0.74-1.66],0.6271619117428143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARSA,Arylsulfatase A,22481,80,1.54 [1.04-2.26],0.029539919153217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARSB,Arylsulfatase B,22343,78,1.07 [0.75-1.54],0.7017328412851285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ART3,Ecto-ADP-ribosyltransferase 3,22574,80,1.11 [0.64-1.94],0.7044843514356125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ART5,Ecto-ADP-ribosyltransferase 5,18910,64,0.93 [0.62-1.40],0.738377024082149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARTN,Artemin,22021,77,0.93 [0.57-1.52],0.778533834821828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASAH1,Acid ceramidase,19366,68,1.43 [0.97-2.13],0.0727987323951041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASAH2,Neutral ceramidase,22257,80,1.31 [0.87-1.96],0.1949735577690667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASGR1,Asialoglycoprotein receptor 1,22257,80,1.23 [0.65-2.34],0.5204723938694666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASGR2,Asialoglycoprotein receptor 2,19567,68,1.67 [0.73-3.81],0.2230593316881278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASPN,Asporin,19554,67,1.35 [0.63-2.89],0.4421692381282796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASPSCR1,Tether containing UBX domain for GLUT4,19512,65,1.07 [0.75-1.52],0.7146134411784992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASRGL1,Isoaspartyl peptidase/L-asparaginase,19070,67,1.02 [0.81-1.29],0.8619948815219391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASS1,Argininosuccinate synthase,18884,64,1.05 [0.77-1.43],0.762940628560795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATF2,Cyclic AMP-dependent transcription factor ATF-2,21936,76,1.02 [0.76-1.36],0.8987403575491589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATF4,Cyclic AMP-dependent transcription factor ATF-4,18853,65,1.29 [0.68-2.45],0.4404366681061979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATG16L1,Autophagy-related protein 16-1,19459,66,1.08 [0.82-1.42],0.5870784981443435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATG4A,Cysteine protease ATG4A,21953,75,1.33 [0.96-1.83],0.085848480248683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATOX1,Copper transport protein ATOX1,22542,79,1.26 [0.94-1.68],0.1220582411145965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,18884,64,1.16 [0.75-1.81],0.5023836248864999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,18884,64,0.87 [0.40-1.85],0.7091790977381784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,18884,64,0.76 [0.38-1.55],0.4544017686623318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B4,Protein ATP1B4,18853,65,1.66 [1.11-2.49],0.0135330201444655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP2B4,Plasma membrane calcium-transporting ATPase 4,18884,64,1.05 [0.71-1.53],0.8156463043076503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5F1D,"ATP synthase subunit delta, mitochondrial",18884,64,1.04 [0.67-1.61],0.8716398807080863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5IF1,"ATPase inhibitor, mitochondrial",22549,81,1.08 [0.90-1.29],0.4251871965120209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5PO,"ATP synthase subunit O, mitochondrial",21936,76,0.77 [0.46-1.30],0.3321027372887324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6AP2,Renin receptor,21953,75,1.02 [0.61-1.71],0.9499338035854696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1D,V-type proton ATPase subunit D,22343,78,0.56 [0.24-1.31],0.1821528557071685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1F,V-type proton ATPase subunit F,21901,76,0.89 [0.65-1.22],0.457395914173174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1G1,V-type proton ATPase subunit G 1,19070,67,0.94 [0.68-1.31],0.7309018615460792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1G2,V-type proton ATPase subunit G 2,18884,64,0.80 [0.61-1.05],0.1071812255277726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRAID,All-trans retinoic acid-induced differentiation factor,19459,66,1.83 [1.14-2.94],0.0117707075183025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRN,"Attractin, Isoform 2",19587,69,3.50 [1.02-11.96],0.0457270709140994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN10,Ataxin-10,21936,76,1.26 [0.95-1.68],0.1078778364252106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN2,Ataxin-2,18910,64,1.21 [1.03-1.42],0.0181443602950473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN2L,Ataxin-2-like protein,19512,65,1.27 [0.81-2.00],0.2975484217202453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN3,Ataxin-3,19518,67,0.98 [0.67-1.42],0.911225292189776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AXIN1,Axin-1,22392,81,1.07 [0.87-1.32],0.4993414034891761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AXL,Tyrosine-protein kinase receptor UFO,22574,80,1.64 [0.82-3.27],0.1623716938704426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AZI2,5-azacytidine-induced protein 2,19512,65,0.98 [0.64-1.51],0.9333812151644476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AZU1,Azurocidin,21764,77,0.98 [0.76-1.28],0.9052953419433244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B2M,Beta-2-microglobulin,19587,69,1.36 [0.84-2.21],0.2168803613428112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,18884,64,0.80 [0.23-2.77],0.7284477701962306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19070,67,1.41 [0.74-2.69],0.2929669032925421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B4GALT1,"Beta-1,4-galactosyltransferase 1",22549,81,1.53 [0.77-3.05],0.2246632547296507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B4GAT1,"Beta-1,4-glucuronyltransferase 1",22481,80,1.12 [0.50-2.54],0.7792881416027393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BABAM1,BRISC and BRCA1-A complex member 1,18976,67,1.34 [0.63-2.85],0.4459661361434281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BACH1,Transcription regulator protein BACH1,22392,81,1.23 [0.95-1.60],0.1172577119828639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG3,BAG family molecular chaperone regulator 3,22223,80,0.99 [0.61-1.60],0.9549116390508564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG4,BAG family molecular chaperone regulator 4,18976,67,1.08 [0.67-1.74],0.745727411490562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG6,Large proline-rich protein BAG6,22040,77,1.26 [0.72-2.19],0.4221886105829547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,21953,75,1.46 [1.10-1.93],0.0093705399631734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAMBI,BMP and activin membrane-bound inhibitor homolog,21953,75,1.72 [0.92-3.23],0.0897750916255569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BANK1,B-cell scaffold protein with ankyrin repeats,22392,81,1.05 [0.87-1.27],0.6222757848872245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAP18,Chromatin complexes subunit BAP18,19518,67,1.18 [0.88-1.59],0.2744885130892086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BATF,Basic leucine zipper transcriptional factor ATF-like,19029,66,1.31 [1.08-1.58],0.0054085478156769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAX,Apoptosis regulator BAX,21902,76,1.01 [0.80-1.27],0.9295579652896266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAM,Basal cell adhesion molecule,22481,80,2.04 [1.02-4.08],0.0439219607945851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAN,Brevican core protein,22257,80,1.34 [0.76-2.38],0.3095586579583588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19554,67,1.82 [0.97-3.41],0.0613842645263472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",18910,64,1.25 [0.88-1.77],0.2110973662885014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCHE,Cholinesterase,19216,67,1.12 [0.47-2.65],0.8052687201219587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2,Apoptosis regulator Bcl-2,19459,66,1.33 [0.97-1.82],0.0725155783034537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L1,Bcl-2-like protein 1,19518,67,1.03 [0.81-1.31],0.7887212094074622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22392,81,1.30 [0.79-2.14],0.2938153813528838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L15,Bcl-2-like protein 15,18976,67,0.83 [0.53-1.30],0.4134037832931974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL7A,B-cell CLL/lymphoma 7 protein family member A,18853,65,1.06 [0.75-1.52],0.7331721247881582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL7B,B-cell CLL/lymphoma 7 protein family member B,19460,68,0.77 [0.42-1.39],0.3835531145362126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCR,Breakpoint cluster region protein,22392,81,1.16 [0.94-1.44],0.1778103905556871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BDNF,Brain-derived neurotrophic factor,19568,68,1.14 [0.86-1.51],0.3597322650416806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BECN1,Beclin-1,19070,67,0.93 [0.62-1.39],0.7142729168995321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BEX3,Protein BEX3,18853,65,1.30 [0.91-1.86],0.1556935502822313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BGLAP,Osteocalcin,19568,68,0.99 [0.77-1.27],0.9141418913309852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BGN,Biglycan,21909,74,0.95 [0.80-1.14],0.5953608218325768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BHLHE40,Class E basic helix-loop-helix protein 40,18910,64,0.90 [0.64-1.28],0.5722104022407546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,18884,64,1.19 [0.46-3.05],0.7167500976450167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BID,BH3-interacting domain death agonist,22392,81,1.04 [0.78-1.38],0.810561015637429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BIN2,Bridging integrator 2,22481,80,1.06 [0.85-1.32],0.5887100289830769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BIRC2,Baculoviral IAP repeat-containing protein 2,21953,75,1.04 [0.75-1.44],0.8308862110878705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLMH,Bleomycin hydrolase,22732,79,1.61 [0.94-2.76],0.0837473960086405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLNK,B-cell linker protein,18976,67,1.24 [0.74-2.10],0.413024175529435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,18910,64,0.84 [0.57-1.22],0.3511784485331524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19518,67,0.84 [0.46-1.54],0.5754920438344928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLVRB,Flavin reductase,22481,80,1.17 [0.89-1.54],0.26064092582164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP10,Bone morphogenetic protein 10,19150,68,1.75 [0.76-4.02],0.1870973203468878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP4,Bone morphogenetic protein 4,22223,80,0.86 [0.55-1.34],0.4921148798287108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP6,Bone morphogenetic protein 6,22012,77,1.32 [0.80-2.17],0.2763504429202956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMPER,BMP-binding endothelial regulator protein,19150,68,2.28 [0.96-5.40],0.0614632375574061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19554,67,1.17 [0.59-2.31],0.648286306309799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,18976,67,1.38 [0.84-2.24],0.2001084979213258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOC,Brother of CDO,22040,77,1.03 [0.43-2.46],0.9470088340873472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOLA1,BolA-like protein 1,18910,64,1.04 [0.67-1.62],0.8443450830162371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOLA2_BOLA2B,BolA-like protein 2,19070,67,0.87 [0.56-1.33],0.5124813925269704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFA2,BPI fold-containing family A member 2,18408,67,0.93 [0.75-1.15],0.5080741367058506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFB1,BPI fold-containing family B member 1,22397,79,0.81 [0.59-1.11],0.1948412358383167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFB2,BPI fold-containing family B member 2,19510,67,1.14 [0.82-1.58],0.4352612711495287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRAP,BRCA1-associated protein,19282,65,1.11 [0.88-1.38],0.379057894081395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD1,Bromodomain-containing protein 1,19201,67,0.74 [0.31-1.75],0.4952538199637351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD2,Bromodomain-containing protein 2,18910,64,1.45 [0.84-2.50],0.1861475744428731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD3,Bromodomain-containing protein 3,18884,64,0.73 [0.40-1.33],0.3095639169683705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRDT,Bromodomain testis-specific protein,18884,64,0.95 [0.49-1.83],0.8698663722892286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRK1,Protein BRICK1,21936,76,1.06 [0.68-1.66],0.7965764820068719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRME1,Break repair meiotic recombinase recruitment factor 1,18910,64,1.23 [0.77-1.96],0.3876294399444364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRSK2,Serine/threonine-protein kinase BRSK2,19512,65,1.32 [0.74-2.36],0.3512699681575126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BSG,Basigin,22635,79,0.94 [0.37-2.36],0.8962007390519737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BSND,Barttin,18853,65,1.15 [0.61-2.17],0.6689460292848035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22637,81,0.84 [0.58-1.20],0.3305163529289335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST2,Bone marrow stromal antigen 2,22637,81,1.61 [1.21-2.16],0.0011869670990593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTC,Probetacellulin,21953,75,1.02 [0.77-1.34],0.8985171661123517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTD,Biotinidase,19587,69,1.33 [0.42-4.18],0.6237063150462232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTLA,B- and T-lymphocyte attenuator,18853,65,1.19 [0.98-1.45],0.0827964360412878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN1A1,Butyrophilin subfamily 1 member A1,19419,68,1.20 [0.74-1.96],0.4609844201253675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN2A1,Butyrophilin subfamily 2 member A1,22549,81,1.09 [0.53-2.23],0.8124047984402565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN3A2,Butyrophilin subfamily 3 member A2,22392,81,1.65 [1.11-2.45],0.013530810626223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTNL10,Butyrophilin-like protein 10,18853,65,0.78 [0.40-1.54],0.4795555849962738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C19orf12,Protein C19orf12,21936,76,1.26 [0.97-1.64],0.0813476198718062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1GALT1C1,C1GALT1-specific chaperone 1,18884,64,1.37 [0.73-2.56],0.3264552412396669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QA,Complement C1q subcomponent subunit A,22564,79,2.80 [1.21-6.48],0.0161536233586731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19512,65,1.00 [0.72-1.37],0.9842449890181124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QL2,Complement C1q-like protein 2,18976,67,1.32 [0.81-2.13],0.2618860509614893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22574,80,2.13 [1.47-3.07],5.538190508791646e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19150,68,2.26 [1.23-4.18],0.0088238452298028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19512,65,1.44 [0.78-2.67],0.2489270794251485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19113,68,1.00 [0.62-1.60],0.9970315983644924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1R,Complement C1r subcomponent,19587,69,0.59 [0.14-2.44],0.4667828511186116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1RL,Complement C1r subcomponent-like protein,19549,69,1.44 [0.44-4.68],0.5462985933913036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1S,Complement C1s subcomponent,19587,69,0.75 [0.25-2.25],0.612891705267414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2,Complement C2,22527,80,2.45 [0.91-6.60],0.0755801146235059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2CD2L,Phospholipid transfer protein C2CD2L,21901,76,1.31 [0.89-1.95],0.1726574736264738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2orf69,UPF0565 protein C2orf69,19029,66,1.13 [0.81-1.58],0.4578634322238596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C3,Complement C3,18574,67,0.95 [0.55-1.63],0.8430764572105183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C4BPB,C4b-binding protein beta chain,22542,79,1.22 [0.75-2.00],0.4175374246462352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C5,Complement C5,19587,69,3.08 [0.89-10.68],0.0764182432599578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C7,Complement component C7,19110,68,1.19 [0.57-2.50],0.6436660688851439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C7orf50,Uncharacterized protein C7orf50,19518,67,0.96 [0.33-2.79],0.9442488881693616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C8B,Complement component C8 beta chain,19587,69,1.87 [0.87-4.03],0.1086248028225576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C9,Complement component C9,19567,68,1.00 [0.65-1.54],0.9925599730378348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C9orf40,Uncharacterized protein C9orf40,19459,66,0.97 [0.73-1.29],0.8539168550393813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA1,Carbonic anhydrase 1,21990,79,1.13 [0.82-1.56],0.4645522395929202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA11,Carbonic anhydrase-related protein 11,21953,75,0.78 [0.37-1.63],0.5052925548588509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA12,Carbonic anhydrase 12,22343,78,1.05 [0.57-1.96],0.8675814066827954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA13,Carbonic anhydrase 13,22224,79,1.10 [0.90-1.34],0.3429002120682957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA14,Carbonic anhydrase 14,22632,81,0.79 [0.45-1.37],0.3986583491829784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA2,Carbonic anhydrase 2,22393,80,1.18 [0.90-1.54],0.2369677337467167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA3,Carbonic anhydrase 3,22696,79,1.22 [0.89-1.67],0.2081491844288001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA4,Carbonic anhydrase 4,22732,79,0.88 [0.39-1.98],0.7622588722802179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA5A,"Carbonic anhydrase 5A, mitochondrial",22040,77,1.19 [0.97-1.47],0.1008685426860184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA6,Carbonic anhydrase 6,22415,80,0.99 [0.72-1.35],0.9400373395763296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA7,Carbonic anhydrase 7,19201,67,0.80 [0.38-1.67],0.5522279498033762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA8,Carbonic anhydrase-related protein,18976,67,0.55 [0.17-1.77],0.3131281971777991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA9,Carbonic anhydrase 9,22632,81,1.61 [1.13-2.30],0.0086671760232186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CABP2,Calcium-binding protein 2,19029,66,0.83 [0.55-1.25],0.3668100454901775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,18910,64,1.32 [0.71-2.44],0.3814421660537934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,18884,64,0.94 [0.60-1.46],0.7878856035592663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,18910,64,0.83 [0.53-1.29],0.4033723500944102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19512,65,1.05 [0.79-1.39],0.7224215833629262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACYBP,Calcyclin-binding protein,19122,68,1.07 [0.85-1.35],0.55234956422364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CADPS,Calcium-dependent secretion activator 1,19029,66,0.89 [0.49-1.65],0.717419286706742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALB1,Calbindin,22343,78,1.17 [0.75-1.82],0.4941410671558356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALB2,Calretinin,21936,76,0.59 [0.28-1.23],0.1607033398680948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCA,Calcitonin,22222,80,1.19 [0.89-1.58],0.2491927471363001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCB,Calcitonin gene-related peptide 2,19518,67,0.97 [0.53-1.77],0.9234815974758664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22555,81,1.10 [0.91-1.33],0.309924035144876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19070,67,0.94 [0.68-1.29],0.6912154374982273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALY,Neuron-specific vesicular protein calcyon,18884,64,1.23 [0.72-2.10],0.44641959658299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,21953,75,1.32 [0.85-2.05],0.2098034725443488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19029,66,0.83 [0.51-1.34],0.4447558687305285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19512,65,1.00 [0.80-1.25],0.9994740618625226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CANT1,Soluble calcium-activated nucleotidase 1,22374,81,3.24 [1.28-8.20],0.0131066671585526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPG,Macrophage-capping protein,22250,80,1.02 [0.73-1.43],0.8922160826441077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPN3,Calpain-3,19460,68,0.75 [0.37-1.50],0.4133888693307802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPS,Calcyphosin,19518,67,0.95 [0.74-1.22],0.6892040088284586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CARHSP1,Calcium-regulated heat-stable protein 1,21936,76,1.06 [0.73-1.56],0.7533471762800853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASC3,Protein CASC3,19029,66,0.80 [0.44-1.47],0.4769412385355063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP1,Caspase-1,21936,76,0.91 [0.68-1.24],0.5622839524644143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP10,Caspase-10,21936,76,1.17 [0.88-1.56],0.2708404223279682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP2,Caspase-2,22392,81,1.10 [0.82-1.46],0.5335558104287046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP3,Caspase-3,22732,79,1.11 [0.88-1.39],0.3781538921542562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP4,Caspase-4,19201,67,1.03 [0.90-1.17],0.7066428734794352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP7,Caspase-7,19518,67,1.06 [0.80-1.40],0.6845538490779506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP8,Caspase-8,22558,80,1.14 [0.84-1.55],0.4154913634021762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP9,Caspase-9,18976,67,0.96 [0.65-1.42],0.8373028200725687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASQ2,Calsequestrin-2,18884,64,0.89 [0.51-1.56],0.6801100775943842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAT,Catalase,19284,68,1.08 [0.72-1.64],0.702114163340686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLIF,Cobalamin binding intrinsic factor,22410,81,1.02 [0.80-1.31],0.8676779801422335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLN1,Cerebellin-1,18910,64,1.24 [1.04-1.49],0.0169363350599082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLN4,Cerebellin-4,22632,81,0.98 [0.54-1.79],0.9552406796397042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBS,Cystathionine beta-synthase,19070,67,1.18 [0.77-1.80],0.4431408427418831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBX2,Chromobox protein homolog 2,18884,64,0.82 [0.41-1.64],0.5707650026858275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22257,80,1.15 [0.88-1.49],0.3036792583719499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCAR2,Cell cycle and apoptosis regulator protein 2,19518,67,0.90 [0.55-1.47],0.6686771011252137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC134,Coiled-coil domain-containing protein 134,19460,68,1.05 [0.65-1.68],0.8396960695600497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC28A,Coiled-coil domain-containing protein 28A,19029,66,0.89 [0.40-1.98],0.776102539019835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC50,Coiled-coil domain-containing protein 50,19512,65,1.03 [0.76-1.39],0.8493580457579455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC80,Coiled-coil domain-containing protein 80,22453,81,1.40 [0.85-2.30],0.1845871445306893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19070,67,0.74 [0.50-1.09],0.126466152191418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL11,Eotaxin,22669,80,1.26 [0.74-2.14],0.4042667685817934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL13,C-C motif chemokine 13,22633,80,1.21 [0.92-1.60],0.1769707814787658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL14,C-C motif chemokine 14,22425,80,1.55 [1.01-2.36],0.0437465723712241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL15,C-C motif chemokine 15,22732,79,1.25 [0.81-1.92],0.309596819621406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL16,C-C motif chemokine 16,22732,79,1.17 [0.80-1.71],0.4200222880240846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL17,C-C motif chemokine 17,22413,81,1.04 [0.85-1.29],0.6846918036790302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL18,C-C motif chemokine 18,22164,80,1.22 [0.95-1.57],0.1138787688359367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL19,C-C motif chemokine 19,22637,81,0.97 [0.83-1.13],0.6794128304955469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL2,C-C motif chemokine 2,22223,80,1.25 [0.87-1.79],0.2285593619674489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL20,C-C motif chemokine 20,22669,80,1.06 [0.86-1.30],0.592443171182353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL21,C-C motif chemokine 21,22549,81,1.11 [0.72-1.72],0.6348333261258231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL22,C-C motif chemokine 22,22253,80,1.24 [0.87-1.78],0.2323000312108428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL23,C-C motif chemokine 23,22549,81,1.40 [0.89-2.21],0.14258083330606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL24,C-C motif chemokine 24,22511,81,0.95 [0.75-1.20],0.6603768542170176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL25,C-C motif chemokine 25,22669,80,1.34 [0.89-2.01],0.160158426172248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL26,C-C motif chemokine 26,22392,81,1.04 [0.85-1.27],0.725717712682564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL27,C-C motif chemokine 27,22453,81,1.34 [0.96-1.87],0.0807687239638738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL28,C-C motif chemokine 28,22309,80,1.23 [0.90-1.67],0.1892466672321638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL3,C-C motif chemokine 3,22392,81,1.00 [0.74-1.36],0.9859685451134028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL4,C-C motif chemokine 4,22483,81,0.81 [0.58-1.14],0.2322921743212196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL5,C-C motif chemokine 5,22574,80,1.06 [0.87-1.29],0.5372921024024621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL7,C-C motif chemokine 7,22392,81,1.25 [0.93-1.68],0.1315814933036154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL8,C-C motif chemokine 8,22595,80,1.06 [0.77-1.47],0.7065557171714707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN1,CCN family member 1,22299,77,1.24 [0.94-1.64],0.1304498852549711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN2,CCN family member 2,22420,80,1.51 [1.07-2.14],0.0199594418817295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN3,CCN family member 3,22693,78,1.62 [0.94-2.77],0.0795406402415024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN4,CCN family member 4,22632,81,1.75 [1.13-2.69],0.0113954999277824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN5,CCN family member 5,22481,80,1.14 [0.68-1.90],0.6128653095363515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCND2,G1/S-specific cyclin-D2,19201,67,1.39 [0.72-2.66],0.3231777408379283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCNE1,G1/S-specific cyclin-E1,18976,67,0.85 [0.59-1.22],0.3773369391495963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCS,Copper chaperone for superoxide dismutase,22257,80,1.03 [0.68-1.56],0.8805643124287617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCT5,T-complex protein 1 subunit epsilon,21953,75,1.16 [0.75-1.80],0.4922511087912729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD101,Immunoglobulin superfamily member 2,19459,66,1.18 [0.68-2.07],0.5588634389366168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD109,CD109 antigen,22481,80,1.25 [0.69-2.27],0.4692261272867905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD14,Monocyte differentiation antigen CD14,22056,78,1.81 [1.16-2.82],0.0091688408239259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD160,CD160 antigen,22669,80,1.19 [0.80-1.76],0.3949843506747308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD163,Scavenger receptor cysteine-rich type 1 protein M130,22574,80,1.84 [1.20-2.82],0.0048478821821058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD164,Sialomucin core protein 24,22481,80,1.44 [0.91-2.29],0.1192177525135042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD164L2,CD164 sialomucin-like 2 protein,19029,66,1.08 [0.57-2.06],0.8103538512793114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD177,CD177 antigen,22444,80,1.09 [0.93-1.29],0.2753202269240112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD1C,T-cell surface glycoprotein CD1c,22542,79,0.75 [0.34-1.65],0.4696035713322349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2,T-cell surface antigen CD2,18884,64,1.50 [1.02-2.20],0.0377240315942129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD200,OX-2 membrane glycoprotein,22392,81,0.96 [0.46-2.01],0.9208255796563576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD200R1,Cell surface glycoprotein CD200 receptor 1,22325,81,0.76 [0.43-1.33],0.3346343562895124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD207,C-type lectin domain family 4 member K,21944,76,0.78 [0.46-1.31],0.3499094178582791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD209,CD209 antigen,22530,78,0.75 [0.44-1.25],0.2687601926141083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD22,B-cell receptor CD22,22669,80,1.11 [0.70-1.75],0.6541301329491453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD226,CD226 antigen,18976,67,1.29 [0.74-2.24],0.3684022273104425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD244,Natural killer cell receptor 2B4,22669,80,2.13 [1.07-4.25],0.0312325112293127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD248,Endosialin,19568,68,1.26 [0.71-2.23],0.4221842148441946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD27,CD27 antigen,22542,79,1.31 [0.84-2.04],0.2292814972376133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD274,Programmed cell death 1 ligand 1,22257,80,1.63 [0.99-2.71],0.0561298785556222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD276,CD276 antigen,22445,81,1.54 [0.88-2.68],0.1310478606728945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD28,T-cell-specific surface glycoprotein CD28,21953,75,1.43 [0.91-2.25],0.1219787598006993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2AP,CD2-associated protein,22453,81,1.26 [0.94-1.69],0.128892360947949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300A,CMRF35-like molecule 8,19150,68,1.74 [0.84-3.62],0.136122185533275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300C,CMRF35-like molecule 6,22637,81,1.12 [0.65-1.92],0.6868103130629348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300E,CMRF35-like molecule 2,22557,81,1.30 [0.83-2.03],0.2533547173028771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300LF,CMRF35-like molecule 1,22632,81,1.21 [0.87-1.68],0.2511219946496865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300LG,CMRF35-like molecule 9,22481,80,0.66 [0.39-1.11],0.1208289450075074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD302,CD302 antigen,22343,78,1.48 [0.80-2.74],0.2093745771442606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD33,Myeloid cell surface antigen CD33,22542,79,1.15 [0.88-1.49],0.304184844227806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD34,Hematopoietic progenitor cell antigen CD34,22573,81,0.36 [0.16-0.82],0.0147349175421416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD36,Platelet glycoprotein 4,18976,67,1.17 [0.70-1.93],0.5487014291158737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22343,78,1.74 [0.97-3.13],0.0630804039332393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3D,T-cell surface glycoprotein CD3 delta chain,18910,64,1.37 [0.82-2.27],0.230909199466947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3E,T-cell surface glycoprotein CD3 epsilon chain,19201,67,1.37 [0.83-2.25],0.2221684377441322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3G,T-cell surface glycoprotein CD3 gamma chain,18976,67,0.53 [0.32-0.86],0.0105919226257378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD4,T-cell surface glycoprotein CD4,22355,80,1.04 [0.54-1.97],0.915114522183918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD40,Tumor necrosis factor receptor superfamily member 5,22445,81,1.39 [0.96-2.01],0.0840680540174727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD40LG,CD40 ligand,22669,80,1.08 [0.84-1.39],0.5444172177383965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD46,Membrane cofactor protein,22351,80,2.04 [1.13-3.69],0.018082506316769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD48,CD48 antigen,22511,81,1.55 [0.83-2.90],0.1727246480187087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5,T-cell surface glycoprotein CD5,22595,80,1.12 [0.64-1.94],0.6983353982884359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD55,Complement decay-accelerating factor,21692,77,1.72 [0.86-3.43],0.1239934467157738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD58,Lymphocyte function-associated antigen 3,22415,81,0.85 [0.28-2.57],0.7719661732881969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD59,CD59 glycoprotein,21681,77,2.17 [1.08-4.36],0.0295203996104549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5L,CD5 antigen-like,19476,69,1.77 [1.10-2.84],0.0177193565838538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD6,T-cell differentiation antigen CD6,22635,79,0.74 [0.51-1.07],0.1070517258320933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD63,CD63 antigen,22223,80,1.19 [0.81-1.77],0.378184806200029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD69,Early activation antigen CD69,22361,81,1.08 [0.86-1.35],0.5072331590167398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD7,T-cell antigen CD7,18931,67,0.81 [0.46-1.42],0.4561500672677968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD70,CD70 antigen,22392,81,1.18 [0.75-1.86],0.4791876146763564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD72,B-cell differentiation antigen CD72,19150,68,1.75 [1.09-2.81],0.0208605262518093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD74,HLA class II histocompatibility antigen gamma chain,22637,81,1.48 [0.86-2.53],0.1528220329189212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD79B,B-cell antigen receptor complex-associated protein beta chain,22669,80,1.24 [0.83-1.86],0.2885319023782809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD80,T-lymphocyte activation antigen CD80,19554,67,1.98 [1.08-3.61],0.0271923462096991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD82,CD82 antigen,19201,67,0.73 [0.37-1.45],0.374693083088439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD83,CD83 antigen,22392,81,1.10 [0.63-1.93],0.7286554075062306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD84,SLAM family member 5,22392,81,1.21 [0.65-2.26],0.5414617316676453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD86,T-lymphocyte activation antigen CD86,19459,66,3.21 [1.59-6.50],0.0011840032094762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD8A,T-cell surface glycoprotein CD8 alpha chain,22637,81,0.85 [0.58-1.25],0.4125753103363775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD93,Complement component C1q receptor,21654,77,1.62 [0.88-3.00],0.1229760460186421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD99,CD99 antigen,22481,80,1.23 [0.46-3.29],0.6798861105105078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD99L2,CD99 antigen-like protein 2,22481,80,1.46 [0.65-3.26],0.3548403541634669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDA,Cytidine deaminase,19509,67,1.54 [1.01-2.37],0.0471932124652995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDAN1,Codanin-1,19518,67,1.06 [0.41-2.73],0.9015003696525632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC123,Cell division cycle protein 123 homolog,18853,65,1.04 [0.72-1.49],0.8443052347396512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC25A,M-phase inducer phosphatase 1,18853,65,1.31 [0.80-2.16],0.2878137393149813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC26,Anaphase-promoting complex subunit CDC26,19417,66,0.96 [0.68-1.36],0.8352241628647871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC27,Cell division cycle protein 27 homolog,21953,75,1.07 [0.78-1.48],0.6638094104611114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC37,Hsp90 co-chaperone Cdc37,22542,79,1.10 [0.87-1.40],0.4249876813054412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC42BPB,Serine/threonine-protein kinase MRCK beta,19459,66,1.04 [0.83-1.31],0.7352896158417983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDCP1,CUB domain-containing protein 1,22257,80,1.29 [0.91-1.81],0.148199358178677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH1,Cadherin-1,21736,78,1.33 [0.84-2.10],0.2254970597030555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH15,Cadherin-15,22602,81,0.89 [0.65-1.23],0.4904198937871518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH17,Cadherin-17,22453,81,1.11 [0.84-1.45],0.4616527744325195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH2,Cadherin-2,22453,81,1.68 [1.00-2.81],0.0497794156844166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH22,Cadherin-22,19201,67,0.66 [0.27-1.60],0.3543860959428171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH23,Cadherin-23,19518,67,0.76 [0.30-1.92],0.5651573596788891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH3,Cadherin-3,22637,81,0.97 [0.57-1.66],0.9226676737992212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH4,Cadherin-4,18910,64,1.31 [0.89-1.93],0.1641881520582319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH5,Cadherin-5,22732,79,1.32 [0.69-2.50],0.3986861833519732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH6,Cadherin-6,22453,81,1.32 [0.79-2.19],0.2845476827694942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR1,Cadherin-related family member 1,21936,76,1.13 [0.74-1.73],0.5776312951234523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR2,Cadherin-related family member 2,22343,78,1.02 [0.76-1.37],0.8844012690657972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR5,Cadherin-related family member 5,22453,81,0.90 [0.55-1.47],0.6755434061849845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDK1,Cyclin-dependent kinase 1,18853,65,1.36 [0.71-2.60],0.3491544814275249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19512,65,0.84 [0.54-1.31],0.4446239503594047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKL5,Cyclin-dependent kinase-like 5,18910,64,1.20 [0.81-1.77],0.360591968285739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKN1A,Cyclin-dependent kinase inhibitor 1,22343,78,1.04 [0.86-1.25],0.7024063875521046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22343,78,1.03 [0.83-1.27],0.8031549883149658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDNF,Cerebral dopamine neurotrophic factor,22343,78,0.98 [0.53-1.80],0.9460475512851736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22479,81,1.14 [0.53-2.43],0.7387098614232401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDSN,Corneodesmosin,22602,80,0.84 [0.54-1.31],0.4416513871011085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22503,79,1.35 [0.58-3.18],0.4855116813021145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19459,66,0.95 [0.71-1.28],0.7371068198516413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19201,67,1.01 [0.73-1.40],0.939168751095003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19459,66,0.85 [0.47-1.54],0.6006181047165002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19201,67,1.34 [0.86-2.08],0.1993166494062174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22392,81,1.04 [0.83-1.30],0.7310762852332199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,21953,75,1.03 [0.67-1.58],0.8868532232028516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21692,74,1.00 [0.73-1.37],0.9957410959046626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19568,68,1.25 [0.74-2.13],0.404407889114116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22040,77,0.97 [0.65-1.44],0.8647140263745521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEBPA,CCAAT/enhancer-binding protein alpha,18976,67,0.87 [0.41-1.84],0.7177531064652583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEBPB,CCAAT/enhancer-binding protein beta,22040,77,1.13 [0.67-1.88],0.6512060813073628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELA2A,Chymotrypsin-like elastase family member 2A,19568,68,0.84 [0.59-1.20],0.3424171815167466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELA3A,Chymotrypsin-like elastase family member 3A,22697,79,1.13 [0.81-1.57],0.475631416228807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19150,68,0.93 [0.43-2.03],0.8581787362436225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEMIP2,Cell surface hyaluronidase,18976,67,1.20 [0.65-2.21],0.5516944420363841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEND1,Cell cycle exit and neuronal differentiation protein 1,18910,64,0.92 [0.59-1.44],0.7219398475130443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CENPF,Centromere protein F,19201,67,0.92 [0.60-1.41],0.7085396393722814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CENPJ,Centromere protein J,19201,67,0.81 [0.56-1.17],0.2645394432129076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP112,Centrosomal protein of 112 kDa,18884,64,1.09 [0.65-1.82],0.7414685609166008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP152,Centrosomal protein of 152 kDa,18853,65,1.10 [0.64-1.88],0.7318074260713487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP164,Centrosomal protein of 164 kDa,22021,77,1.27 [1.02-1.57],0.0300870408678505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP170,Centrosomal protein of 170 kDa,19070,67,0.93 [0.68-1.28],0.6566982358940656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP20,Centrosomal protein 20,21953,75,1.15 [0.88-1.50],0.3203072134445776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP290,Centrosomal protein of 290 kDa,19201,67,1.14 [0.76-1.70],0.5302540653162854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP350,Centrosome-associated protein 350,18853,65,1.13 [0.61-2.07],0.6991748279781043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP43,Centrosomal protein 43,21866,76,1.17 [0.87-1.56],0.2986237622482149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP85,Centrosomal protein of 85 kDa,21953,75,1.10 [0.80-1.50],0.5573882620849988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CERT,Ceramide transfer protein,21936,76,1.21 [0.87-1.68],0.2631242922601015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES1,Liver carboxylesterase 1,22529,79,1.37 [1.10-1.71],0.0048085315032306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES2,Cocaine esterase,22343,78,1.12 [0.79-1.59],0.508131097519288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES3,Carboxylesterase 3,22343,78,1.05 [0.79-1.39],0.739227751338819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CETN2,Centrin-2,21936,76,1.03 [0.76-1.39],0.8627431644348748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CETN3,Centrin-3,19459,66,0.99 [0.73-1.35],0.9481678241706925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFB,Complement factor B,19233,69,1.49 [0.73-3.03],0.2739928146115309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFC1,Cryptic protein,21953,75,1.13 [0.72-1.76],0.5958331959413148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFD,Complement factor D,19587,69,1.50 [0.55-4.12],0.4299350940172772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFH,Complement factor H,18437,67,0.81 [0.29-2.27],0.6849381690763701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR2,Complement factor H-related protein 2,19439,69,0.85 [0.58-1.25],0.4015587961069997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR4,Complement factor H-related protein 4,19552,69,0.96 [0.70-1.31],0.7815927799742235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR5,Complement factor H-related protein 5,19304,66,0.95 [0.55-1.65],0.8620623767628417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFI,Complement factor I,19587,69,1.86 [0.58-5.98],0.2996445769274115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFP,Properdin,19587,69,0.82 [0.27-2.54],0.7373735013671155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGA,Glycoprotein hormones alpha chain,22481,80,0.98 [0.71-1.34],0.8806036525065544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19567,68,1.91 [1.02-3.58],0.0421518770167082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGN,Cingulin,19029,66,1.46 [0.95-2.27],0.0869682048846951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGREF1,Cell growth regulator with EF hand domain protein 1,22453,81,1.19 [0.76-1.86],0.4532628843742849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,21953,75,1.49 [1.13-1.96],0.0042656464884611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAD,Chondroadherin,19150,68,0.88 [0.56-1.38],0.5726764962366679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19518,67,1.77 [1.12-2.80],0.0152832483330542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD6,MICOS complex subunit MIC25,19460,68,1.69 [0.91-3.15],0.0954055598339151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHEK2,Serine/threonine-protein kinase Chk2,22040,77,1.13 [0.61-2.07],0.6973632929048729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHGA,Chromogranin-A,19568,68,1.24 [1.01-1.53],0.0370503070803386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHGB,Secretogranin-1,22571,81,1.00 [0.62-1.60],0.9979139313685368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHI3L1,Chitinase-3-like protein 1,22004,76,1.03 [0.81-1.31],0.8194544031653215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHIT1,Chitotriosidase-1,22556,79,1.27 [1.05-1.54],0.014045252981178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHL1,Neural cell adhesion molecule L1-like protein,22539,80,1.03 [0.54-1.96],0.9380905022751546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHM,Rab proteins geranylgeranyltransferase component A 1,19029,66,0.96 [0.65-1.42],0.8342619492050867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHMP1A,Charged multivesicular body protein 1a,22257,80,1.11 [0.86-1.44],0.4058899605320556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHMP6,Charged multivesicular body protein 6,19554,67,1.12 [0.74-1.70],0.5858085556731063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHP1,Calcineurin B homologous protein 1,18910,64,0.96 [0.68-1.36],0.8085949825626855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRDL1,Chordin-like protein 1,22511,81,1.36 [0.74-2.51],0.3179437476235434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRDL2,Chordin-like protein 2,22453,81,0.96 [0.63-1.45],0.832266824287313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRM1,Muscarinic acetylcholine receptor M1,19029,66,0.64 [0.30-1.36],0.2443637393868182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIAPIN1,Anamorsin,22542,79,1.24 [0.90-1.70],0.182507484428932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CILP,Cartilage intermediate layer protein 1,19568,68,0.91 [0.60-1.39],0.6644093214769304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CINP,Cyclin-dependent kinase 2-interacting protein,19201,67,0.95 [0.56-1.63],0.8631187505113325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIRBP,Cold-inducible RNA-binding protein,19459,66,1.04 [0.81-1.33],0.7678055747179144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIT,Citron Rho-interacting kinase,19029,66,0.92 [0.54-1.57],0.7635982614008308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKAP4,Cytoskeleton-associated protein 4,22570,79,1.46 [0.77-2.76],0.2508728862575757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKB,Creatine kinase B-type,19568,68,1.02 [0.69-1.52],0.9167667194220658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22381,81,1.36 [1.01-1.84],0.0417087380083088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLASP1,CLIP-associating protein 1,18853,65,0.85 [0.59-1.23],0.3920965823148329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLC,Galectin-10,22414,81,0.87 [0.64-1.18],0.362876046496851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC10A,C-type lectin domain family 10 member A,22257,80,1.17 [0.68-2.03],0.5665893911312765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC11A,C-type lectin domain family 11 member A,22446,80,1.43 [0.95-2.14],0.0852066774375779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC12A,C-type lectin domain family 12 member A,18976,67,0.83 [0.25-2.75],0.7603868430384232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC14A,C-type lectin domain family 14 member A,22481,80,1.29 [0.72-2.34],0.3918581617379677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC1A,C-type lectin domain family 1 member A,22040,77,1.15 [0.64-2.08],0.6305728856864166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC1B,C-type lectin domain family 1 member B,22637,81,1.18 [0.96-1.44],0.1170250794839062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC2L,C-type lectin domain family 2 member L,19029,66,0.82 [0.47-1.45],0.5012009961164248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC3B,Tetranectin,19116,69,0.55 [0.18-1.66],0.2863075570440258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4A,C-type lectin domain family 4 member A,22392,81,0.61 [0.37-1.03],0.0651493660889741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4C,C-type lectin domain family 4 member C,22392,81,0.87 [0.58-1.31],0.5112801575959027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4D,C-type lectin domain family 4 member D,22392,81,1.06 [0.78-1.43],0.7311956791706846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4G,C-type lectin domain family 4 member G,22392,81,1.53 [0.85-2.74],0.1557089494470563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4M,C-type lectin domain family 4 member M,19532,68,0.76 [0.47-1.22],0.2545441399414119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC5A,C-type lectin domain family 5 member A,22389,81,0.86 [0.45-1.66],0.6565829305711819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC6A,C-type lectin domain family 6 member A,21953,75,1.38 [0.92-2.07],0.117712077267678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC7A,C-type lectin domain family 7 member A,22669,80,1.11 [0.79-1.58],0.5454037174185876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLGN,Calmegin,19029,66,1.36 [0.89-2.09],0.1534598732503367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLIC5,Chloride intracellular channel protein 5,19029,66,1.01 [0.49-2.12],0.9692811148937468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLINT1,Clathrin interactor 1,18853,65,0.90 [0.51-1.58],0.7164534617566561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLIP2,CAP-Gly domain-containing linker protein 2,22392,81,1.07 [0.89-1.27],0.4759324707490519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLMP,CXADR-like membrane protein,22632,81,0.66 [0.27-1.63],0.3678393569814705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLNS1A,Methylosome subunit pICln,19029,66,1.06 [0.53-2.11],0.8702350610298526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22222,80,1.08 [0.88-1.33],0.461903275827389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLPS,Colipase,22438,80,1.08 [0.82-1.42],0.579631716780995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSPN,Claspin,21901,76,0.85 [0.45-1.63],0.6317915396979485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN1,Calsyntenin-1,21936,76,1.18 [0.84-1.66],0.3394175662055798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN2,Calsyntenin-2,22669,80,1.27 [0.79-2.04],0.3243055673539018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN3,Calsyntenin-3,19518,67,1.31 [0.62-2.75],0.4821596185305739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLTA,Clathrin light chain A,22040,77,1.49 [1.06-2.10],0.021609838186217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLU,Clusterin,19587,69,1.44 [0.85-2.44],0.1780521861945797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLUL1,Clusterin-like protein 1,22417,81,0.96 [0.62-1.48],0.8474791831819891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CMC1,COX assembly mitochondrial protein homolog,19554,67,1.05 [0.82-1.36],0.6878859949071313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CMIP,C-Maf-inducing protein,19460,68,1.10 [0.84-1.46],0.4880141711715886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNDP1,Beta-Ala-His dipeptidase,22574,80,1.35 [0.86-2.11],0.1917698481842405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNGB3,Cyclic nucleotide-gated cation channel beta-3,18910,64,1.15 [0.79-1.67],0.4586269227979965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19035,67,1.02 [0.76-1.37],0.9047769999523918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNPY2,Protein canopy homolog 2,22040,77,1.11 [0.83-1.49],0.475048981442143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNPY4,Protein canopy homolog 4,22343,78,1.09 [0.84-1.43],0.5154298821379915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNST,Consortin,22453,81,1.12 [0.93-1.34],0.2242287587033924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTF,Ciliary neurotrophic factor,18910,64,1.65 [0.87-3.11],0.1228956973884538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN1,Contactin-1,22732,79,0.79 [0.39-1.58],0.5051751237509916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN2,Contactin-2,22632,81,1.11 [0.72-1.72],0.6344555689196323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN3,Contactin-3,22481,80,0.92 [0.49-1.71],0.7847224964407863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN4,Contactin-4,22481,80,0.90 [0.39-2.05],0.7954524360766209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN5,Contactin-5,22499,81,0.72 [0.43-1.23],0.2292567400625236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTNAP2,Contactin-associated protein-like 2,22392,81,2.10 [1.40-3.15],0.0003361353480245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTNAP4,Contactin-associated protein-like 4,19029,66,0.87 [0.65-1.15],0.3199555213473778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COCH,Cochlin,19554,67,1.47 [0.92-2.34],0.1057265428871789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL15A1,Collagen alpha-1(XV) chain,19568,68,1.11 [0.48-2.58],0.8079418505400726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL18A1,Collagen alpha-1(XVIII) chain,22572,78,3.01 [1.34-6.75],0.0074079409573359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL1A1,Collagen alpha-1(I) chain,22732,79,1.15 [0.52-2.52],0.7304526462183274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL24A1,Collagen alpha-1(XXIV) chain,19459,66,1.25 [0.81-1.91],0.308081765912954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL28A1,Collagen alpha-1(XXVIII) chain,19029,66,1.03 [0.76-1.40],0.8374318887648238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL2A1,Collagen alpha-1(II) chain,19070,67,1.07 [0.80-1.44],0.6444571408994466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL3A1,Collagen alpha-1(III) chain,19568,68,2.69 [1.09-6.64],0.0318028095571155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL4A1,Collagen alpha-1(IV) chain,22453,81,1.56 [0.96-2.52],0.0711326990857286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL4A4,Collagen alpha-4(IV) chain,19171,67,0.74 [0.51-1.07],0.1094748144907432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL5A1,Collagen alpha-1(V) chain,19150,68,1.96 [1.18-3.25],0.0094202342027094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL6A3,Collagen alpha-3(VI) chain,22732,79,1.43 [0.85-2.39],0.177905200842395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL9A1,Collagen alpha-1(IX) chain,22392,81,1.11 [0.74-1.66],0.6080256498641472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL9A2,Collagen alpha-2(IX) chain,19201,67,0.67 [0.36-1.27],0.2244256069339567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COLEC12,Collectin-12,22445,81,1.60 [0.80-3.19],0.1861666376392782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMMD1,COMM domain-containing protein 1,19070,67,0.99 [0.67-1.46],0.9573529550012888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMMD9,COMM domain-containing protein 9,19460,68,0.98 [0.55-1.76],0.9489049865226988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMP,Cartilage oligomeric matrix protein,22230,80,1.77 [0.98-3.18],0.0575022490422351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMT,Catechol O-methyltransferase,21811,77,1.14 [0.89-1.46],0.2869438670057079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COPB2,Coatomer subunit beta',18884,64,0.90 [0.51-1.59],0.7123919350664566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COPE,Coatomer subunit epsilon,21936,76,0.90 [0.57-1.42],0.6539401948478937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19070,67,1.30 [0.80-2.12],0.2893024440696491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CORO1A,Coronin-1A,21992,76,1.03 [0.82-1.28],0.8231742531505405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CORO6,Coronin-6,18910,64,1.22 [0.67-2.25],0.5175384183200911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22343,78,1.28 [0.98-1.66],0.0720473310161405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COX6B1,Cytochrome c oxidase subunit 6B1,19554,67,1.30 [0.65-2.61],0.4549320148291594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA1,Carboxypeptidase A1,22732,79,1.02 [0.74-1.39],0.9244701231561664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA2,Carboxypeptidase A2,22570,80,1.03 [0.77-1.38],0.8310208219119923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA4,Carboxypeptidase A4,18768,68,0.85 [0.50-1.46],0.5581476405026214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPB1,Carboxypeptidase B,22732,79,1.07 [0.78-1.46],0.6952852564247503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPB2,Carboxypeptidase B2,19555,69,0.58 [0.21-1.62],0.3015900975097813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPE,Carboxypeptidase E,22440,80,0.83 [0.51-1.35],0.4467471439512324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPLX2,Complexin-2,18853,65,0.88 [0.40-1.91],0.7384768765669767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPM,Carboxypeptidase M,22518,81,1.16 [0.66-2.02],0.6110616269771516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",18976,67,1.43 [0.72-2.84],0.3073357137957663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPPED1,Serine/threonine-protein phosphatase CPPED1,22637,81,1.01 [0.75-1.37],0.9408664867453042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPQ,Carboxypeptidase Q,19529,68,1.47 [0.77-2.82],0.2389098429808632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPTP,Ceramide-1-phosphate transfer protein,18884,64,1.28 [0.73-2.23],0.3824299648475971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPVL,Probable serine carboxypeptidase CPVL,22600,81,1.49 [0.90-2.46],0.1191646083985621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPXM1,Probable carboxypeptidase X1,22542,79,1.25 [0.95-1.65],0.1071038114150508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPXM2,Inactive carboxypeptidase-like protein X2,19554,67,1.90 [0.88-4.12],0.1024334558666316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR1,Complement receptor type 1,19493,68,2.15 [1.15-4.01],0.016600529834417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR2,Complement receptor type 2,22574,80,1.54 [1.03-2.30],0.0350145186260135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,21953,75,1.07 [0.84-1.35],0.591103434918426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRADD,Death domain-containing protein CRADD,22222,80,1.04 [0.80-1.35],0.7863327073156889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREB3,Cyclic AMP-responsive element-binding protein 3,18853,65,1.52 [1.13-2.04],0.0060562091909588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREBZF,CREB/ATF bZIP transcription factor,18853,65,1.71 [0.79-3.71],0.1762366324947288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREG1,Protein CREG1,22189,79,1.18 [0.72-1.92],0.5105500015016363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRELD1,Protein disulfide isomerase CRELD1,19150,68,1.75 [0.95-3.23],0.0714454216109857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRELD2,Protein disulfide isomerase CRELD2,22511,81,1.35 [0.93-1.96],0.1102573943984783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRH,Corticoliberin,21914,75,0.70 [0.54-0.90],0.005500072213328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRHBP,Corticotropin-releasing factor-binding protein,22445,81,1.22 [0.61-2.46],0.5748799845159356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRHR1,Corticotropin-releasing factor receptor 1,22040,77,1.02 [0.74-1.41],0.8988598977394888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIM1,Cysteine-rich motor neuron 1 protein,22549,81,2.72 [1.10-6.74],0.0303732631360091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIP2,Cysteine-rich protein 2,22257,80,1.71 [1.19-2.46],0.0036732937144122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRISP2,Cysteine-rich secretory protein 2,22632,81,1.40 [0.99-1.99],0.0563649501712158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRISP3,Cysteine-rich secretory protein 3,19395,67,1.12 [0.48-2.62],0.79024986519339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRKL,Crk-like protein,22481,81,1.08 [0.89-1.30],0.4380372753661691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRLF1,Cytokine receptor-like factor 1,22549,81,1.75 [0.80-3.84],0.1618033919193913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRNN,Cornulin,21835,80,0.69 [0.53-0.90],0.0059953910417183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAC1,Cartilage acidic protein 1,22732,79,0.91 [0.47-1.76],0.7826941086236865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAM,Cytotoxic and regulatory T-cell molecule,22257,80,1.37 [0.94-2.01],0.1059475721871619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAP,Cartilage-associated protein,19029,66,0.49 [0.25-0.96],0.0370616589737662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRX,Cone-rod homeobox protein,22040,77,0.77 [0.59-1.00],0.05004718026535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYBB1,Beta-crystallin B1,19554,67,0.93 [0.65-1.35],0.7186745126580693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYBB2,Beta-crystallin B2,19518,67,1.04 [0.80-1.36],0.7649807773004127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYGD,Gamma-crystallin D,19518,67,0.84 [0.66-1.07],0.1658630408894915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYM,Ketimine reductase mu-crystallin,18910,64,0.89 [0.62-1.26],0.4995201046702563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYZL1,Quinone oxidoreductase-like protein 1,19070,67,0.95 [0.73-1.23],0.7076715034824317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSDE1,Cold shock domain-containing protein E1,18884,64,0.85 [0.67-1.09],0.1987445106885521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1,Macrophage colony-stimulating factor 1,22549,81,1.26 [0.62-2.55],0.5177313808231008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1R,Macrophage colony-stimulating factor 1 receptor,19567,68,2.66 [1.63-4.34],8.828790875869685e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2,Granulocyte-macrophage colony-stimulating factor,18884,64,1.13 [0.59-2.15],0.7163962423738903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22257,80,1.23 [0.91-1.65],0.1800619676641504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2RB,Cytokine receptor common subunit beta,18976,67,0.68 [0.40-1.16],0.1543202330933169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF3,Granulocyte colony-stimulating factor,22021,77,1.11 [0.74-1.67],0.6156966053737298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF3R,Granulocyte colony-stimulating factor receptor,18976,67,0.74 [0.33-1.68],0.4754226698669637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSH1,Chorionic somatomammotropin hormone 1,19567,68,1.36 [0.63-2.96],0.4355143295697701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSNK1D,Casein kinase I isoform delta,18976,67,1.07 [0.74-1.55],0.7216404408580193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSNK2A1,Casein kinase II subunit alpha,19512,65,0.70 [0.41-1.20],0.1934313432562658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG4,Chondroitin sulfate proteoglycan 4,19568,68,2.95 [1.52-5.73],0.00135873122925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG5,Chondroitin sulfate proteoglycan 5,18910,64,1.14 [0.73-1.78],0.5623697244059941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSRP3,Cysteine and glycine-rich protein 3,18884,64,1.18 [0.96-1.46],0.1210092213882838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST1,Cystatin-SN,17022,63,1.04 [0.82-1.31],0.7683006412032332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST3,Cystatin-C,22537,80,2.10 [1.15-3.83],0.0156376823961298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST5,Cystatin-D,22026,78,0.88 [0.62-1.27],0.5033881503344426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST6,Cystatin-M,21849,77,0.90 [0.60-1.36],0.6225310084097535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST7,Cystatin-F,22483,81,1.11 [0.93-1.33],0.2445325425281799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSTB,Cystatin-B,22152,77,1.38 [0.88-2.17],0.1624116695217096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTAG1A_CTAG1B,Cancer/testis antigen 1,19169,67,1.11 [0.70-1.76],0.6475107599162551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTBS,Di-N-acetylchitobiase,19259,66,0.83 [0.35-1.98],0.6776095532641917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTF1,Cardiotrophin-1,22040,77,1.08 [0.85-1.37],0.5146064149529985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTHRC1,Collagen triple helix repeat-containing protein 1,19568,68,0.97 [0.43-2.18],0.9447208427524132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTLA4,Cytotoxic T-lymphocyte protein 4,19568,68,1.47 [0.81-2.69],0.2066162006803036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTNNA1,Catenin alpha-1,18910,64,1.41 [0.90-2.22],0.1365979001214951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRB1,Chymotrypsinogen B,22481,80,0.95 [0.67-1.33],0.7462949681194645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRC,Chymotrypsin-C,22447,81,1.00 [0.74-1.35],0.9866119199164451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRL,Chymotrypsin-like protease CTRL-1,19518,67,1.01 [0.73-1.41],0.934534288461194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSB,Cathepsin B,22500,78,1.07 [0.74-1.55],0.7110240254853302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSC,Dipeptidyl peptidase 1,22401,80,1.38 [0.90-2.11],0.137420180759605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSD,Cathepsin D,21050,71,1.29 [0.81-2.06],0.2793967428416517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSE,Cathepsin E,19150,68,1.25 [0.81-1.94],0.3121825220548647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSF,Cathepsin F,22542,79,0.69 [0.42-1.15],0.155537015551628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSH,Pro-cathepsin H,21959,76,0.91 [0.69-1.20],0.5054357580030022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSL,Cathepsin L1,22453,81,2.10 [0.99-4.44],0.0533164194624697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSO,Cathepsin O,22669,80,2.35 [1.33-4.13],0.0030849479539447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSS,Cathepsin S,17556,65,1.16 [0.42-3.16],0.773710140435558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSV,Cathepsin L2,22557,81,0.94 [0.59-1.48],0.7860312276521059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSZ,Cathepsin Z,22512,80,2.15 [1.19-3.88],0.0112667637078076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CUZD1,CUB and zona pellucida-like domain-containing protein 1,19029,66,1.09 [0.62-1.90],0.7684449084192386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CWC15,Spliceosome-associated protein CWC15 homolog,19341,66,0.94 [0.61-1.44],0.7628433418468576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CX3CL1,Fractalkine,22257,80,1.25 [0.70-2.23],0.4436475121482739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXADR,Coxsackievirus and adenovirus receptor,22392,81,1.14 [0.78-1.66],0.4956198683597271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL1,Growth-regulated alpha protein,22410,81,0.91 [0.73-1.12],0.3772197589451319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL10,C-X-C motif chemokine 10,22549,81,1.30 [1.01-1.69],0.0445295716682042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL11,C-X-C motif chemokine 11,22637,81,1.17 [0.94-1.45],0.167295939100243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL12,Stromal cell-derived factor 1,22021,77,1.26 [0.77-2.06],0.3586340038749529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL13,C-X-C motif chemokine 13,22637,81,1.19 [0.92-1.52],0.1811501317642052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL14,C-X-C motif chemokine 14,22021,77,1.12 [0.81-1.54],0.5066200487965566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL16,C-X-C motif chemokine 16,22703,79,0.78 [0.33-1.80],0.5527660287367198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL17,C-X-C motif chemokine 17,22669,80,1.38 [0.89-2.13],0.1468654572838063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL3,C-X-C motif chemokine 3,22445,81,1.00 [0.81-1.23],0.9892899198182749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL5,C-X-C motif chemokine 5,22384,80,1.10 [0.93-1.31],0.2512866934850163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL6,C-X-C motif chemokine 6,22669,80,1.18 [0.92-1.52],0.1938395548686356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL8,Interleukin-8,22285,81,1.02 [0.78-1.35],0.8636111896943911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL9,C-X-C motif chemokine 9,22549,81,1.16 [0.88-1.53],0.2976314700936077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5A,Cytochrome b5,18853,65,1.48 [1.23-1.78],3.6787624201203846e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5R2,NADH-cytochrome b5 reductase 2,19257,66,0.92 [0.61-1.39],0.6953550445855546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",18884,64,1.03 [0.79-1.36],0.8150210717290813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYTH3,Cytohesin-3,18853,65,0.97 [0.69-1.36],0.8402949353172757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYTL1,Cytokine-like protein 1,19568,68,1.02 [0.41-2.58],0.9604068401579012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAAM1,Disheveled-associated activator of morphogenesis 1,19150,68,1.12 [0.85-1.48],0.4201801681490823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAB2,Disabled homolog 2,22632,81,1.08 [0.90-1.29],0.418533438218208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAG1,Dystroglycan,22549,81,1.24 [0.82-1.89],0.310852335601249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAND5,DAN domain family member 5,18976,67,0.84 [0.55-1.30],0.4415371328862602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAPK2,Death-associated protein kinase 2,18976,67,0.84 [0.53-1.34],0.4622767637481745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22392,81,1.03 [0.87-1.21],0.7535169207548745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DARS1,"Aspartate--tRNA ligase, cytoplasmic",22222,80,1.10 [0.84-1.45],0.4925053489438897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBH,Dopamine beta-hydroxylase,19522,68,1.03 [0.83-1.27],0.8087598359039803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBI,Acyl-CoA-binding protein,22382,80,1.15 [0.90-1.49],0.2682410328915506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBN1,Drebrin,18976,67,0.96 [0.59-1.56],0.8727359506791232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBNL,Drebrin-like protein,22549,81,1.07 [0.86-1.32],0.5570091914861119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22542,79,1.80 [1.03-3.14],0.0391741592350568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCC,Netrin receptor DCC,19029,66,0.81 [0.25-2.55],0.7139781331048205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCDC2C,Doublecortin domain-containing protein 2C,18853,65,1.29 [0.96-1.74],0.0943134553665586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCLRE1C,Protein artemis,18853,65,0.75 [0.33-1.68],0.4811958658198811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCN,Decorin,22040,77,1.24 [0.54-2.86],0.6172966244740836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTD,Deoxycytidylate deaminase,19150,68,1.05 [0.82-1.35],0.6737127314493048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN1,Dynactin subunit 1,22632,81,1.18 [0.87-1.59],0.2872145964667748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN2,Dynactin subunit 2,22343,78,0.91 [0.73-1.13],0.3930808564165635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN6,Dynactin subunit 6,21936,76,1.11 [0.86-1.44],0.4116517082769946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTPP1,dCTP pyrophosphatase 1,22453,81,1.82 [1.00-3.31],0.0488378378460098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCUN1D1,DCN1-like protein 1,18910,64,1.02 [0.74-1.41],0.8841861075065018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCUN1D2,DCN1-like protein 2,18853,65,1.15 [0.89-1.49],0.296155186763078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCXR,L-xylulose reductase,22542,79,1.58 [1.12-2.24],0.0100453543902726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDA1,DET1- and DDB1-associated protein 1,18884,64,0.83 [0.42-1.61],0.5766958174880773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22343,78,1.26 [0.82-1.95],0.2875586864936369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDC,Aromatic-L-amino-acid decarboxylase,22410,81,1.37 [0.92-2.04],0.121864439175069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDHD2,Phospholipase DDHD2,19512,65,0.96 [0.66-1.38],0.809050471848483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDI2,Protein DDI1 homolog 2,19150,68,1.04 [0.78-1.39],0.7720782493745109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDR1,Epithelial discoidin domain-containing receptor 1,22637,81,1.39 [0.60-3.23],0.44295043762922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDT,D-dopachrome decarboxylase,19568,68,1.08 [0.63-1.83],0.7883117157236024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX1,ATP-dependent RNA helicase DDX1,19459,66,0.89 [0.53-1.49],0.662071894109018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX25,ATP-dependent RNA helicase DDX25,19029,66,0.99 [0.52-1.87],0.9680411359029444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX39A,ATP-dependent RNA helicase DDX39A,18976,67,1.29 [0.54-3.07],0.5703503962510345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX4,Probable ATP-dependent RNA helicase DDX4,18976,67,1.13 [0.75-1.69],0.5574395559261753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX53,Probable ATP-dependent RNA helicase DDX53,19029,66,0.59 [0.30-1.18],0.1356437153621262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX58,Antiviral innate immune response receptor RIG-I,21953,75,1.27 [0.94-1.71],0.1233536972772957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22392,81,1.07 [0.88-1.32],0.4898799434407078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFA1_DEFA1B,Neutrophil defensin 1,22022,78,1.08 [0.76-1.53],0.6845204333725199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB103A_DEFB103B,Beta-defensin 103,18818,66,0.90 [0.49-1.65],0.724760447823082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB104A_DEFB104B,Beta-defensin 104,18910,64,1.06 [0.69-1.62],0.8020136183383069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB116,Beta-defensin 116,18910,64,1.00 [0.72-1.38],0.9850069010890568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB118,Beta-defensin 118,18910,64,1.02 [0.67-1.55],0.9177949531687576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB4A_DEFB4B,Beta-defensin 4A,22151,78,1.01 [0.89-1.16],0.8523757350044165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DENND2B,DENN domain-containing protein 2B,18884,64,0.93 [0.55-1.58],0.7974456862472854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DENR,Density-regulated protein,18976,67,0.93 [0.60-1.43],0.7416773734607991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DFFA,DNA fragmentation factor subunit alpha,22669,80,1.14 [0.85-1.52],0.3728228653931689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGCR6,Protein DGCR6,18910,64,1.32 [0.86-2.04],0.2016360582730756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGKA,Diacylglycerol kinase alpha,18976,67,1.04 [0.67-1.60],0.8712178171241689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGKZ,Diacylglycerol kinase zeta,22021,77,1.49 [0.87-2.57],0.1453438965750319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHODH,Dihydroorotate dehydrogenase,18884,64,1.00 [0.61-1.66],0.9899961793734828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHPS,Deoxyhypusine synthase,19460,68,1.23 [0.76-2.01],0.3954077056194377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19518,67,1.15 [0.72-1.83],0.5580901428117686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIABLO,"Diablo homolog, mitochondrial",22389,81,1.08 [0.90-1.29],0.4265866367256293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIPK1C,Divergent protein kinase domain 1C,19029,66,0.67 [0.35-1.29],0.2279477673356958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIPK2B,Divergent protein kinase domain 2B,19150,68,1.61 [0.76-3.42],0.2130188174380221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK1,Dickkopf-related protein 1,22637,81,1.31 [0.94-1.83],0.1132799375584684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK3,Dickkopf-related protein 3,22732,79,1.85 [0.98-3.51],0.059438994306874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK4,Dickkopf-related protein 4,22226,80,1.14 [0.75-1.72],0.5475078762307221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKKL1,Dickkopf-like protein 1,22343,78,1.00 [0.80-1.26],0.9771319411977016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLG4,Disks large homolog 4,19518,67,0.92 [0.66-1.30],0.6515317975675513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLGAP5,Disks large-associated protein 5,19512,65,0.82 [0.47-1.44],0.4968569614281125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLK1,Protein delta homolog 1,22732,79,0.92 [0.64-1.31],0.6325993217805661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLL1,Delta-like protein 1,22542,79,1.90 [1.04-3.49],0.0367611316281071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLL4,Delta-like protein 4,19070,67,1.07 [0.86-1.32],0.5661657623039715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DMD,Dystrophin,19070,67,0.95 [0.58-1.56],0.8501380933275032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DMP1,Dentin matrix acidic phosphoprotein 1,19070,67,0.89 [0.61-1.28],0.5243911316646659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA1,DnaJ homolog subfamily A member 1,18853,65,1.14 [0.71-1.83],0.5936326954922246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA2,DnaJ homolog subfamily A member 2,22604,80,1.10 [0.86-1.40],0.4351314538491996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA4,DnaJ homolog subfamily A member 4,19518,67,1.12 [0.82-1.54],0.4751508211374556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB1,DnaJ homolog subfamily B member 1,22343,78,1.11 [0.88-1.39],0.3889051087576951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB14,DnaJ homolog subfamily B member 14,19459,66,1.11 [0.77-1.61],0.5608943055612629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB2,DnaJ homolog subfamily B member 2,19150,68,1.04 [0.68-1.59],0.84741001138223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB6,DnaJ homolog subfamily B member 6,18968,68,1.12 [0.84-1.47],0.4389788939408868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB8,DnaJ homolog subfamily B member 8,22040,77,1.32 [1.01-1.73],0.0397518952911091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC21,DnaJ homolog subfamily C member 21,19518,67,0.79 [0.42-1.52],0.4864381132915436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC6,Putative tyrosine-protein phosphatase auxilin,19070,67,0.95 [0.72-1.27],0.7479006900853558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC9,DnaJ homolog subfamily C member 9,19459,66,1.03 [0.76-1.40],0.852897859349562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNER,Delta and Notch-like epidermal growth factor-related receptor,22404,81,0.70 [0.32-1.53],0.3708239250157708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNLZ,DNL-type zinc finger protein,18910,64,0.98 [0.74-1.29],0.8735363696809417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNM1,Dynamin-1,19459,66,1.06 [0.86-1.30],0.5985563152014591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNM3,Dynamin-3,19512,65,0.88 [0.56-1.38],0.5673651826068962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNMBP,Dynamin-binding protein,22257,80,1.14 [0.83-1.56],0.4227181558341267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNPEP,Aspartyl aminopeptidase,19518,67,1.16 [0.76-1.77],0.4979165817403284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22519,81,1.35 [0.93-1.95],0.1127324152818532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOC2B,Double C2-like domain-containing protein beta,19029,66,0.72 [0.33-1.57],0.4077338513496662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOCK9,Dedicator of cytokinesis protein 9,18910,64,1.04 [0.85-1.26],0.7169886208718541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOK1,Docking protein 1,19518,67,1.05 [0.88-1.25],0.5961718283885022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOK2,Docking protein 2,22453,81,1.03 [0.88-1.21],0.7212035579554845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPEP1,Dipeptidase 1,22222,80,0.91 [0.61-1.35],0.6348778062482066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPEP2,Dipeptidase 2,22343,78,0.80 [0.41-1.57],0.5159046253605354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP10,Inactive dipeptidyl peptidase 10,22392,81,1.30 [0.79-2.14],0.2959347145613796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP4,Dipeptidyl peptidase 4,22075,77,1.75 [0.85-3.61],0.1273169751283625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP6,Dipeptidyl aminopeptidase-like protein 6,22343,78,1.91 [1.08-3.39],0.0270680274101745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP7,Dipeptidyl peptidase 2,22284,81,1.19 [0.87-1.64],0.2750126547427953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPT,Dermatopontin,22732,79,1.01 [0.46-2.20],0.98742610342803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPY30,Protein dpy-30 homolog,22551,81,1.50 [1.14-1.97],0.0034120313132817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DRAXIN,Draxin,22257,80,1.08 [0.69-1.71],0.7286955531049009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DRG2,Developmentally-regulated GTP-binding protein 2,22343,78,0.91 [0.63-1.30],0.5946190967755833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSC2,Desmocollin-2,22255,78,1.29 [0.75-2.23],0.3603340777922438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSCAM,Down syndrome cell adhesion molecule,19512,65,2.15 [1.15-4.01],0.0162285246883473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG2,Desmoglein-2,22481,80,0.86 [0.42-1.77],0.6915613072793912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG3,Desmoglein-3,22548,81,0.78 [0.44-1.37],0.3852048359333132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG4,Desmoglein-4,22276,78,0.97 [0.66-1.44],0.8787079583317545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTD1,D-aminoacyl-tRNA deacylase 1,19150,68,1.05 [0.80-1.38],0.7203460877926515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTNB,Dystrobrevin beta,19418,68,1.52 [0.92-2.54],0.1046659343421716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTX2,Probable E3 ubiquitin-protein ligase DTX2,19029,66,0.99 [0.66-1.46],0.9441106031259952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTX3,Probable E3 ubiquitin-protein ligase DTX3,22343,78,1.65 [0.79-3.47],0.1863696855755305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTYMK,Thymidylate kinase,19554,67,1.01 [0.72-1.42],0.949686399139599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUOX2,Dual oxidase 2,22040,77,1.23 [0.98-1.53],0.0735223821769458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP13,Dual specificity protein phosphatase 13 isoform A,19460,68,1.54 [0.97-2.45],0.0653850888822134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP29,Dual specificity phosphatase 29,19029,66,1.11 [0.80-1.54],0.5286265699055609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP3,Dual specificity protein phosphatase 3,21936,76,1.05 [0.84-1.32],0.6462955408593491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19459,66,1.12 [0.89-1.40],0.3347385000687912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DXO,Decapping and exoribonuclease protein,19518,67,1.09 [0.65-1.83],0.7367071338276923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19460,68,0.92 [0.54-1.58],0.7694795605920223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNLT1,Dynein light chain Tctex-type 1,19029,66,0.88 [0.64-1.21],0.4247415906204067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNLT3,Dynein light chain Tctex-type 3,19460,68,0.94 [0.55-1.61],0.8312464087923197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22257,80,1.06 [0.86-1.31],0.5764199704319525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EBI3_IL27,Interleukin-27,22595,81,1.79 [0.96-3.35],0.0660484126412941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECE1,Endothelin-converting enzyme 1,21936,76,1.31 [0.77-2.24],0.3169679140854164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19554,67,1.44 [1.11-1.89],0.0070607525815258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19070,67,1.16 [0.92-1.48],0.2161859588035154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECI2,Enoyl-CoA delta isomerase 2,18884,64,1.13 [0.79-1.62],0.51275571815431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECM1,Extracellular matrix protein 1,19070,66,0.78 [0.43-1.44],0.4336860351213267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECSCR,Endothelial cell-specific chemotaxis regulator,18910,64,0.83 [0.47-1.46],0.509654033546413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDA2R,Tumor necrosis factor receptor superfamily member 27,22632,81,1.48 [0.91-2.40],0.1102280678682777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDAR,Tumor necrosis factor receptor superfamily member EDAR,22392,81,0.95 [0.77-1.19],0.6673669562445214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDDM3B,Epididymal secretory protein E3-beta,19460,68,1.29 [0.85-1.95],0.2341819255972135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,18884,64,1.11 [0.60-2.04],0.7404842043049338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDF1,Endothelial differentiation-related factor 1,19512,65,0.93 [0.64-1.34],0.6875939434053024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22040,77,1.58 [0.92-2.71],0.0956599967988389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDN1,Endothelin-1,19070,67,1.18 [0.54-2.60],0.6763501179495239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDNRB,Endothelin receptor type B,18976,67,1.16 [0.73-1.86],0.5351922956503017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EEF1D,Elongation factor 1-delta,19554,67,1.06 [0.83-1.37],0.6363736279166478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFCAB14,EF-hand calcium-binding domain-containing protein 14,19459,66,1.31 [0.67-2.59],0.4299966403123562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFCAB2,Dynein regulatory complex protein 8,19201,67,0.89 [0.45-1.78],0.7430001229205632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22545,80,2.03 [1.13-3.68],0.0187240147799813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFHD1,EF-hand domain-containing protein D1,19512,65,1.06 [0.55-2.06],0.8581174753078615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNA1,Ephrin-A1,22449,80,1.51 [0.80-2.87],0.2034283434700438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNA4,Ephrin-A4,22223,80,1.23 [0.68-2.25],0.4919321162048453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNB2,Ephrin-B2,19029,66,1.30 [0.93-1.81],0.1300644886869526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGF,Pro-epidermal growth factor,22413,81,1.07 [0.88-1.29],0.4905960041236534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFL7,Epidermal growth factor-like protein 7,21953,75,1.56 [1.00-2.45],0.0512108858625017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFLAM,Pikachurin,19459,66,2.10 [1.23-3.60],0.006874029329585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFR,Epidermal growth factor receptor,22732,79,0.43 [0.13-1.42],0.1659303546064507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGLN1,Egl nine homolog 1,22392,81,1.18 [0.89-1.58],0.2546933891374335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EHBP1,EH domain-binding protein 1,19554,67,1.00 [0.73-1.37],0.9962487566513883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EHD3,EH domain-containing protein 3,19070,67,1.03 [0.85-1.27],0.7398061632091145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19518,67,0.83 [0.51-1.35],0.4527602912418867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19374,66,1.11 [0.90-1.38],0.3173166739080452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,18884,64,1.14 [0.81-1.61],0.4516055858387853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19070,67,0.59 [0.30-1.15],0.1216149158434955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4B,Eukaryotic translation initiation factor 4B,22257,80,1.20 [0.84-1.70],0.3205652729504719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4E,Eukaryotic translation initiation factor 4E,18976,67,1.01 [0.78-1.32],0.9230472522913185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22453,81,1.30 [0.98-1.72],0.0676962149164554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22669,80,1.08 [0.88-1.31],0.474761655256492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19512,65,0.98 [0.68-1.41],0.9071839955797434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF5,Eukaryotic translation initiation factor 5,18884,64,0.72 [0.39-1.35],0.3063267760941446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF5A,Eukaryotic translation initiation factor 5A-1,22021,77,0.82 [0.40-1.68],0.5929176037012922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELAC1,Zinc phosphodiesterase ELAC protein 1,19512,65,0.94 [0.71-1.24],0.6552497819273033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELAVL4,ELAV-like protein 4,18910,64,1.05 [0.79-1.39],0.7268354276354593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELN,Elastin,19554,67,1.69 [0.90-3.19],0.1044320731231143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELOA,Elongin-A,22343,78,1.26 [0.95-1.67],0.1041731018126559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELOB,Elongin-B,18884,64,1.00 [0.53-1.88],0.9945632782761832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENAH,Protein enabled homolog,22021,77,1.41 [0.95-2.09],0.0840255269425946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENDOU,Poly(U)-specific endoribonuclease,18037,63,0.82 [0.52-1.32],0.4178142791729757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENG,Endoglin,22732,79,1.43 [0.45-4.48],0.5426113545003768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO1,Alpha-enolase,22435,79,1.06 [0.82-1.36],0.6620418850842554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO2,Gamma-enolase,22637,81,1.07 [0.79-1.45],0.661998157372748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO3,Beta-enolase,19070,67,1.20 [0.82-1.75],0.3579735418335734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENOPH1,Enolase-phosphatase E1,19460,68,1.05 [0.67-1.62],0.8435598406045036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,18884,64,1.24 [0.53-2.91],0.6127768295549687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPEP,Glutamyl aminopeptidase,18884,64,0.98 [0.57-1.67],0.9279502446047188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22732,79,1.30 [0.63-2.67],0.474614060908969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22549,81,1.08 [0.66-1.76],0.7584329903257779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19070,67,0.73 [0.39-1.39],0.3424435017108572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21701,80,1.04 [0.82-1.31],0.7583843447938083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENSA,Alpha-endosulfine,19460,68,1.37 [0.97-1.93],0.0722364735179508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,21953,75,1.44 [0.92-2.26],0.1139874309144499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22040,77,0.63 [0.26-1.55],0.31905961631373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22040,77,1.26 [0.58-2.73],0.5633725993635382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTR1,Endosome-associated-trafficking regulator 1,19070,67,1.05 [0.70-1.57],0.8274969147824822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EP300,Histone acetyltransferase p300,18976,67,1.31 [0.71-2.40],0.3904350096875361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPB41L5,Band 4.1-like protein 5,19029,66,0.87 [0.57-1.32],0.508525698643254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPCAM,Epithelial cell adhesion molecule,22435,81,1.09 [0.90-1.33],0.3809963794294728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPGN,Epigen,19460,68,1.27 [0.86-1.89],0.2340933035125272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA1,Ephrin type-A receptor 1,22519,81,1.02 [0.56-1.83],0.9597240925670266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA10,Ephrin type-A receptor 10,21936,76,0.92 [0.66-1.29],0.6396789637061939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA2,Ephrin type-A receptor 2,21638,76,0.95 [0.50-1.81],0.8738369261670225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA4,Ephrin type-A receptor 4,19150,68,1.02 [0.46-2.26],0.9614913558566536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHB4,Ephrin type-B receptor 4,22732,79,1.66 [0.80-3.44],0.1715167304997193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHB6,Ephrin type-B receptor 6,22222,80,0.94 [0.51-1.71],0.833863252957842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHX2,Bifunctional epoxide hydrolase 2,22040,77,1.21 [0.93-1.58],0.1586859528312466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPN1,Epsin-1,19201,67,1.21 [0.75-1.95],0.4269180516883626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPO,Erythropoietin,22392,81,1.11 [0.86-1.42],0.4213706065472767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPPK1,Epiplakin,19070,67,0.96 [0.70-1.33],0.8221040102513777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22588,81,1.28 [0.68-2.40],0.4470455384328081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB2,Receptor tyrosine-protein kinase erbB-2,22542,79,1.46 [0.63-3.39],0.3798016132141623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB3,Receptor tyrosine-protein kinase erbB-3,22383,81,0.99 [0.36-2.76],0.9885779005552012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB4,Receptor tyrosine-protein kinase erbB-4,22542,79,1.28 [0.56-2.94],0.5558209821350013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBIN,Erbin,22343,78,1.07 [0.88-1.30],0.5153306313818731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERC2,ERC protein 2,19029,66,0.99 [0.71-1.36],0.9341116028367038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERCC1,DNA excision repair protein ERCC-1,18853,65,1.19 [0.62-2.28],0.6026736381412257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EREG,Proepiregulin,22222,80,1.11 [0.87-1.41],0.3975310621450351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERI1,3'-5' exoribonuclease 1,19201,67,0.89 [0.44-1.80],0.743783145868142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERMAP,Erythroid membrane-associated protein,18976,67,1.75 [1.07-2.86],0.0248295609047449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19460,68,1.13 [0.61-2.10],0.6893236622341319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERP29,Endoplasmic reticulum resident protein 29,19150,68,1.05 [0.86-1.28],0.6465444696121144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERP44,Endoplasmic reticulum resident protein 44,22299,77,1.79 [0.83-3.85],0.1395030226910241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,18884,64,1.02 [0.59-1.77],0.9334647084583536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESAM,Endothelial cell-selective adhesion molecule,22732,79,1.76 [0.98-3.15],0.0577327322194364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESM1,Endothelial cell-specific molecule 1,22445,81,1.67 [0.96-2.92],0.0700283043276269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESPL1,Separin,18853,65,1.17 [0.83-1.65],0.3715552506574967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESR1,Estrogen receptor,18976,67,0.85 [0.51-1.39],0.5128713641496676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESYT2,Extended synaptotagmin-2,19518,67,1.00 [0.75-1.33],0.9890598165005338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVI2B,Protein EVI2B,18853,65,0.98 [0.53-1.81],0.9574935385233632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVI5,Ecotropic viral integration site 5 protein homolog,18976,67,1.13 [0.87-1.47],0.3480274036469141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVPL,Envoplakin,19201,67,0.50 [0.21-1.16],0.1056404937943195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EXOSC10,Exosome component 10,18884,64,0.93 [0.60-1.45],0.7456540738186254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EXTL1,Exostosin-like 1,18884,64,0.99 [0.60-1.64],0.9663112218267434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EZR,Ezrin,22637,81,1.18 [0.53-2.60],0.686596136384881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F10,Coagulation factor X,19567,68,0.66 [0.30-1.47],0.3132518162089792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F11,Coagulation factor XI,19310,68,1.14 [0.54-2.43],0.7308873965186082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F11R,Junctional adhesion molecule A,22481,80,1.32 [0.94-1.86],0.1074338554673837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F12,Coagulation factor XII,19587,69,0.63 [0.38-1.04],0.0725934172788942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F13B,Coagulation factor XIII B chain,19476,69,0.74 [0.30-1.83],0.5161262059388673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F2,Prothrombin,19587,69,0.90 [0.19-4.19],0.8905372302443899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F2R,Proteinase-activated receptor 1,22511,81,1.19 [0.84-1.68],0.3357446193876129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F3,Tissue factor,22497,80,0.70 [0.34-1.47],0.3521560825754424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F7,Coagulation factor VII,22537,80,0.94 [0.50-1.78],0.8512249756420089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F9,Coagulation factor IX,22527,80,3.81 [1.37-10.61],0.0105601618338126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP1,"Fatty acid-binding protein, liver",22445,81,1.25 [1.03-1.52],0.024668762063684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP2,"Fatty acid-binding protein, intestinal",22453,81,1.23 [0.98-1.55],0.0788007911586373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP3,"Fatty acid-binding protein, heart",19554,67,1.44 [0.96-2.15],0.077396695256799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP4,"Fatty acid-binding protein, adipocyte",22732,79,1.27 [0.87-1.86],0.2143998854059104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP5,Fatty acid-binding protein 5,22552,81,1.11 [0.83-1.47],0.4757602590284272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP6,Gastrotropin,22000,76,1.15 [0.83-1.59],0.3993064922373137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP9,Fatty acid-binding protein 9,22392,81,0.90 [0.64-1.28],0.5746550562283442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FADD,FAS-associated death domain protein,22453,81,1.05 [0.81-1.37],0.6858396017892263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM13A,Protein FAM13A,19459,66,1.02 [0.72-1.44],0.9223510932203122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM171A2,Protein FAM171A2,19512,65,1.04 [0.90-1.20],0.5894639144605013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM171B,Protein FAM171B,19460,68,0.85 [0.34-2.12],0.7355225870656691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM172A,Cotranscriptional regulator FAM172A,19070,67,0.88 [0.59-1.30],0.509234304262979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM20A,Pseudokinase FAM20A,19554,67,2.10 [1.09-4.05],0.0269980491689776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3B,Protein FAM3B,22343,78,1.12 [0.64-1.98],0.684212637449576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3C,Protein FAM3C,22410,81,1.36 [0.73-2.56],0.3337917489336277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3D,Protein FAM3D,19459,66,1.37 [1.04-1.80],0.0238867220811646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAP,Prolyl endopeptidase FAP,22732,79,1.14 [0.55-2.37],0.7246845997086053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FARSA,Phenylalanine--tRNA ligase alpha subunit,19029,66,0.84 [0.58-1.22],0.3524954138956251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAS,Tumor necrosis factor receptor superfamily member 6,22666,79,1.30 [0.80-2.10],0.2891176352596633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FASLG,Tumor necrosis factor ligand superfamily member 6,22669,80,1.14 [0.67-1.94],0.6312183005559677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBLN2,Fibulin-2,19568,68,1.55 [0.78-3.06],0.2094222743473473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBN2,Fibrillin-2,19029,66,0.86 [0.58-1.27],0.4419914776134942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBP1,"Fructose-1,6-bisphosphatase 1",22453,81,1.18 [0.91-1.52],0.2166390477823462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19554,67,1.35 [0.99-1.83],0.0559251825311741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCAR,Immunoglobulin alpha Fc receptor,22392,81,1.35 [0.91-1.99],0.1319495076167703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19512,65,0.44 [0.17-1.16],0.0964814690657804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCER2,Low affinity immunoglobulin epsilon Fc receptor,22481,80,0.81 [0.55-1.19],0.2808921405271745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22383,80,1.35 [0.91-1.99],0.1394433512251564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,21953,75,1.23 [0.89-1.70],0.2142149150179421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22501,80,1.39 [0.92-2.10],0.1193309807253155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCN1,Ficolin-1,19522,68,1.48 [0.94-2.35],0.0911538475345115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCN2,Ficolin-2,22386,80,1.37 [0.82-2.28],0.233613518189658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL1,Fc receptor-like protein 1,22453,81,1.11 [0.73-1.69],0.6332940035448693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL2,Fc receptor-like protein 2,22554,79,1.40 [1.00-1.94],0.0478947066275441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL3,Fc receptor-like protein 3,22021,77,1.16 [0.81-1.66],0.4044364147515281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL5,Fc receptor-like protein 5,22481,80,1.17 [0.84-1.63],0.3558676497254859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL6,Fc receptor-like protein 6,22392,81,1.06 [0.80-1.40],0.6859224027830366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRLB,Fc receptor-like B,21953,75,1.27 [1.00-1.62],0.0543350068379357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FDX1,"Adrenodoxin, mitochondrial",18884,64,0.91 [0.60-1.38],0.66659511144721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FDX2,"Ferredoxin-2, mitochondrial",18884,64,0.98 [0.63-1.51],0.9140392218072804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FEN1,Flap endonuclease 1,21953,75,1.24 [0.99-1.56],0.0663092268321141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FES,Tyrosine-protein kinase Fes/Fps,21953,75,0.98 [0.63-1.52],0.9204332456171938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FETUB,Fetuin-B,22527,80,1.89 [0.98-3.64],0.0579028876260772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGA,Fibrinogen alpha chain,19133,69,1.32 [0.63-2.77],0.4669152224447989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19512,65,1.06 [0.79-1.43],0.7005180962873251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF12,Fibroblast growth factor 12,18976,67,0.67 [0.32-1.41],0.2912029346226407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF16,Fibroblast growth factor 16,18976,67,1.19 [0.76-1.86],0.4451089996455303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF19,Fibroblast growth factor 19,22549,81,1.00 [0.78-1.29],0.9929743013940048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF2,Fibroblast growth factor 2,22392,81,1.09 [0.82-1.45],0.5391710856470455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF20,Fibroblast growth factor 20,18976,67,0.79 [0.42-1.47],0.45420110520495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF21,Fibroblast growth factor 21,22595,81,1.09 [0.92-1.28],0.3211817316421813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF23,Fibroblast growth factor 23,22599,81,1.44 [1.08-1.91],0.0119128640019446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF3,Fibroblast growth factor 3,18976,67,1.16 [0.58-2.34],0.6739221766671286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF5,Fibroblast growth factor 5,22021,77,1.30 [0.72-2.35],0.3933759200074026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF6,Fibroblast growth factor 6,18976,67,1.10 [0.65-1.85],0.7173125037797803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF7,Fibroblast growth factor 7,18853,65,1.24 [1.00-1.54],0.0517702131731576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF9,Fibroblast growth factor 9,18823,65,1.33 [0.76-2.34],0.3206415060598193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP1,Fibroblast growth factor-binding protein 1,22542,79,0.52 [0.28-0.94],0.0310875802527016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP2,Fibroblast growth factor-binding protein 2,19568,68,0.79 [0.50-1.26],0.3240220174402031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP3,Fibroblast growth factor-binding protein 3,19518,67,1.18 [0.63-2.23],0.6019982917929484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR2,Fibroblast growth factor receptor 2,22542,79,2.75 [1.19-6.32],0.0175316622999683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR4,Fibroblast growth factor receptor 4,19150,68,0.85 [0.55-1.32],0.4700393693145795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGL1,Fibrinogen-like protein 1,19567,68,1.69 [1.21-2.36],0.0018572986171716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGR,Tyrosine-protein kinase Fgr,21936,76,1.15 [0.86-1.54],0.3617087800524891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FH,"Fumarate hydratase, mitochondrial",18910,64,1.02 [0.76-1.35],0.9182669423841028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FHIP2A,FHF complex subunit HOOK interacting protein 2A,18884,64,0.80 [0.46-1.40],0.4388793695842199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FHIT,Bis(5'-adenosyl)-triphosphatase,21936,76,1.09 [0.82-1.44],0.542433671274414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FIS1,Mitochondrial fission 1 protein,22453,81,1.11 [0.87-1.44],0.4007916831522898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19512,65,1.00 [0.79-1.27],0.9920927313534552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22492,78,1.07 [0.90-1.28],0.4470438188753068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22257,80,1.07 [0.68-1.70],0.7576691204272407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22257,80,1.12 [0.91-1.39],0.2930486637895191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,21901,76,0.73 [0.44-1.21],0.2236439637780468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBPL,FK506-binding protein-like,19459,66,1.05 [0.70-1.56],0.822641643173254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLI1,Friend leukemia integration 1 transcription factor,21953,75,1.07 [0.89-1.29],0.4487772429054357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22257,80,2.58 [1.42-4.69],0.0019201233697926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT1,Vascular endothelial growth factor receptor 1,22306,77,1.44 [0.69-3.04],0.3347950264543321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT3,Receptor-type tyrosine-protein kinase FLT3,21953,75,0.81 [0.41-1.62],0.5536377312544568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT3LG,Fms-related tyrosine kinase 3 ligand,22669,80,1.21 [0.68-2.15],0.524498682971098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT4,Vascular endothelial growth factor receptor 3,22542,79,1.31 [0.72-2.41],0.3794588290222427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FMNL1,Formin-like protein 1,21936,76,1.19 [0.93-1.53],0.1657386552948422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FMR1,Synaptic functional regulator FMR1,21953,75,0.74 [0.41-1.33],0.3136652976267844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FN1,Fibronectin,19587,69,0.48 [0.20-1.14],0.0962484461807022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FNDC1,Fibronectin type III domain-containing protein 1,19518,67,1.18 [0.71-1.96],0.5255794585438751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19460,68,1.17 [0.62-2.23],0.623917238551725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLH1,Glutamate carboxypeptidase 2,18976,67,0.88 [0.65-1.19],0.3936154617432674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR1,Folate receptor alpha,22444,79,1.37 [0.71-2.63],0.3441309661865895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR2,Folate receptor beta,22637,81,1.22 [0.63-2.36],0.5464512060684072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR3,Folate receptor gamma,22471,79,0.99 [0.89-1.10],0.8486848105992904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOS,Proto-oncogene c-Fos,18823,65,1.20 [0.62-2.33],0.5918625804408246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOSB,Protein fosB,21936,76,0.92 [0.53-1.60],0.7717909474308353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXJ3,Forkhead box protein J3,18976,67,0.89 [0.51-1.55],0.6762434465729614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXO1,Forkhead box protein O1,22392,81,1.12 [0.89-1.41],0.3273479196129975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXO3,Forkhead box protein O3,21953,75,0.90 [0.71-1.13],0.362108932987806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRMD4B,FERM domain-containing protein 4B,18884,64,1.10 [0.79-1.54],0.5738386400373086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRMD7,FERM domain-containing protein 7,19029,66,0.63 [0.32-1.23],0.1772331696889293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRZB,Secreted frizzled-related protein 3,22190,80,0.62 [0.30-1.31],0.2093611188126838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSHB,Follitropin subunit beta,19070,67,1.01 [0.65-1.57],0.9601115536166605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FST,Follistatin,22511,81,1.31 [0.90-1.93],0.1596217108210953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSTL1,Follistatin-related protein 1,19070,67,1.32 [0.46-3.75],0.6026022248774365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSTL3,Follistatin-related protein 3,22405,81,1.22 [0.68-2.20],0.5023324656396173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FTCD,Formimidoyltransferase-cyclodeaminase,19476,67,1.32 [1.02-1.70],0.0336013296493605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUCA1,Tissue alpha-L-fucosidase,22610,78,1.34 [1.01-1.77],0.0394174211448681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUOM,Fucose mutarotase,19150,68,1.83 [1.33-2.52],0.0002163910625358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FURIN,Furin,22542,79,1.61 [0.87-2.95],0.1266901853474712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUS,RNA-binding protein FUS,21921,75,1.56 [1.01-2.41],0.044789212071285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19159,66,1.10 [0.78-1.55],0.5834014995462663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22637,81,0.90 [0.60-1.35],0.605930357348186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT8,"Alpha-(1,6)-fucosyltransferase",22257,80,1.16 [0.84-1.61],0.3749225080477586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FXN,"Frataxin, mitochondrial",22632,81,1.17 [0.90-1.52],0.2472965693377115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FXYD5,FXYD domain-containing ion transport regulator 5,22021,77,0.97 [0.71-1.34],0.859314801707704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FYB1,FYN-binding protein 1,22438,80,1.14 [0.92-1.41],0.2372260619502925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD10,Frizzled-10,19029,66,1.09 [0.75-1.58],0.6695148485732219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD8,Frizzled-8,18910,64,1.53 [1.07-2.18],0.0186845571425396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABARAP,Gamma-aminobutyric acid receptor-associated protein,19460,68,1.30 [0.88-1.91],0.1824322380143899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19201,67,0.93 [0.63-1.37],0.7157822517527976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,18910,64,0.83 [0.53-1.28],0.3946571020064023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAD1,Glutamate decarboxylase 1,18853,65,1.49 [0.60-3.68],0.3916186510497318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAD2,Glutamate decarboxylase 2,18976,67,1.03 [0.65-1.65],0.8865428900449426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19201,67,0.89 [0.51-1.55],0.6877621630402143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19070,67,0.78 [0.48-1.25],0.2977513873916128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAGE2A,G antigen 2A,18853,65,1.10 [0.79-1.53],0.5795603131535861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAL,Galanin peptides,22549,81,0.85 [0.62-1.15],0.294177810055751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22343,78,2.44 [1.23-4.83],0.0106117887660373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22632,81,1.30 [0.63-2.69],0.4805444382325992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22021,77,1.33 [0.85-2.09],0.2124734642597694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19554,67,0.70 [0.30-1.63],0.411285870042567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT7,N-acetylgalactosaminyltransferase 7,22343,78,0.89 [0.35-2.30],0.8103395485257785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAMT,Guanidinoacetate N-methyltransferase,18884,64,0.89 [0.44-1.82],0.7542102389255637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18716,67,1.26 [0.59-2.70],0.5567543184168637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GART,Trifunctional purine biosynthetic protein adenosine-3,19512,65,0.76 [0.29-2.01],0.5822627979593568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAS2,Growth arrest-specific protein 2,19201,67,1.27 [0.89-1.79],0.1853194375320595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAS6,Growth arrest-specific protein 6,22601,79,1.31 [0.59-2.88],0.5082626247776628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GASK1A,Golgi-associated kinase 1A,18884,64,1.31 [0.76-2.28],0.3280624089073712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAST,Gastrin,19518,67,1.18 [1.03-1.36],0.0201861077038519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,18853,65,1.94 [0.89-4.22],0.094946713281026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19070,67,1.04 [0.76-1.41],0.8204171481043979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBA,Lysosomal acid glucosylceramidase,19029,66,1.24 [0.82-1.87],0.3147341497225968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP1,Guanylate-binding protein 1,19484,67,1.33 [0.94-1.87],0.1022165338079365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP2,Guanylate-binding protein 2,22021,77,1.18 [0.85-1.62],0.3214840416395704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP4,Guanylate-binding protein 4,21936,76,1.24 [0.84-1.84],0.275319672437137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP6,Guanylate-binding protein 6,18884,64,0.88 [0.49-1.60],0.6826249515591727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GC,Vitamin D-binding protein,19587,69,0.54 [0.22-1.37],0.1974256092988685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCC1,GRIP and coiled-coil domain-containing protein 1,19518,67,1.05 [0.84-1.30],0.6704672455840746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCG,Pro-glucagon,21953,75,1.13 [0.96-1.32],0.1434368349769935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18681,68,1.40 [0.94-2.09],0.0993513707632792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCLM,Glutamate--cysteine ligase regulatory subunit,18884,64,0.78 [0.43-1.41],0.4032117656866375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22343,78,0.89 [0.50-1.59],0.6913601516665482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF15,Growth/differentiation factor 15,22732,79,1.70 [1.18-2.45],0.0042625876733308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF2,Growth/differentiation factor 2,22453,81,0.96 [0.55-1.67],0.8905121009100673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDNF,Glial cell line-derived neurotrophic factor,21936,76,1.70 [1.09-2.67],0.0203548036032318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GET3,ATPase GET3,19554,67,0.88 [0.56-1.39],0.581298462230049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFAP,Glial fibrillary acidic protein,21914,74,1.55 [1.05-2.30],0.0289997227740864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFER,FAD-linked sulfhydryl oxidase ALR,21953,75,1.17 [0.85-1.61],0.3297982958491273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,21953,75,1.03 [0.87-1.21],0.756968481810155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA1,GDNF family receptor alpha-1,22595,81,0.92 [0.47-1.83],0.8215163943177419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA2,GDNF family receptor alpha-2,22343,78,1.09 [0.42-2.79],0.860960572487401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA3,GDNF family receptor alpha-3,22193,80,1.44 [0.73-2.84],0.2990505692582826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRAL,GDNF family receptor alpha-like,18925,66,1.14 [0.79-1.65],0.4894878014530722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGA1,ADP-ribosylation factor-binding protein GGA1,21936,76,0.92 [0.66-1.29],0.6387452810310992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGACT,Gamma-glutamylaminecyclotransferase,19554,67,1.14 [0.82-1.58],0.4291055375820423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGCT,Gamma-glutamylcyclotransferase,19515,67,0.93 [0.57-1.53],0.7763638160755402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGH,Gamma-glutamyl hydrolase,22120,77,1.26 [0.72-2.22],0.423527594076339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT1,Glutathione hydrolase 1 proenzyme,22449,80,1.58 [1.13-2.23],0.0079064435242753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT5,Glutathione hydrolase 5 proenzyme,22257,80,1.61 [0.69-3.72],0.2675332078615971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH1,Somatotropin,22410,81,1.02 [0.91-1.14],0.7522044683931758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH2,Growth hormone variant,21953,75,1.15 [1.04-1.27],0.005601370725654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHR,Growth hormone receptor,19150,68,1.26 [0.55-2.88],0.5911234901741679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHRHR,Growth hormone-releasing hormone receptor,21936,76,0.92 [0.62-1.37],0.6731686379109836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHRL,Appetite-regulating hormone,22453,81,1.13 [0.90-1.43],0.2867644303068851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GID8,Glucose-induced degradation protein 8 homolog,19512,65,0.86 [0.39-1.90],0.7171341638842766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIGYF2,GRB10-interacting GYF protein 2,19512,65,0.94 [0.68-1.30],0.7150107000213515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP7,GTPase IMAP family member 7,19150,68,1.44 [0.81-2.56],0.2159627409230375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP8,GTPase IMAP family member 8,18853,65,1.49 [1.09-2.04],0.012790756441831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIP,Gastric inhibitory polypeptide,19070,67,1.14 [0.77-1.67],0.517046704464376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPC2,PDZ domain-containing protein GIPC2,19518,67,1.96 [1.02-3.78],0.044846396327325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPC3,PDZ domain-containing protein GIPC3,19459,66,1.05 [0.82-1.33],0.7072985324234468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPR,Gastric inhibitory polypeptide receptor,18976,67,1.14 [0.73-1.78],0.5688602968139642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIT1,ARF GTPase-activating protein GIT1,18976,67,1.06 [0.83-1.35],0.6412514963128855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GJA8,Gap junction alpha-8 protein,18853,65,1.10 [0.77-1.55],0.6012913133408417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GKN1,Gastrokine-1,21519,74,0.88 [0.41-1.87],0.7419908681547058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLA,Alpha-galactosidase A,19122,68,1.69 [0.93-3.08],0.0863940032829734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLB1,Beta-galactosidase,22257,80,1.30 [0.82-2.08],0.2692550415541856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLI2,Zinc finger protein GLI2,18976,67,1.07 [0.50-2.27],0.8661150279400646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLO1,Lactoylglutathione lyase,22040,77,1.23 [0.88-1.71],0.2296618937701295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLOD4,Glyoxalase domain-containing protein 4,22415,81,1.30 [0.74-2.27],0.3633862592013197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLP1R,Glucagon-like peptide 1 receptor,18910,64,1.20 [0.68-2.10],0.531757095120887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLRX,Glutaredoxin-1,22303,80,1.13 [0.81-1.58],0.461084797037497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19150,68,1.21 [0.94-1.57],0.1380653723873208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,21936,76,1.17 [0.82-1.66],0.3980465708156553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLYR1,Putative oxidoreductase GLYR1,19460,68,1.16 [0.81-1.66],0.4333293324042364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GM2A,Ganglioside GM2 activator,19072,67,1.19 [0.68-2.05],0.5444504089568414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMFG,Glia maturation factor gamma,19554,67,1.01 [0.73-1.41],0.9376020621068216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMPR,GMP reductase 1,22669,80,1.28 [0.85-1.93],0.2302152250785329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMPR2,GMP reductase 2,19150,68,1.11 [0.78-1.57],0.5544446987581937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNAS,Neuroendocrine secretory protein 55,19512,65,1.11 [0.86-1.43],0.431933086248413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,21953,75,1.09 [0.80-1.48],0.5886340320037984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19029,66,1.17 [0.79-1.74],0.436143972722318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNLY,Granulysin,22481,80,1.39 [0.97-1.97],0.0714855502285412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNPDA1,Glucosamine-6-phosphate isomerase 1,19070,67,1.31 [0.80-2.13],0.2792941415244152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNPDA2,Glucosamine-6-phosphate isomerase 2,19150,68,1.24 [0.67-2.32],0.4946972613660584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOLGA3,Golgin subfamily A member 3,19512,65,0.91 [0.66-1.25],0.5559744448752402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOLM2,Protein GOLM2,22637,81,1.35 [0.65-2.78],0.4211472407492536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22392,81,1.08 [0.89-1.32],0.4313452571349713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GORASP2,Golgi reassembly-stacking protein 2,19459,66,1.00 [0.60-1.65],0.9861554523719936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOT1,"Aspartate aminotransferase, cytoplasmic",19568,68,1.49 [0.92-2.41],0.1077264895742917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP1BA,Platelet glycoprotein Ib alpha chain,22381,80,1.61 [0.91-2.86],0.1030840008106467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP1BB,Platelet glycoprotein Ib beta chain,18884,64,1.09 [0.77-1.56],0.6188463184583739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,21767,77,1.20 [0.96-1.49],0.1086969492156461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP5,Platelet glycoprotein V,19150,68,1.30 [0.68-2.51],0.4300058952769016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP6,Platelet glycoprotein VI,22438,80,1.08 [0.86-1.36],0.5021087783746334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPA33,Cell surface A33 antigen,22343,78,1.04 [0.90-1.21],0.5550210647729226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPC1,Glypican-1,22632,81,1.17 [0.61-2.25],0.644464151765823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPC5,Glypican-5,22257,80,0.98 [0.69-1.40],0.9162894951325108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPD1,Glycerol-3-phosphate dehydrogenase,19460,68,1.58 [1.08-2.33],0.0193269305556423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPHA2,Glycoprotein hormone alpha-2,19459,66,0.84 [0.47-1.50],0.5513169165081866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPI,Glucose-6-phosphate isomerase,19567,68,1.36 [0.85-2.17],0.2040603157361663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19459,66,0.88 [0.65-1.20],0.4255726330900361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPKOW,G-patch domain and KOW motifs-containing protein,21936,76,1.24 [0.69-2.22],0.4709205343623859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPNMB,Transmembrane glycoprotein NMB,21836,80,1.90 [0.97-3.74],0.0630035490070324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR101,Probable G-protein coupled receptor 101,18910,64,1.35 [1.01-1.80],0.0398102484158856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR158,Probable G-protein coupled receptor 158,19512,65,1.20 [0.65-2.23],0.5549526238433194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR15L,Protein GPR15L,19459,66,1.15 [0.79-1.67],0.4657871749653511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR37,Prosaposin receptor GPR37,22040,77,1.32 [0.98-1.79],0.0668005936388804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPRC5C,G-protein coupled receptor family C group 5 member C,19460,68,1.58 [1.16-2.16],0.0035538527973445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRAP2,GRB2-related adapter protein 2,22453,81,1.06 [0.91-1.24],0.4541265735463633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19554,67,0.95 [0.66-1.38],0.8020069936585972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRIK2,"Glutamate receptor ionotropic, kainate 2",19512,65,1.02 [0.61-1.73],0.927726374929884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",18910,64,1.26 [0.90-1.75],0.1735072567206355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRK5,G protein-coupled receptor kinase 5,22040,77,0.95 [0.63-1.45],0.8259870748999493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRN,Progranulin,22375,79,1.99 [0.91-4.32],0.0828809762598589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRP,Gastrin-releasing peptide,19070,67,1.14 [0.75-1.74],0.5366335580687429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRPEL1,"GrpE protein homolog 1, mitochondrial",22343,78,1.68 [1.27-2.21],0.000224190694523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRSF1,G-rich sequence factor 1,18754,65,1.01 [0.75-1.36],0.9452348989830708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSAP,Gamma-secretase-activating protein,21953,75,0.89 [0.67-1.18],0.4223946040192904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSN,Gelsolin,19503,68,0.74 [0.25-2.20],0.5849917197768308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSR,"Glutathione reductase, mitochondrial",19449,67,4.29 [1.74-10.56],0.0015479956328298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTA1,Glutathione S-transferase A1,22414,81,1.16 [0.92-1.47],0.2006197939265533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTA3,Glutathione S-transferase A3,21953,75,1.20 [0.93-1.55],0.1637528469563806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTM4,Glutathione S-transferase Mu 4,18884,64,1.22 [0.94-1.57],0.1283010102955533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTP1,Glutathione S-transferase P,21795,75,0.74 [0.53-1.03],0.0709249553247493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTT2B,Glutathione S-transferase theta-2B,19518,67,1.02 [0.92-1.13],0.6915937716418702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19201,67,1.29 [1.01-1.63],0.0392850507389841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTPBP2,GTP-binding protein 2,19029,66,1.06 [0.79-1.42],0.7101838142963199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUCA2A,Guanylin,22367,79,1.16 [0.66-2.02],0.6084095839154707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUCY2C,Heat-stable enterotoxin receptor,19201,67,1.08 [0.82-1.41],0.5816815678690856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUK1,Guanylate kinase,18884,64,1.37 [0.82-2.28],0.2289482569987656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUSB,Beta-glucuronidase,22575,78,1.24 [0.91-1.70],0.1730527944896226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GYS1,"Glycogen [starch] synthase, muscle",22040,77,1.02 [0.82-1.27],0.8862156565467423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMA,Granzyme A,22669,80,1.82 [1.10-2.99],0.0187503222192735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMB,Granzyme B,22392,81,1.23 [0.97-1.57],0.0867799300289313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMH,Granzyme H,22040,77,1.15 [0.92-1.43],0.2289288051499503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,H2AP,Huntingtin-interacting protein M,18853,65,1.04 [0.66-1.65],0.8622530200557911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",18884,64,1.21 [0.93-1.58],0.1646663407325967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22558,80,1.13 [0.87-1.47],0.360281442473057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAO1,Hydroxyacid oxidase 1,22632,81,1.19 [1.03-1.38],0.0199713984975063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HARS1,"Histidine--tRNA ligase, cytoplasmic",22481,80,1.15 [0.89-1.48],0.3012756303374678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAVCR1,Hepatitis A virus cellular receptor 1,22595,80,1.15 [0.85-1.55],0.3728590278771568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAVCR2,Hepatitis A virus cellular receptor 2,22481,80,1.46 [0.86-2.48],0.1564181567155706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBEGF,Proheparin-binding EGF-like growth factor,22558,80,1.11 [0.85-1.45],0.4439594633267641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBQ1,Hemoglobin subunit theta-1,22632,81,1.05 [0.77-1.44],0.736705157577124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBZ,Hemoglobin subunit zeta,19554,67,0.91 [0.73-1.13],0.3946157088329828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HCG22,Protein PBMUCL2,18884,64,1.00 [0.66-1.51],0.9934164358098918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HCLS1,Hematopoietic lineage cell-specific protein,22669,80,1.08 [0.76-1.55],0.6597092148470168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDAC8,Histone deacetylase 8,18976,67,0.78 [0.46-1.31],0.3412354524137754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDAC9,Histone deacetylase 9,18910,64,0.74 [0.45-1.20],0.2173158057414345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDDC2,5'-deoxynucleotidase HDDC2,19459,66,0.98 [0.58-1.67],0.9444314405512122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDGF,Hepatoma-derived growth factor,22590,81,1.04 [0.84-1.28],0.7138353044182684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDGFL2,Hepatoma-derived growth factor-related protein 2,19518,67,1.01 [0.70-1.47],0.9394119088964455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEBP1,Heme-binding protein 1,22040,77,1.05 [0.73-1.51],0.7744845321537961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEG1,Protein HEG homolog 1,19150,68,2.64 [1.13-6.14],0.0244957634122771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEPACAM2,HEPACAM family member 2,19518,67,1.05 [0.61-1.82],0.8592024890231929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEPH,Hephaestin,19554,67,1.23 [0.50-3.02],0.6552731849942324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEXIM1,Protein HEXIM1,22392,81,1.08 [0.85-1.38],0.514754682764246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGF,Hepatocyte growth factor,22669,80,1.42 [0.82-2.46],0.2055822152858832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGFAC,Hepatocyte growth factor activator,19382,67,1.23 [0.52-2.92],0.634927148025886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,21953,75,1.18 [0.91-1.51],0.2084630790630146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HHEX,Hematopoietically-expressed homeobox protein HHEX,19518,67,1.07 [0.79-1.46],0.6623238392644215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIF1A,Hypoxia-inducible factor 1-alpha,18976,67,1.05 [0.73-1.50],0.7891319744367478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1,Huntingtin-interacting protein 1,18884,64,1.05 [0.52-2.11],0.895106799931422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1R,Huntingtin-interacting protein 1-related protein,19473,67,1.56 [1.14-2.13],0.00544470884356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HJV,Hemojuvelin,19512,65,1.65 [1.18-2.31],0.0031541563014563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HK2,Hexokinase-2,22040,77,0.91 [0.43-1.89],0.7921054327790003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19512,65,0.84 [0.41-1.71],0.6256014825182274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22326,81,1.99 [1.26-3.15],0.0034139631967004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22392,81,1.27 [0.67-2.40],0.4653890808066905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMBS,Porphobilinogen deaminase,22632,81,1.20 [0.76-1.89],0.4266859601027568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMCN2,Hemicentin-2,19118,67,1.30 [0.86-1.98],0.2160704175178811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19070,67,0.88 [0.53-1.45],0.6113792243185263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",18884,64,1.31 [0.83-2.07],0.2544959676213086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMMR,Hyaluronan mediated motility receptor,18812,65,0.98 [0.60-1.61],0.9512619090665756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMOX1,Heme oxygenase 1,22200,80,1.13 [0.75-1.68],0.5627167552110703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMOX2,Heme oxygenase 2,21936,76,1.40 [0.96-2.03],0.0782443412973094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNF1A,Hepatocyte nuclear factor 1-alpha,19029,66,1.06 [0.78-1.45],0.7105712483173214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNMT,Histamine N-methyltransferase,22155,80,1.52 [1.01-2.28],0.0431012771088061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,21982,77,1.04 [0.80-1.36],0.7411810264931957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19512,65,0.95 [0.58-1.56],0.8363415452815801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPCAL1,Hippocalcin-like protein 1,22669,80,1.13 [0.86-1.49],0.3773523808147774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPGDS,Hematopoietic prostaglandin D synthase,21953,75,1.15 [0.67-1.96],0.6058818567521336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPSE,Heparanase,19303,68,1.09 [0.85-1.40],0.4952167104180115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRAS,GTPase Hras,19154,67,1.11 [0.90-1.36],0.3419959175015732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19070,67,0.96 [0.49-1.86],0.8926031446044747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRG,Histidine-rich glycoprotein,19476,69,0.71 [0.41-1.22],0.2174902127668537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS1BP3,HCLS1-binding protein 3,19070,67,1.00 [0.77-1.31],0.9931758079248292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22343,78,0.91 [0.54-1.55],0.7300763821655698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22632,81,1.56 [0.99-2.47],0.0573331139264845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,18976,67,0.98 [0.50-1.91],0.9433472238441316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSBP1,Heat shock factor-binding protein 1,19070,67,1.06 [0.83-1.35],0.6608108823866045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22392,81,0.79 [0.48-1.29],0.343602043209374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19518,67,1.58 [1.10-2.25],0.0124911019363687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD17B3,Testosterone 17-beta-dehydrogenase 3,18884,64,1.10 [0.68-1.76],0.7033881252202774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19070,67,0.67 [0.40-1.12],0.1287612936916143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSP90B1,Endoplasmin,21824,76,1.12 [0.86-1.46],0.3991362402902337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPA1A,Heat shock 70 kDa protein 1A,22519,81,1.22 [0.94-1.59],0.1406905825532764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPA2,Heat shock-related 70 kDa protein 2,19460,68,1.53 [0.88-2.66],0.1276767956736447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPB1,Heat shock protein beta-1,22116,80,1.19 [0.88-1.61],0.2635640276803972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPB6,Heat shock protein beta-6,22632,81,1.42 [0.88-2.30],0.1538775714117898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22308,80,2.00 [1.05-3.83],0.0353999274821713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTR1A,5-hydroxytryptamine receptor 1A,18910,64,0.98 [0.71-1.35],0.8967184058282057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTR1B,5-hydroxytryptamine receptor 1B,18910,64,0.99 [0.56-1.72],0.958026255790524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTRA2,"Serine protease HTRA2, mitochondrial",22542,79,1.37 [1.00-1.88],0.0504901580743872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HYAL1,Hyaluronidase-1,22361,80,0.93 [0.40-2.20],0.8722653639905199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HYOU1,Hypoxia up-regulated protein 1,22732,79,1.08 [0.46-2.53],0.8530949651400705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICA1,Islet cell autoantigen 1,22021,77,1.08 [0.84-1.39],0.5623491450938086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM1,Intercellular adhesion molecule 1,22376,80,1.73 [0.90-3.30],0.0992342296279548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM2,Intercellular adhesion molecule 2,22732,79,1.17 [0.63-2.16],0.6288373242858842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM3,Intercellular adhesion molecule 3,22732,79,1.46 [0.71-3.02],0.3026457094739604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM4,Intercellular adhesion molecule 4,22392,81,1.13 [0.77-1.65],0.5424683353155779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM5,Intercellular adhesion molecule 5,22453,81,0.82 [0.54-1.25],0.363981721119553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICOSLG,ICOS ligand,22343,78,0.78 [0.28-2.22],0.6439445103726404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ID4,DNA-binding protein inhibitor ID-4,19201,67,1.23 [0.79-1.94],0.3587395206757545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDI2,Isopentenyl-diphosphate delta-isomerase 2,21936,76,0.94 [0.61-1.45],0.7865018237300212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDO1,"Indoleamine 2,3-dioxygenase 1",19070,67,1.00 [0.70-1.44],0.988024494158393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDS,Iduronate 2-sulfatase,22669,80,4.63 [0.41-51.80],0.2134720881730365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDUA,Alpha-L-iduronidase,22632,81,0.78 [0.52-1.17],0.2315764355995002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,18971,66,2.00 [1.21-3.30],0.0067133775711176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19201,67,1.29 [0.86-1.93],0.2233268605570095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19201,67,1.13 [0.62-2.08],0.6853917684310937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNAR1,Interferon alpha/beta receptor 1,19459,66,0.69 [0.25-1.89],0.4726451025420468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNG,Interferon gamma,22021,77,1.02 [0.85-1.22],0.8356026123145992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNGR1,Interferon gamma receptor 1,22549,81,1.37 [0.56-3.36],0.49192750830791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNGR2,Interferon gamma receptor 2,22257,80,1.16 [0.81-1.68],0.4220045615179497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNL1,Interferon lambda-1,21936,76,0.92 [0.58-1.46],0.7362666556703923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNL2,Interferon lambda-2,18910,64,1.17 [0.84-1.62],0.3605688095441728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNLR1,Interferon lambda receptor 1,22392,81,0.90 [0.51-1.60],0.7267430403617595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNW1,Interferon omega-1,18884,64,1.27 [0.76-2.13],0.366163038325086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFT20,Intraflagellar transport protein 20 homolog,19029,66,0.73 [0.40-1.34],0.3075195324775241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGBP1,Immunoglobulin-binding protein 1,19512,65,0.93 [0.63-1.37],0.6992079874439925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,18910,64,1.26 [0.87-1.83],0.2207718944907655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19568,68,0.53 [0.23-1.20],0.1270310164633447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF1R,Insulin-like growth factor 1 receptor,22343,78,0.92 [0.36-2.38],0.8714394203743686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,18884,64,0.88 [0.49-1.58],0.6670592498171986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF2R,Cation-independent mannose-6-phosphate receptor,22481,80,1.25 [0.53-2.94],0.609145860240343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP1,Insulin-like growth factor-binding protein 1,22696,79,1.06 [0.90-1.25],0.4818697971832654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP2,Insulin-like growth factor-binding protein 2,22704,79,1.07 [0.77-1.48],0.6954068511548758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP3,Insulin-like growth factor-binding protein 3,22574,80,0.84 [0.46-1.54],0.5709999091558542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP4,Insulin-like growth factor-binding protein 4,22191,79,1.04 [0.67-1.62],0.8539135583054298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP6,Insulin-like growth factor-binding protein 6,22377,80,1.47 [0.82-2.65],0.1958767106490978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP7,Insulin-like growth factor-binding protein 7,22732,79,2.11 [1.37-3.25],0.000648517686231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBPL1,Insulin-like growth factor-binding protein-like 1,22453,81,1.35 [0.77-2.37],0.3020720638531895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFL4,Insulin growth factor-like family member 4,18976,67,1.04 [0.77-1.40],0.7967337054927434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGHMBP2,DNA-binding protein SMUBP-2,18884,64,0.96 [0.61-1.50],0.8431661888958856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGLC2,Immunoglobulin lambda constant 2,19547,69,1.56 [0.85-2.84],0.1499594157988156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGLON5,IgLON family member 5,18853,65,1.13 [0.92-1.39],0.2430316274119186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF21,Immunoglobulin superfamily member 21,19070,67,1.13 [0.65-1.98],0.6610983415127039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF3,Immunoglobulin superfamily member 3,22343,78,1.36 [0.80-2.31],0.2535308068913651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF8,Immunoglobulin superfamily member 8,22453,81,2.16 [1.27-3.67],0.0042713708079304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF9,Protein turtle homolog A,19554,67,1.25 [0.95-1.64],0.1102134241185697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IKBKG,NF-kappa-B essential modulator,22392,81,1.13 [0.91-1.41],0.2646096613216171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IKZF2,Zinc finger protein Helios,21953,75,1.03 [0.82-1.31],0.7814028543154303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10,Interleukin-10,22021,77,1.08 [0.86-1.36],0.5047803222816878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10RA,Interleukin-10 receptor subunit alpha,22021,77,0.77 [0.50-1.20],0.2518947905808156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10RB,Interleukin-10 receptor subunit beta,22549,81,1.10 [0.57-2.11],0.7781192370861465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL11,Interleukin-11,22021,77,0.91 [0.64-1.29],0.5969800088894044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12A_IL12B,Interleukin-12,22343,78,0.90 [0.70-1.17],0.4401142637694308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12B,Interleukin-12 subunit beta,22669,80,0.85 [0.60-1.21],0.3644540749478689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB1,Interleukin-12 receptor subunit beta-1,22021,77,2.07 [1.34-3.20],0.0011096991283367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB2,Interleukin-12 receptor subunit beta-2,18976,67,1.23 [0.71-2.11],0.457687975915522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13,Interleukin-13,22021,77,0.94 [0.60-1.48],0.8029832028052823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13RA1,Interleukin-13 receptor subunit alpha-1,22200,78,1.80 [0.74-4.37],0.1926197992735805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13RA2,Interleukin-13 receptor subunit alpha-2,18910,64,1.11 [0.48-2.57],0.8052548775909747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL15,Interleukin-15,22392,81,1.16 [0.65-2.09],0.6119042070056171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL15RA,Interleukin-15 receptor subunit alpha,22021,77,1.35 [0.76-2.38],0.3031137973245619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL16,Pro-interleukin-16,22669,80,1.37 [0.91-2.06],0.130801520455508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17A,Interleukin-17A,21990,76,1.00 [0.62-1.59],0.985361380233787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17C,Interleukin-17C,22021,77,1.02 [0.78-1.34],0.8788718301397657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17D,Interleukin-17D,22021,77,1.39 [0.91-2.12],0.1289336755626135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17F,Interleukin-17F,22021,77,0.89 [0.66-1.20],0.4381493049277514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17RA,Interleukin-17 receptor A,22481,80,1.35 [0.87-2.10],0.1815067440141737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17RB,Interleukin-17 receptor B,22123,80,0.89 [0.61-1.30],0.5419635600897199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18,Interleukin-18,22376,81,1.31 [0.88-1.94],0.1811025406374383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18BP,Interleukin-18-binding protein,22574,80,1.80 [1.02-3.17],0.0439677984526787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18R1,Interleukin-18 receptor 1,22669,80,1.70 [0.95-3.05],0.0719111460008819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18RAP,Interleukin-18 receptor accessory protein,22118,80,1.02 [0.91-1.14],0.7510874401426821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL19,Interleukin-19,21886,80,1.09 [0.83-1.43],0.5224580711825071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1A,Interleukin-1 alpha,22021,77,0.88 [0.61-1.28],0.5029501968049561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1B,Interleukin-1 beta,21921,76,0.98 [0.68-1.40],0.909570815673542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1R1,Interleukin-1 receptor type 1,22449,80,2.09 [0.92-4.74],0.0791112012609809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1R2,Interleukin-1 receptor type 2,22408,81,1.32 [0.50-3.54],0.57635292807357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RAP,Interleukin-1 receptor accessory protein,22481,80,0.56 [0.34-0.89],0.0157011909710079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RL1,Interleukin-1 receptor-like 1,22666,79,1.30 [0.84-2.01],0.2437327901236379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RL2,Interleukin-1 receptor-like 2,22021,77,0.92 [0.54-1.55],0.7436164635063836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RN,Interleukin-1 receptor antagonist protein,22410,81,0.95 [0.66-1.38],0.7863582433355479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2,Interleukin-2,22021,77,1.74 [1.06-2.86],0.0295426440053607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20,Interleukin-20,22021,77,0.51 [0.30-0.88],0.0160683201641061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20RA,Interleukin-20 receptor subunit alpha,22021,77,1.18 [0.80-1.74],0.3949718832926718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20RB,Interleukin-20 receptor subunit beta,18976,67,0.93 [0.52-1.65],0.8005622298558308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL21R,Interleukin-21 receptor,18976,67,1.16 [0.81-1.65],0.4185647441042726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL22,Interleukin-22,19460,68,1.00 [0.72-1.40],0.97996228891945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL22RA1,Interleukin-22 receptor subunit alpha-1,22021,77,1.11 [0.74-1.67],0.5980308783317922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL24,Interleukin-24,22021,77,1.08 [0.74-1.57],0.6950019721676133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL25,Interleukin-25,18786,65,1.12 [0.57-2.22],0.7383706387815268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RA,Interleukin-2 receptor subunit alpha,22278,78,1.09 [0.67-1.76],0.7311499495434285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RB,Interleukin-2 receptor subunit beta,22021,77,1.25 [0.82-1.90],0.3067584567185539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RG,Cytokine receptor common subunit gamma,19460,68,0.85 [0.42-1.71],0.6461809612461357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL3,Interleukin-3,18853,65,1.17 [0.77-1.77],0.4550096281579477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL31,Interleukin-31,18976,67,1.20 [0.84-1.72],0.3264785668043807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL31RA,Interleukin-31 receptor subunit alpha,18896,67,1.33 [0.72-2.46],0.3542150632028541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL32,Interleukin-32,22392,81,1.32 [0.86-2.02],0.2029774944842531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL33,Interleukin-33,22021,77,1.43 [0.85-2.41],0.1770311068211174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL34,Interleukin-34,21902,76,0.89 [0.51-1.57],0.699953884220536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL36A,Interleukin-36 alpha,18976,67,0.85 [0.53-1.37],0.510360889239137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL36G,Interleukin-36 gamma,18887,67,0.91 [0.64-1.31],0.6169773284517097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL3RA,Interleukin-3 receptor subunit alpha,22021,77,1.35 [0.74-2.48],0.3301409804698759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL4,Interleukin-4,22021,77,1.04 [0.83-1.31],0.7438723497786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL4R,Interleukin-4 receptor subunit alpha,22392,81,1.52 [0.92-2.49],0.0998274353828342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5,Interleukin-5,22021,77,1.14 [1.01-1.28],0.0315468686901433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5RA,Interleukin-5 receptor subunit alpha,22392,81,1.41 [1.02-1.93],0.0349208999485437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6,Interleukin-6,22343,78,1.17 [0.95-1.45],0.1331244087225803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6R,Interleukin-6 receptor subunit alpha,22350,80,1.71 [0.96-3.05],0.0667116301956417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6ST,Interleukin-6 receptor subunit beta,22453,81,1.26 [0.40-3.95],0.6876367689524714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL7,Interleukin-7,22392,81,1.20 [0.89-1.63],0.2240513133135316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL7R,Interleukin-7 receptor subunit alpha,22481,80,0.94 [0.64-1.37],0.7462871965676987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL9,Interleukin-9,19201,67,1.11 [0.77-1.59],0.5804861201795685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,21897,76,1.05 [0.74-1.49],0.7892617611987017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMMT,MICOS complex subunit MIC60,19460,68,1.62 [1.10-2.39],0.0151728869656974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPA1,Inositol monophosphatase 1,22257,80,0.94 [0.67-1.31],0.7063476526740327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPACT,Protein IMPACT,19518,67,1.00 [0.66-1.51],0.9928707014141438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPG1,Interphotoreceptor matrix proteoglycan 1,18910,64,0.95 [0.42-2.18],0.9100956767552008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ING1,Inhibitor of growth protein 1,21901,76,1.08 [0.72-1.64],0.7017650483952779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBB,Inhibin beta B chain,19150,68,1.64 [1.10-2.43],0.0148664191709062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBC,Inhibin beta C chain,22481,80,1.62 [0.97-2.69],0.0639524158184929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP1,Inositol polyphosphate 1-phosphatase,22343,78,1.20 [0.83-1.73],0.3217643366000334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19070,67,0.93 [0.61-1.43],0.7532951295873165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19512,65,1.05 [0.61-1.79],0.8634522465526779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22343,78,1.07 [0.87-1.31],0.5367704757656245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL3,Insulin-like 3,19518,67,1.02 [0.76-1.37],0.8820804596711661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL4,Early placenta insulin-like peptide,19460,68,1.30 [0.89-1.88],0.1720122433325303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL5,Insulin-like peptide INSL5,19459,66,1.16 [0.92-1.47],0.2003246070615486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSR,Insulin receptor,18976,67,1.35 [0.34-5.28],0.670091286278348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IPCEF1,Interactor protein for cytohesin exchange factors 1,22223,80,1.20 [0.96-1.50],0.1086820931244596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IQGAP2,Ras GTPase-activating-like protein IQGAP2,22343,78,1.11 [0.77-1.59],0.5756065600854818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22040,77,1.08 [0.87-1.35],0.4806183169074743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAK1,Interleukin-1 receptor-associated kinase 1,22021,77,1.06 [0.79-1.42],0.7051036645387716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAK4,Interleukin-1 receptor-associated kinase 4,22392,81,1.09 [0.90-1.33],0.3564027037691739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21646,75,1.12 [0.65-1.94],0.6860422590878976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISM1,Isthmin-1,22392,81,0.89 [0.54-1.47],0.6416131078537533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISM2,Isthmin-2,19568,68,1.05 [0.62-1.78],0.8646981174190719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IST1,IST1 homolog,19313,66,1.03 [0.81-1.32],0.7847149799363035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA11,Integrin alpha-11,22392,81,0.62 [0.35-1.09],0.0988235487019395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA2,Integrin alpha-2,19150,68,1.01 [0.52-1.99],0.965915957853998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA5,Integrin alpha-5,22481,80,1.54 [0.71-3.36],0.2780742456692598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA6,Integrin alpha-6,22392,81,1.05 [0.72-1.54],0.7828394374503602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAL,Integrin alpha-L,18976,67,1.05 [0.61-1.80],0.8658139779314459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAM,Integrin alpha-M,22481,80,1.11 [0.59-2.07],0.75010191257817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAV,Integrin alpha-V,22632,81,0.44 [0.13-1.44],0.1738550267513202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAX,Integrin alpha-X,19201,67,1.14 [0.77-1.69],0.5024050676624359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1,Integrin beta-1,22463,80,2.75 [1.26-5.98],0.0108828438093893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1BP1,Integrin beta-1-binding protein 1,21953,75,1.20 [0.73-1.98],0.4797958917501143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1BP2,Integrin beta-1-binding protein 2,22040,77,1.02 [0.85-1.23],0.8120856148454765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB2,Integrin beta-2,22335,78,1.07 [0.53-2.17],0.8525689406372219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB5,Integrin beta-5,22542,79,1.96 [1.25-3.09],0.0036088698986636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB6,Integrin beta-6,22021,77,1.71 [0.88-3.34],0.1148677305162279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB7,Integrin beta-7,22632,81,1.09 [0.72-1.66],0.682378935911886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGBL1,Integrin beta-like protein 1,19568,68,1.72 [1.01-2.92],0.0456954296501789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19587,69,0.94 [0.27-3.28],0.9244703659043152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22574,80,2.17 [1.28-3.70],0.0043251477372168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19587,69,0.82 [0.33-2.06],0.6722315085472869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19460,68,1.04 [0.63-1.72],0.8790031686203584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITM2A,Integral membrane protein 2A,22392,81,1.09 [0.79-1.50],0.5946517587246851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPA,Inosine triphosphate pyrophosphatase,18884,64,0.93 [0.64-1.33],0.6738099660941312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19070,67,1.05 [0.75-1.48],0.7636618218753712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",18910,64,1.08 [0.63-1.85],0.7713347519653109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",21936,76,0.86 [0.56-1.32],0.4815593476283673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IZUMO1,Izumo sperm-egg fusion protein 1,18853,65,1.08 [0.66-1.76],0.7576836470530096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JAM2,Junctional adhesion molecule B,22637,81,1.34 [0.67-2.68],0.415040584962019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JAM3,Junctional adhesion molecule C,19150,68,1.31 [0.85-2.02],0.2199100832893793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JCHAIN,Immunoglobulin J chain,22021,77,1.30 [0.95-1.78],0.0970543979750575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,18853,65,0.64 [0.38-1.06],0.0821311727401689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JPT2,Jupiter microtubule associated homolog 2,19459,66,1.08 [0.82-1.42],0.5863185827997063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JUN,Transcription factor AP-1,22021,77,0.89 [0.56-1.41],0.6152251974899507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22343,78,0.96 [0.62-1.49],0.8718298981137023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KAZN,Kazrin,19459,66,1.03 [0.82-1.29],0.8028106241637658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNC4,Potassium voltage-gated channel subfamily C member 4,18910,64,1.12 [0.76-1.65],0.5515676137371516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNH2,Potassium voltage-gated channel subfamily H member 2,19029,66,1.08 [0.81-1.44],0.6103510733854485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNIP4,Kv channel-interacting protein 4,21936,76,0.58 [0.34-1.00],0.0495557029842168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCTD5,BTB/POZ domain-containing protein KCTD5,19162,66,1.22 [0.75-1.98],0.4199377431192015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KDM3A,Lysine-specific demethylase 3A,18976,67,0.93 [0.68-1.27],0.6580687809917376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KDR,Vascular endothelial growth factor receptor 2,22542,79,0.81 [0.37-1.79],0.5983548753715527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KEL,Kell blood group glycoprotein,21936,76,1.46 [0.84-2.55],0.179644493204186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KHDC3L,KH domain-containing protein 3,18853,65,1.24 [0.96-1.61],0.1050073058505114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KHK,Ketohexokinase,19070,67,1.22 [0.84-1.78],0.2948610721810542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA0319,Dyslexia-associated protein KIAA0319,19518,67,1.20 [0.58-2.50],0.6202813343004162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA1549,UPF0606 protein KIAA1549,19201,67,1.21 [0.88-1.67],0.2387195987819297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA1549L,UPF0606 protein KIAA1549L,19201,67,0.97 [0.43-2.19],0.9329460121585352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA2013,Uncharacterized protein KIAA2013,19460,68,0.90 [0.55-1.46],0.6607233202185168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF1C,Kinesin-like protein KIF1C,18884,64,0.95 [0.46-1.96],0.8832324094139744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF20B,Kinesin-like protein KIF20B,18910,64,1.19 [0.91-1.56],0.1984575334521684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF22,Kinesin-like protein KIF22,18884,64,1.15 [0.94-1.40],0.1718701634701629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIFBP,KIF-binding protein,22343,78,1.01 [0.80-1.29],0.9213144939355026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19460,68,1.10 [0.85-1.43],0.4520645099625349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,21953,75,1.24 [0.97-1.60],0.089724064399326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19459,66,0.94 [0.81-1.08],0.3591275119555223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,21953,75,1.05 [0.90-1.24],0.5272255294777208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,18853,65,1.27 [1.04-1.54],0.0172520315768676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIRREL1,Kin of IRRE-like protein 1,18910,64,1.19 [0.85-1.68],0.3096610896051479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIRREL2,Kin of IRRE-like protein 2,21936,76,0.97 [0.58-1.61],0.9023285509601094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIT,Mast/stem cell growth factor receptor Kit,22527,80,1.31 [0.68-2.52],0.4212690729932973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KITLG,Kit ligand,22453,81,0.48 [0.29-0.78],0.0034529399285354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLB,Beta-klotho,21936,76,1.00 [0.76-1.31],0.9788463531398726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLF4,Krueppel-like factor 4,18910,64,1.39 [0.82-2.33],0.2175001240146685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLHL41,Kelch-like protein 41,19512,65,0.85 [0.50-1.46],0.5605299966297008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK1,Kallikrein-1,22249,77,0.93 [0.79-1.09],0.3671131797665049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK10,Kallikrein-10,22475,79,0.99 [0.61-1.62],0.9794224763930094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK11,Kallikrein-11,22334,79,1.17 [0.65-2.09],0.608643093934494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK12,Kallikrein-12,21953,75,0.84 [0.73-0.97],0.0144164244598014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK13,Kallikrein-13,21960,77,1.07 [0.70-1.65],0.747842609093055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK14,Kallikrein-14,22632,81,0.93 [0.61-1.40],0.7262891559428561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK15,Kallikrein-15,19419,67,1.17 [0.75-1.82],0.4867438349065626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK3,Prostate-specific antigen,19568,68,0.97 [0.77-1.23],0.8171311788779593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK4,Kallikrein-4,22632,81,1.09 [0.80-1.48],0.5732147285563318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK6,Kallikrein-6,22499,79,1.72 [0.91-3.23],0.0926756319565795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK7,Kallikrein-7,18664,66,1.14 [0.63-2.05],0.6638585702876489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK8,Kallikrein-8,21710,76,0.87 [0.50-1.53],0.6269006238931913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLKB1,Plasma kallikrein,19178,69,1.58 [0.62-4.06],0.3420499509093923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRB1,Killer cell lectin-like receptor subfamily B member 1,22669,80,1.44 [0.89-2.33],0.132813368337954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,18910,64,1.05 [0.71-1.54],0.80457181898606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRD1,Natural killer cells antigen CD94,22669,80,1.76 [1.17-2.64],0.0067692472225165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRF1,Killer cell lectin-like receptor subfamily F member 1,18976,67,1.31 [0.90-1.90],0.1627569061268361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRK1,NKG2-D type II integral membrane protein,19518,67,1.51 [0.96-2.38],0.0771658834200937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT14,"Keratin, type I cytoskeletal 14",21253,75,0.61 [0.27-1.37],0.2311973750168177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT17,"Keratin, type I cytoskeletal 17",18884,64,1.07 [0.58-1.98],0.833485315747208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT18,"Keratin, type I cytoskeletal 18",22343,78,1.36 [1.09-1.69],0.0071254487503331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT19,"Keratin, type I cytoskeletal 19",22346,81,1.16 [0.88-1.52],0.2843967583424821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT5,"Keratin, type II cytoskeletal 5",21936,76,1.01 [0.67-1.52],0.9519333925490672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT6C,"Keratin, type II cytoskeletal 6C",18884,64,1.20 [0.67-2.17],0.5357747045702573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT8,"Keratin, type II cytoskeletal 8",18910,64,1.20 [0.95-1.51],0.1269878335684857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KYAT1,Kynurenine--oxoglutarate transaminase 1,22424,81,1.27 [0.91-1.76],0.1585440916819738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KYNU,Kynureninase,22669,80,1.48 [0.97-2.26],0.068747446170194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,L1CAM,Neural cell adhesion molecule L1,22542,79,0.99 [0.50-1.94],0.9665482048802836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19554,67,1.11 [0.86-1.43],0.4399518517727362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LACRT,Extracellular glycoprotein lacritin,19422,68,0.86 [0.51-1.43],0.551833630545808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LACTB2,Endoribonuclease LACTB2,22453,81,1.11 [0.82-1.49],0.4958289415362167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAG3,Lymphocyte activation gene 3 protein,22343,78,1.28 [0.80-2.03],0.3017248887681075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22445,81,1.28 [0.86-1.92],0.227472068031402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22257,80,1.16 [0.96-1.42],0.1323262421559875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMA1,Laminin subunit alpha-1,18884,64,1.18 [0.80-1.75],0.4089214432577331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMA4,Laminin subunit alpha-4,22549,81,1.32 [0.74-2.34],0.3477957986387844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMB1,Laminin subunit beta-1,19070,67,0.92 [0.42-2.01],0.8302949624735698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP1,Lysosome-associated membrane glycoprotein 1,19012,67,0.56 [0.19-1.65],0.292199192618074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP2,Lysosome-associated membrane glycoprotein 2,21783,74,1.02 [0.36-2.91],0.9762703639695308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP3,Lysosome-associated membrane glycoprotein 3,22635,79,1.32 [0.91-1.90],0.1380309690830813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMTOR5,Ragulator complex protein LAMTOR5,19460,68,1.36 [0.83-2.24],0.2226929024091972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAP3,Cytosol aminopeptidase,22021,77,1.16 [0.78-1.72],0.4745999604417282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LARP1,La-related protein 1,19460,68,1.00 [0.69-1.45],0.9851829630949388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAT,Linker for activation of T-cells family member 1,22669,80,1.13 [0.87-1.47],0.3729059979331484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAT2,Linker for activation of T-cells family member 2,22343,78,1.04 [0.89-1.22],0.6020996313618711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LATS1,Serine/threonine-protein kinase LATS1,18976,67,1.01 [0.76-1.33],0.9655331152230218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAYN,Layilin,22222,80,1.49 [0.90-2.48],0.1218101663566502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LBP,Lipopolysaccharide-binding protein,22574,80,1.37 [0.98-1.91],0.0677159717378777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LBR,Delta(14)-sterol reductase LBR,22637,81,1.22 [0.95-1.56],0.1141132598450791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCAT,Phosphatidylcholine-sterol acyltransferase,19567,68,2.15 [0.72-6.46],0.1707586272800128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCN15,Lipocalin-15,19512,65,0.92 [0.62-1.38],0.6902611451283238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCN2,Neutrophil gelatinase-associated lipocalin,21813,79,1.24 [0.78-1.98],0.3685573982932838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCP1,Plastin-2,19568,68,0.98 [0.60-1.58],0.9245972575972854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LDLR,Low-density lipoprotein receptor,22517,78,1.03 [0.70-1.51],0.8877532017959203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LDLRAP1,Low density lipoprotein receptor adapter protein 1,19512,65,1.06 [0.83-1.35],0.652652444004481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LECT2,Leukocyte cell-derived chemotaxin-2,19554,67,1.57 [1.14-2.18],0.0064969101732498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEFTY2,Left-right determination factor 2,22595,81,1.00 [0.68-1.48],0.9966475460742258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEG1,Protein LEG1 homolog,18533,68,1.36 [1.01-1.84],0.0456712011029804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LELP1,Late cornified envelope-like proline-rich protein 1,18910,64,0.88 [0.61-1.27],0.4966581837388619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEO1,RNA polymerase-associated protein LEO1,19512,65,1.16 [0.62-2.18],0.6455569704765693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEP,Leptin,22453,81,0.83 [0.63-1.11],0.2215679543955652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEPR,Leptin receptor,22453,81,1.34 [0.74-2.45],0.3344759914431323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LETM1,Mitochondrial proton/calcium exchanger protein,19512,65,1.32 [0.88-1.98],0.179736336986044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS1,Galectin-1,22453,81,1.23 [0.71-2.12],0.4634022649375724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS3,Galectin-3,22514,79,1.67 [0.88-3.16],0.1150797207066941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS3BP,Galectin-3-binding protein,19587,69,1.49 [0.80-2.78],0.2093107666176987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS4,Galectin-4,22445,81,1.33 [0.96-1.86],0.0893854091935126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS7_LGALS7B,Galectin-7,22358,81,1.49 [1.04-2.13],0.0308955591912985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS8,Galectin-8,22637,81,1.09 [0.79-1.50],0.6124673783047034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS9,Galectin-9,22445,81,1.64 [0.92-2.93],0.0945994009120997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGMN,Legumain,22549,81,1.70 [1.01-2.87],0.0473735016823474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LHB,Lutropin subunit beta,21953,75,0.99 [0.78-1.26],0.9377271322755928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22476,81,1.26 [0.93-1.71],0.1415517699574264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIF,Leukemia inhibitory factor,21936,76,0.70 [0.44-1.13],0.1449511299040807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIFR,Leukemia inhibitory factor receptor,22392,81,2.55 [1.17-5.54],0.0182305677697973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22481,80,1.21 [0.70-2.09],0.5012300184334137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19568,68,1.21 [0.94-1.54],0.1344178316994304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,18884,64,1.52 [1.09-2.12],0.0130678728115431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22410,81,1.24 [0.68-2.26],0.4841975093545821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19554,67,1.21 [0.88-1.66],0.2326419398216546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22732,79,2.03 [1.00-4.13],0.0510546735598122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22638,79,1.82 [1.00-3.31],0.0504190159860438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22021,77,1.62 [1.07-2.47],0.0242535963675935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,22732,79,1.10 [0.83-1.47],0.5046347747502502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIPF,Gastric triacylglycerol lipase,19070,67,1.08 [0.74-1.56],0.6959216103061412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB1,Lamin-B1,19426,66,0.90 [0.61-1.35],0.6196336191795346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB2,Lamin-B2,19518,67,2.22 [1.08-4.53],0.0294012172962029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMOD1,Leiomodin-1,19512,65,1.33 [0.73-2.41],0.3549285711115488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMOD2,Leiomodin-2,18910,64,0.74 [0.47-1.16],0.1910357907618728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LONP1,"Lon protease homolog, mitochondrial",19070,67,1.11 [0.85-1.45],0.4551816631686622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPA,Apolipoprotein(a),19143,69,0.94 [0.83-1.07],0.3404990885687219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPCAT2,Lysophosphatidylcholine acyltransferase 2,22343,78,1.22 [0.85-1.76],0.2789762323490067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPL,Lipoprotein lipase,22453,81,1.05 [0.69-1.59],0.8287722843400063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPO,Lactoperoxidase,21691,78,1.44 [1.06-1.96],0.0185288574263905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPP,Lipoma-preferred partner,18884,64,1.05 [0.73-1.52],0.79103505166702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,18884,64,1.03 [0.72-1.47],0.8717045255227517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19029,66,0.99 [0.59-1.67],0.9673587608636052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRG1,Leucine-rich alpha-2-glycoprotein,19587,69,1.24 [0.52-2.91],0.6285703673262563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22558,80,1.43 [0.82-2.48],0.2060441848464266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,18911,67,0.42 [0.15-1.13],0.0860771828332637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP1,Prolow-density lipoprotein receptor-related protein 1,22343,78,1.12 [0.53-2.38],0.768989660600041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP11,Low-density lipoprotein receptor-related protein 11,22453,81,1.02 [0.60-1.72],0.9553166885899173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP2,Low-density lipoprotein receptor-related protein 2,19029,66,0.88 [0.45-1.73],0.7078113184176316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP2BP,LRP2-binding protein,19029,66,0.77 [0.53-1.11],0.1656401443975261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22637,81,1.09 [0.79-1.50],0.6008383487744494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC25,Leucine-rich repeat-containing protein 25,22343,78,1.10 [0.68-1.79],0.6941693847666754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC37A2,Leucine-rich repeat-containing protein 37A2,19459,66,1.29 [0.75-2.23],0.3613434102311927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC38,Leucine-rich repeat-containing protein 38,19029,66,1.41 [0.94-2.11],0.0988794683554765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC59,Leucine-rich repeat-containing protein 59,19554,67,1.14 [0.72-1.82],0.5743963623392461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19460,68,1.05 [0.65-1.70],0.837236062132487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRN1,Leucine-rich repeat neuronal protein 1,22021,77,0.96 [0.57-1.59],0.8624225692798037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19029,66,1.19 [0.71-1.99],0.5056300120091513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19512,65,1.71 [0.80-3.66],0.1678923248108561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSM1,U6 snRNA-associated Sm-like protein LSm1,21953,75,1.21 [0.90-1.65],0.2115397703366213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSM8,U6 snRNA-associated Sm-like protein LSm8,19201,67,1.09 [0.85-1.39],0.4912480003421985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSP1,Lymphocyte-specific protein 1,22392,81,1.39 [0.87-2.21],0.1700059183466712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTA,Lymphotoxin-alpha,22392,81,1.23 [0.75-2.00],0.409375865462556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTA4H,Leukotriene A-4 hydrolase,22632,81,0.95 [0.67-1.33],0.7465627626078156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTB,Lymphotoxin-beta,19460,68,1.00 [0.51-1.96],0.9951708088257364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP2,Latent-transforming growth factor beta-binding protein 2,22732,79,2.36 [1.35-4.11],0.0025047947827752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP3,Latent-transforming growth factor beta-binding protein 3,21953,75,1.47 [1.13-1.91],0.0038526447716887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBR,Tumor necrosis factor receptor superfamily member 3,22349,81,1.34 [0.71-2.56],0.3663840932058126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTO1,Protein LTO1 homolog,22021,77,1.22 [0.81-1.84],0.3355523181322102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LUZP2,Leucine zipper protein 2,19460,68,0.98 [0.58-1.65],0.9267418744591014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LXN,Latexin,22162,79,1.11 [0.84-1.46],0.4680763265398672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY6D,Lymphocyte antigen 6D,22344,81,1.30 [0.81-2.08],0.2735578713631923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY75,Lymphocyte antigen 75,22392,81,0.93 [0.56-1.53],0.7630171903434221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY9,T-lymphocyte surface antigen Ly-9,22165,77,1.21 [0.62-2.36],0.5720019863270825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY96,Lymphocyte antigen 96,22257,80,1.56 [0.94-2.58],0.0820931647756151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYAR,Cell growth-regulating nucleolar protein,21953,75,1.18 [0.88-1.58],0.270141869577301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYN,Tyrosine-protein kinase Lyn,22343,78,1.08 [0.85-1.37],0.5105561192769446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD1,Ly6/PLAUR domain-containing protein 1,21936,76,0.97 [0.69-1.37],0.8608218774828756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD3,Ly6/PLAUR domain-containing protein 3,22353,79,0.78 [0.43-1.42],0.4208653589554342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD8,Ly6/PLAUR domain-containing protein 8,21953,75,1.11 [0.79-1.57],0.5405615628523777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPLA2,Acyl-protein thioesterase 2,18910,64,1.03 [0.83-1.27],0.8004750818856191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19029,66,1.14 [0.94-1.38],0.1924979141506755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19587,69,0.79 [0.24-2.57],0.6985166780255276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYZL2,Lysozyme-like protein 2,18853,65,1.54 [0.89-2.68],0.1237646813816373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LZTFL1,Leucine zipper transcription factor-like protein 1,19150,68,1.11 [0.80-1.53],0.548894513658372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,M6PR,Cation-dependent mannose-6-phosphate receptor,19070,67,0.72 [0.35-1.45],0.3545806854212052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22178,80,1.39 [1.06-1.84],0.0184684034217946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAEA,E3 ubiquitin-protein transferase MAEA,21953,75,1.19 [0.72-1.95],0.4974832173360376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAG,Myelin-associated glycoprotein,19029,66,1.25 [0.77-2.01],0.368199442434111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAGEA3,Melanoma-associated antigen 3,19201,67,0.95 [0.74-1.23],0.6935963216603332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAGED1,Melanoma-associated antigen D1,21953,75,1.03 [0.68-1.57],0.8870219608239379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAMDC2,MAM domain-containing protein 2,19554,67,1.17 [0.62-2.22],0.6263376298027543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAMDC4,Apical endosomal glycoprotein,19460,68,1.08 [0.72-1.64],0.7018001828545857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19070,67,1.30 [0.51-3.32],0.5866798929095902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAN2B2,Epididymis-specific alpha-mannosidase,19554,67,0.97 [0.66-1.43],0.8781182145040678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",18853,65,1.24 [0.80-1.93],0.3256502563925186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANF,Mesencephalic astrocyte-derived neurotrophic factor,22549,81,1.05 [0.89-1.25],0.5395530697387374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANSC1,MANSC domain-containing protein 1,22542,79,1.30 [0.64-2.63],0.4703985081558804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANSC4,MANSC domain-containing protein 4,18884,64,1.34 [0.98-1.81],0.0641946556967218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,18910,64,1.67 [0.81-3.44],0.1661974592052786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,18884,64,1.09 [0.79-1.51],0.5842765858729205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2,Microtubule-associated protein 2,19518,67,1.32 [0.84-2.08],0.228534242562526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19459,66,1.15 [0.80-1.66],0.4443521661454704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22392,81,1.02 [0.84-1.25],0.8183573012579046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,21953,75,0.95 [0.77-1.18],0.6573887590954131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22222,80,1.10 [0.92-1.32],0.2839345804026308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPK13,Mitogen-activated protein kinase 13,18853,65,1.26 [0.76-2.07],0.3710761056433465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPK9,Mitogen-activated protein kinase 9,22392,81,1.31 [0.83-2.09],0.2475725433650379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPKAPK2,MAP kinase-activated protein kinase 2,19201,67,0.84 [0.60-1.16],0.2811044495690419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPRE3,Microtubule-associated protein RP/EB family member 3,18853,65,1.03 [0.88-1.22],0.6913601594611003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPT,Microtubule-associated protein tau,21936,76,0.85 [0.58-1.23],0.3810641785084907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MARCO,Macrophage receptor MARCO,22453,81,2.06 [0.99-4.26],0.0529864032860816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MARS1,"Methionine--tRNA ligase, cytoplasmic",19122,68,1.16 [0.88-1.52],0.2839468335085311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MASP1,Mannan-binding lectin serine protease 1,22222,80,1.58 [0.68-3.70],0.2912391684245827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN2,Matrilin-2,22479,81,2.01 [1.04-3.86],0.0367066239969872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN3,Matrilin-3,22223,80,1.47 [0.83-2.60],0.1815306267878086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAVS,Mitochondrial antiviral-signaling protein,21953,75,1.09 [0.87-1.36],0.4618829381319966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAX,Protein max,21936,76,1.05 [0.86-1.27],0.641931916941332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MB,Myoglobin,22732,79,1.31 [0.93-1.85],0.1180148871897246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MBL2,Mannose-binding protein C,19307,69,1.01 [0.82-1.25],0.910264548192675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCAM,Cell surface glycoprotein MUC18,22574,80,1.43 [0.81-2.54],0.2190719289681053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19512,65,0.69 [0.36-1.32],0.2668643877533259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCEMP1,Mast cell-expressed membrane protein 1,18976,67,1.02 [0.79-1.33],0.8528661747237316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCFD2,Multiple coagulation factor deficiency protein 2,22338,81,1.39 [0.90-2.17],0.1403978498682258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCTS1,Malignant T-cell-amplified sequence 1,19459,66,0.91 [0.38-2.21],0.8416274818995239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22257,80,1.22 [0.91-1.64],0.1844947655050862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDH1,"Malate dehydrogenase, cytoplasmic",19458,68,1.25 [0.72-2.19],0.4328461882236166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDK,Midkine,22479,78,1.37 [1.01-1.87],0.044603311573022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDM1,Nuclear protein MDM1,19029,66,0.84 [0.39-1.83],0.660860837743495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19070,67,1.01 [0.78-1.31],0.9111320500692404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MED18,Mediator of RNA polymerase II transcription subunit 18,21953,75,1.15 [0.88-1.50],0.3099028837684777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MED21,Mediator of RNA polymerase II transcription subunit 21,18884,64,0.76 [0.42-1.39],0.3786869082575066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF10,Multiple epidermal growth factor-like domains protein 10,22445,81,0.91 [0.54-1.54],0.7314776138747072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF11,Multiple epidermal growth factor-like domains protein 11,18884,64,1.36 [0.74-2.47],0.320789752828142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF9,Multiple epidermal growth factor-like domains protein 9,22666,79,0.96 [0.34-2.67],0.930731636727857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MELTF,Melanotransferrin,19554,67,1.71 [0.86-3.43],0.1286994301557964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MENT,Protein MENT,19150,68,0.53 [0.20-1.42],0.2060216540576121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEP1A,Meprin A subunit alpha,19459,66,1.26 [0.92-1.72],0.1496384641276638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEP1B,Meprin A subunit beta,22453,81,0.98 [0.83-1.15],0.790933386025846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEPE,Matrix extracellular phosphoglycoprotein,22445,81,0.77 [0.37-1.58],0.4705661632528661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MERTK,Tyrosine-protein kinase Mer,22669,80,1.26 [0.58-2.70],0.5601390711475168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MESD,LRP chaperone MESD,22481,80,1.07 [0.91-1.25],0.4472238522252892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MET,Hepatocyte growth factor receptor,22516,78,0.95 [0.35-2.57],0.9170392574104546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP1,Methionine aminopeptidase 1,21936,76,0.86 [0.42-1.76],0.6783571020093189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22392,81,1.13 [0.89-1.43],0.3009412884502698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP2,Methionine aminopeptidase 2,22595,81,1.22 [0.86-1.73],0.2634202057333999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP3,Microfibril-associated glycoprotein 3,22040,77,0.96 [0.63-1.46],0.8415529295358954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP3L,Microfibrillar-associated protein 3-like,19029,66,0.76 [0.48-1.21],0.2529160245195472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP4,Microfibril-associated glycoprotein 4,19150,68,2.55 [1.28-5.10],0.0080874196727731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP5,Microfibrillar-associated protein 5,22732,79,1.28 [0.78-2.10],0.3243125736992257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFGE8,Lactadherin,22481,80,1.54 [1.00-2.36],0.0490738622799198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MGLL,Monoglyceride lipase,22511,81,1.10 [0.88-1.39],0.4104745659310644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MGMT,Methylated-DNA--protein-cysteine methyltransferase,22392,81,1.00 [0.85-1.17],0.9517251881367614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MIA,Melanoma-derived growth regulatory protein,22542,79,0.97 [0.57-1.67],0.920826360498336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MICALL2,MICAL-like protein 2,19029,66,1.14 [0.83-1.56],0.4122883838925489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22392,81,1.00 [0.88-1.13],0.9754542934950317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MIF,Macrophage migration inhibitory factor,22446,80,1.15 [0.85-1.54],0.3587683787746691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MILR1,Allergin-1,22021,77,1.46 [1.00-2.13],0.0511495744856521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19460,68,1.14 [0.92-1.41],0.2441272610983001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MINK1,Misshapen-like kinase 1,19518,67,1.03 [0.80-1.32],0.8271116602418147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MITD1,MIT domain-containing protein 1,22257,80,1.06 [0.86-1.30],0.5879726252461588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MKI67,Proliferation marker protein Ki-67,18976,67,0.76 [0.38-1.54],0.4498853445484327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MLLT1,Protein ENL,18853,65,0.88 [0.59-1.31],0.5241326525476255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MLN,Promotilin,22392,81,0.92 [0.74-1.14],0.4491344620172183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MME,Neprilysin,22343,78,1.24 [0.98-1.56],0.0783454271948919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP1,Interstitial collagenase,21623,76,1.41 [1.11-1.79],0.0047305091490048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP10,Stromelysin-2,22388,80,0.81 [0.58-1.15],0.247780675178937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP12,Macrophage metalloelastase,22450,80,1.15 [0.81-1.63],0.444153269240469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP13,Collagenase 3,21936,76,0.84 [0.45-1.56],0.57420603810055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP15,Matrix metalloproteinase-15,19554,67,0.84 [0.48-1.48],0.5498788314658821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP3,Stromelysin-1,22481,80,1.10 [0.75-1.62],0.6255789175003514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP7,Matrilysin,22005,77,1.36 [0.89-2.08],0.1588894766470327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP8,Neutrophil collagenase,22595,81,1.04 [0.80-1.35],0.7806439057800754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP9,Matrix metalloproteinase-9,22436,80,1.07 [0.77-1.48],0.6736269057776525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",18884,64,0.82 [0.49-1.38],0.4561008992473359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MN1,Transcriptional activator MN1,19029,66,1.37 [1.01-1.87],0.0462991938890195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MNAT1,CDK-activating kinase assembly factor MAT1,19201,67,0.95 [0.54-1.66],0.8586469131335149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MNDA,Myeloid cell nuclear differentiation antigen,22414,81,1.08 [0.90-1.29],0.4252730066947953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MOCS2,Molybdopterin synthase catalytic subunit,19150,68,1.28 [0.91-1.80],0.1548669864517658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MOG,Myelin-oligodendrocyte glycoprotein,22632,81,1.54 [0.87-2.72],0.1342556263712647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORC3,MORC family CW-type zinc finger protein 3,19518,67,0.90 [0.37-2.17],0.8139236393463027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORF4L1,Mortality factor 4-like protein 1,19201,67,0.80 [0.42-1.53],0.498379121746956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORF4L2,Mortality factor 4-like protein 2,18853,65,0.47 [0.20-1.07],0.0721458808307273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORN4,MORN repeat-containing protein 4,18853,65,0.91 [0.65-1.27],0.5618603829613538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPHOSPH8,M-phase phosphoprotein 8,22040,77,1.15 [0.89-1.49],0.2737070538228737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPI,Mannose-6-phosphate isomerase,22343,78,1.08 [0.85-1.36],0.5235609714818992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22511,81,1.11 [0.85-1.46],0.4303327163775026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPO,Myeloperoxidase,22481,80,1.15 [0.77-1.72],0.4874809337731925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPRIP,Myosin phosphatase Rho-interacting protein,19418,67,0.78 [0.45-1.36],0.3822024583739826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRC1,Macrophage mannose receptor 1,19567,68,3.37 [1.71-6.64],0.0004309171640096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRI1,Methylthioribose-1-phosphate isomerase,19029,66,0.98 [0.69-1.39],0.907082425870366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL24,"39S ribosomal protein L24, mitochondrial",18884,64,0.92 [0.47-1.80],0.8038779994295919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL28,"39S ribosomal protein L28, mitochondrial",19512,65,1.02 [0.56-1.88],0.937894914258691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL46,"39S ribosomal protein L46, mitochondrial",21936,76,0.74 [0.34-1.64],0.4628959380192029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL52,"39S ribosomal protein L52, mitochondrial",18812,65,1.13 [0.51-2.50],0.7666172219297865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19512,65,1.18 [0.88-1.57],0.2630671731144218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPS16,"28S ribosomal protein S16, mitochondrial",18976,67,0.67 [0.38-1.17],0.1594085115478537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSLN,Mesothelin,22299,78,1.05 [0.76-1.46],0.7565397187976897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSLNL,Mesothelin-like protein,19029,66,0.79 [0.41-1.54],0.4890615979527827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSMB,Beta-microseminoprotein,22411,79,1.08 [0.82-1.42],0.5957564606369996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSR1,Macrophage scavenger receptor types I and II,22637,81,1.56 [1.02-2.39],0.0391261923473177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSRA,Mitochondrial peptide methionine sulfoxide reductase,22542,79,1.12 [0.85-1.48],0.4031120258193224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MST1,Hepatocyte growth factor-like protein,19270,67,1.01 [0.70-1.45],0.963820554482263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSTN,Growth/differentiation factor 8,22040,77,0.80 [0.55-1.17],0.2457926795046255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTDH,Protein LYRIC,18976,67,1.09 [0.85-1.39],0.5173091393173641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19518,67,0.66 [0.24-1.79],0.4090703868379348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19201,67,0.99 [0.81-1.22],0.9546940788932888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTIF3,"Translation initiation factor IF-3, mitochondrial",19459,66,1.02 [0.78-1.33],0.895035018411618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTPN,Myotrophin,22040,77,1.08 [0.60-1.93],0.8073235740382037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTR,Methionine synthase,18884,64,1.08 [0.77-1.52],0.6481760839519466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTSS1,Protein MTSS 1,19459,66,1.12 [0.91-1.38],0.3009455851617152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTSS2,Protein MTSS 2,19460,68,1.10 [0.87-1.38],0.4294216459627339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTUS1,Microtubule-associated tumor suppressor 1,19201,67,1.42 [1.00-1.99],0.0469068207956905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC13,Mucin-13,21936,76,1.15 [0.78-1.70],0.4670015800214614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC16,Mucin-16,22343,78,0.99 [0.89-1.10],0.8580969385919565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC2,Mucin-2,19568,68,1.17 [0.92-1.49],0.1973992107508835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUCL3,Mucin-like protein 3,18853,65,0.95 [0.54-1.67],0.8543323288076303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MVK,Mevalonate kinase,22021,77,1.33 [1.05-1.68],0.0193382096709161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MXRA8,Matrix remodeling-associated protein 8,19150,68,0.71 [0.34-1.51],0.3786453257747499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYBPC1,"Myosin-binding protein C, slow-type",19554,67,1.34 [0.99-1.80],0.0572562838273642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYBPC2,"Myosin-binding protein C, fast-type",19070,67,1.02 [0.77-1.34],0.8961051661606927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19512,65,0.98 [0.68-1.41],0.9008231052292244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYDGF,Myeloid-derived growth factor,19554,67,1.10 [0.87-1.40],0.4227131635498188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH4,Myosin-4,18884,64,1.16 [0.72-1.85],0.5490053193885684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH7B,Myosin-7B,18853,65,1.05 [0.62-1.78],0.8645364638182413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH9,Myosin-9,19568,68,1.04 [0.85-1.28],0.6915293397713318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",18884,64,1.23 [0.78-1.95],0.3710844726297835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL3,Myosin light chain 3,19070,67,1.09 [0.79-1.50],0.587711565427268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL4,Myosin light chain 4,19070,67,0.83 [0.52-1.32],0.4281644044188446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL6B,Myosin light chain 6B,19029,66,0.83 [0.61-1.14],0.2566887701029668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19029,66,1.01 [0.61-1.67],0.9641738462495102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYO6,Unconventional myosin-VI,19512,65,0.91 [0.46-1.81],0.7898016267589594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYO9B,Unconventional myosin-IXb,22021,77,0.96 [0.70-1.31],0.7761978755709446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOC,Myocilin,22481,80,0.94 [0.60-1.47],0.7959264855298145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM1,Myomesin-1,18910,64,0.94 [0.55-1.62],0.8268797573991958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM2,Myomesin-2,18884,64,0.84 [0.50-1.41],0.5157948500256955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM3,Myomesin-3,19150,68,1.03 [0.80-1.32],0.8354804956830053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MZB1,Marginal zone B- and B1-cell-specific protein,22517,81,1.24 [0.87-1.78],0.2330010621654847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MZT1,Mitotic-spindle organizing protein 1,21953,75,1.18 [0.83-1.68],0.3680589206050452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAA10,N-alpha-acetyltransferase 10,18884,64,1.06 [0.66-1.70],0.8054506443119621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAA80,N-alpha-acetyltransferase 80,19029,66,1.00 [0.82-1.21],0.9671532606796678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAAA,N-acylethanolamine-hydrolyzing acid amidase,22160,79,0.83 [0.59-1.17],0.296839481536751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NACC1,Nucleus accumbens-associated protein 1,19460,68,1.07 [0.71-1.62],0.7548254371151212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NADK,NAD kinase,22453,81,1.32 [0.99-1.75],0.0585672407699326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGA,Alpha-N-acetylgalactosaminidase,18931,67,1.02 [0.67-1.58],0.9122292411951124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGK,N-acetyl-D-glucosamine kinase,19035,67,0.89 [0.58-1.36],0.5799209035451229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19150,68,3.75 [1.40-10.04],0.0086302965951899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAMPT,Nicotinamide phosphoribosyltransferase,21953,75,1.06 [0.74-1.52],0.737582678836968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAP1L4,Nucleosome assembly protein 1-like 4,19417,66,0.99 [0.56-1.75],0.9605446972522798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAPRT,Nicotinate phosphoribosyltransferase,19518,67,0.83 [0.40-1.74],0.6218642092870009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NARS1,"Asparagine--tRNA ligase, cytoplasmic",19512,65,1.08 [0.65-1.80],0.7613532486868668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NBL1,Neuroblastoma suppressor of tumorigenicity 1,22542,79,1.25 [0.61-2.56],0.5489390383402218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NBN,Nibrin,22021,77,1.32 [1.01-1.71],0.0383677032908763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAM1,Neural cell adhesion molecule 1,22574,80,1.58 [0.85-2.94],0.1489994994217548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAM2,Neural cell adhesion molecule 2,22481,80,0.74 [0.35-1.54],0.4170044466933944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAN,Neurocan core protein,22637,81,0.76 [0.46-1.26],0.2875763766799636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCF2,Neutrophil cytosol factor 2,22360,81,1.08 [0.87-1.35],0.4595083087604926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCK2,Cytoplasmic protein NCK2,22549,81,1.08 [0.90-1.31],0.3900087888839956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCLN,Nicalin,22021,77,0.54 [0.29-1.03],0.0608726893914667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR1,Natural cytotoxicity triggering receptor 1,22359,80,1.32 [0.79-2.21],0.282763499152488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19459,66,2.20 [1.17-4.13],0.0144917645524924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCS1,Neuronal calcium sensor 1,22632,81,1.38 [0.70-2.72],0.3558538441466836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDRG1,Protein NDRG1,21936,76,0.62 [0.40-0.97],0.0364568163277454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19460,68,1.04 [0.73-1.49],0.830030833671588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,18953,67,1.48 [0.77-2.86],0.237879399606573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19459,66,1.09 [0.83-1.41],0.5379068626624848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",21953,75,1.13 [0.90-1.42],0.2970147762826195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEB,Nebulin,18884,64,1.07 [0.59-1.95],0.8172362027839158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECAP2,Adaptin ear-binding coat-associated protein 2,18884,64,0.82 [0.55-1.20],0.3028498619474263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN1,Nectin-1,18976,67,0.90 [0.43-1.88],0.7745713705053353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN2,Nectin-2,22410,81,1.79 [0.99-3.24],0.055057428126667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN4,Nectin-4,22542,79,1.27 [0.72-2.26],0.4076926540501698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,18976,67,0.79 [0.50-1.25],0.3208632507721662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEDD9,Enhancer of filamentation 1,18976,67,1.24 [0.67-2.32],0.4918017314094062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEFL,Neurofilament light polypeptide,21868,76,1.93 [1.35-2.76],0.0003447369569169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEK7,Serine/threonine-protein kinase Nek7,19201,67,1.09 [0.81-1.46],0.5695339048338597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NELL1,Protein kinase C-binding protein NELL1,22542,79,1.25 [0.79-1.99],0.3397028027242305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NELL2,Protein kinase C-binding protein NELL2,22549,81,1.46 [0.76-2.78],0.2525430810809351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NENF,Neudesin,19460,68,0.89 [0.69-1.14],0.3445276998300747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEO1,Neogenin,19512,65,1.37 [0.50-3.71],0.5393154656698538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEXN,Nexilin,19567,68,0.98 [0.70-1.38],0.9237699605376948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFASC,Neurofascin,22669,80,2.00 [1.03-3.87],0.0410766068405138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFAT5,Nuclear factor of activated T-cells 5,18976,67,1.02 [0.78-1.33],0.9034701014259492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22392,81,1.11 [0.90-1.35],0.3251229864640048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22021,77,1.30 [0.96-1.77],0.0928993998290439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFE2,Transcription factor NF-E2 45 kDa subunit,19070,67,0.94 [0.68-1.29],0.6946980534737578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFIC,Nuclear factor 1 C-type,19512,65,1.02 [0.61-1.72],0.933583602695168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKB1,Nuclear factor NF-kappa-B p105 subunit,18884,64,1.10 [0.79-1.54],0.553391537704822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKB2,Nuclear factor NF-kappa-B p100 subunit,19201,67,0.79 [0.46-1.37],0.4041339947255894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKBIE,NF-kappa-B inhibitor epsilon,21953,75,1.44 [0.99-2.10],0.0581484493877116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19459,66,1.07 [0.85-1.35],0.5564119804471399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFX1,Transcriptional repressor NF-X1,18884,64,1.06 [0.74-1.51],0.7447535065853312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFYA,Nuclear transcription factor Y subunit alpha,18884,64,1.20 [0.70-2.07],0.5118136154673428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGF,Beta-nerve growth factor,22257,80,0.40 [0.14-1.17],0.0950159951621392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGFR,Tumor necrosis factor receptor superfamily member 16,19554,67,1.20 [0.57-2.51],0.6269049701734313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGRN,Neugrin,19518,67,1.04 [0.38-2.88],0.9405944228468252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NHLRC3,NHL repeat-containing protein 3,18661,67,2.75 [1.30-5.81],0.0081177168896717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID1,Nidogen-1,22491,80,2.20 [1.35-3.57],0.001491914885696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID2,Nidogen-2,22481,80,1.25 [0.97-1.61],0.0877486050263174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NINJ1,Ninjurin-1,21953,75,0.96 [0.65-1.44],0.8569098278535608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NIT1,Deaminated glutathione amidase,19070,67,0.90 [0.55-1.46],0.6697845232887044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NIT2,Omega-amidase NIT2,19482,67,1.07 [0.78-1.48],0.6606540286123802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NLGN1,Neuroligin-1,19029,66,0.83 [0.54-1.27],0.3940761081935658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NLGN2,Neuroligin-2,18910,64,0.88 [0.50-1.55],0.6688341080796316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NME1,Nucleoside diphosphate kinase A,18976,67,0.53 [0.17-1.65],0.2703151102012408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NME3,Nucleoside diphosphate kinase 3,22479,81,0.76 [0.32-1.83],0.5435097555636197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMI,N-myc-interactor,19396,68,1.27 [0.93-1.72],0.1286193362689709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22257,80,1.12 [0.89-1.42],0.3313724410307391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMRK2,Nicotinamide riboside kinase 2,18853,65,0.95 [0.51-1.75],0.8689915099666473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19512,65,0.80 [0.53-1.20],0.2868041221541093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOMO1,Nodal modulator 1,22481,80,0.98 [0.42-2.30],0.9584217132534418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOP56,Nucleolar protein 56,18884,64,1.10 [0.90-1.33],0.3512218744267837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS1,"Nitric oxide synthase, brain",21936,76,1.38 [0.96-1.97],0.0789695589610414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS2,"Nitric oxide synthase, inducible",18884,64,1.16 [0.65-2.08],0.6070703028070408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS3,"Nitric oxide synthase, endothelial",21936,76,1.47 [1.15-1.89],0.0024189116426902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH1,Neurogenic locus notch homolog protein 1,22732,79,1.00 [0.29-3.47],0.9945990431371924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH2,Neurogenic locus notch homolog protein 2,19568,68,1.44 [0.54-3.86],0.4672568971586442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH3,Neurogenic locus notch homolog protein 3,22732,79,1.10 [0.62-1.97],0.7414438517098378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPC2,NPC intracellular cholesterol transporter 2,19226,67,1.84 [1.04-3.25],0.0363740657836362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPDC1,Neural proliferation differentiation and control protein 1,22453,81,1.62 [0.94-2.77],0.0798160614147754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPHS1,Nephrin,18976,67,1.21 [0.62-2.37],0.5842514395126066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPHS2,Podocin,18976,67,1.09 [0.89-1.34],0.416950102183006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPL,N-acetylneuraminate lyase,19554,67,1.74 [1.12-2.69],0.0131800394961944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPPB,Natriuretic peptides B,22040,77,1.14 [0.99-1.33],0.0736028965022135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPPC,C-type natriuretic peptide,22392,81,1.23 [0.84-1.78],0.284447849862018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPR1,Atrial natriuretic peptide receptor 1,18884,64,0.90 [0.47-1.74],0.7583622205022755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTN,Neuroplastin,21953,75,1.09 [0.87-1.38],0.4457369515401254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTX1,Neuronal pentraxin-1,22481,80,1.42 [0.89-2.29],0.1446490016837222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTX2,Neuronal pentraxin-2,19568,68,1.70 [0.85-3.41],0.1323947277830804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTXR,Neuronal pentraxin receptor,22453,81,1.58 [0.95-2.65],0.0796645092032586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPY,Pro-neuropeptide Y,22632,81,1.16 [0.85-1.57],0.3523496503617571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRCAM,Neuronal cell adhesion molecule,22453,81,1.28 [0.65-2.49],0.4750464836173833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRGN,Neurogranin,19567,68,1.10 [0.86-1.42],0.4434423673367303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRN1,Neuritin,19512,65,0.69 [0.31-1.56],0.3781495145328816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRP1,Neuropilin-1,22603,80,1.61 [0.79-3.26],0.1909046368934094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRP2,Neuropilin-2,22481,80,1.79 [0.95-3.37],0.071730374515905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRTN,Neurturin,22021,77,1.43 [1.04-1.96],0.0268472225707922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRXN3,Neurexin-3,19029,66,0.40 [0.16-1.02],0.0541312086787077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NSFL1C,NSFL1 cofactor p47,22637,81,1.22 [0.91-1.64],0.1762573735647342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19554,67,1.03 [0.74-1.42],0.8674147450422611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C1A,Cytosolic 5'-nucleotidase 1A,19518,67,1.75 [1.03-2.96],0.0390580168949145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C3A,Cytosolic 5'-nucleotidase 3A,22361,81,1.06 [0.85-1.34],0.598786116309803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5E,5'-nucleotidase,22542,79,1.46 [1.07-2.01],0.0174566643002955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF3,Neurotrophin-3,22392,81,1.99 [1.30-3.04],0.0014263984105849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF4,Neurotrophin-4,21953,75,1.35 [0.91-2.00],0.1381522921202526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTRK2,BDNF/NT-3 growth factors receptor,22453,81,0.70 [0.32-1.52],0.3648610979284858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTRK3,NT-3 growth factor receptor,22637,81,0.61 [0.25-1.50],0.280586977049802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTproBNP,N-terminal prohormone of brain natriuretic peptide,22453,81,1.21 [1.03-1.41],0.0195280371474191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUB1,NEDD8 ultimate buster 1,22392,81,1.11 [0.88-1.40],0.3754042696127276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19460,68,0.96 [0.74-1.24],0.7442675275582729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUCB2,Nucleobindin-2,22588,81,1.75 [1.06-2.90],0.0291713515915394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDC,Nuclear migration protein nudC,22669,80,1.17 [0.85-1.61],0.3240377493922616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19070,67,0.57 [0.19-1.74],0.3222706980657455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,18884,64,1.01 [0.63-1.61],0.9703352606622624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT16,U8 snoRNA-decapping enzyme,19421,66,1.10 [0.84-1.44],0.4876281140111631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22343,78,1.10 [0.78-1.56],0.5750432858432902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT5,ADP-sugar pyrophosphatase,22481,80,1.19 [0.81-1.73],0.3724993565248612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUMB,Protein numb homolog,18976,67,1.09 [0.82-1.45],0.5691364706400881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUP50,Nuclear pore complex protein Nup50,18884,64,1.14 [0.59-2.21],0.6934614857038806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPE4,NXPE family member 4,18884,64,1.45 [0.82-2.55],0.1989889258835525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPH1,Neurexophilin-1,21936,76,1.43 [0.94-2.20],0.0980400003196262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPH3,Neurexophilin-3,18976,67,1.17 [0.54-2.54],0.6999495282857296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OBP2B,Odorant-binding protein 2b,22190,80,0.88 [0.64-1.21],0.425893315504383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OCLN,Occludin,19512,65,1.74 [1.09-2.78],0.0209402590495288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ODAM,Odontogenic ameloblast-associated protein,21902,76,1.07 [0.76-1.52],0.6919329417277971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OFD1,Oral-facial-digital syndrome 1 protein,19201,67,1.01 [0.71-1.45],0.9357738953486816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGA,Protein O-GlcNAcase,19459,66,1.11 [0.80-1.55],0.533572761633965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGFR,Opioid growth factor receptor,22343,78,1.34 [0.74-2.42],0.339632795337896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGN,Mimecan,22481,80,1.19 [0.76-1.86],0.4563376969021908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19201,67,1.00 [0.68-1.46],0.9933743468571906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OLFM4,Olfactomedin-4,18431,66,1.03 [0.85-1.26],0.7460776478933688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OLR1,Oxidized low-density lipoprotein receptor 1,22231,80,0.98 [0.70-1.37],0.922900874911526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMD,Osteomodulin,22549,81,1.14 [0.72-1.82],0.572364735526105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMG,Oligodendrocyte-myelin glycoprotein,22343,78,1.27 [0.95-1.71],0.11229371279572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMP,Olfactory marker protein,18910,64,0.94 [0.56-1.57],0.8120916902086757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPHN1,Oligophrenin-1,19518,67,1.09 [0.87-1.35],0.46005782627864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPLAH,5-oxoprolinase,19070,67,0.91 [0.64-1.29],0.5872985659255594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPTC,Opticin,22343,78,0.93 [0.59-1.45],0.7440037959741892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ORM1,Alpha-1-acid glycoprotein 1,19513,68,1.01 [0.31-3.24],0.986717346264679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSBPL2,Oxysterol-binding protein-related protein 2,19518,67,0.86 [0.44-1.67],0.6519870964565593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSCAR,Osteoclast-associated immunoglobulin-like receptor,22479,81,0.95 [0.54-1.67],0.8643240916511916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSM,Oncostatin-M,22293,81,1.02 [0.77-1.34],0.90200236737278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSMR,Oncostatin-M-specific receptor subunit beta,22603,80,2.55 [0.98-6.62],0.0540864687666716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSTN,Osteocrin,19029,66,0.75 [0.39-1.46],0.4053268514735586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTOA,Otoancorin,18910,64,0.89 [0.55-1.45],0.6523494780196126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTUD6B,Deubiquitinase OTUD6B,19459,66,1.04 [0.70-1.56],0.83500636083937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTUD7B,OTU domain-containing protein 7B,19512,65,1.04 [0.71-1.53],0.8294083790905986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19070,67,1.11 [0.80-1.55],0.5346634059013937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OXT,Oxytocin-neurophysin 1,22637,81,1.05 [0.92-1.21],0.4715255230450684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,P4HB,Protein disulfide-isomerase,22357,79,1.56 [0.94-2.58],0.0848457075823661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PACS2,Phosphofurin acidic cluster sorting protein 2,18884,64,0.94 [0.63-1.41],0.7771387709247952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PADI2,Protein-arginine deiminase type-2,22021,77,1.05 [0.74-1.48],0.7961860134988615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PADI4,Protein-arginine deiminase type-4,21902,76,0.96 [0.73-1.27],0.8014374205918702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAEP,Glycodelin,22257,80,1.07 [0.87-1.32],0.5291225815353608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19512,65,0.87 [0.67-1.12],0.2802592835101153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19201,67,0.74 [0.44-1.22],0.2359866058912204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22040,77,1.22 [0.87-1.71],0.2556988826833377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAGR1,PAXIP1-associated glutamate-rich protein 1,19070,67,0.77 [0.42-1.39],0.3807132020767759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,18823,65,0.94 [0.59-1.52],0.8125502039047117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAK4,Serine/threonine-protein kinase PAK 4,21936,76,1.13 [0.82-1.56],0.447559894632377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALLD,Palladin,18976,67,0.71 [0.35-1.46],0.3548134917667599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM,Paralemmin-1,19347,66,1.38 [0.69-2.76],0.3663470450419863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM2,Paralemmin-2,19518,67,2.08 [1.25-3.47],0.0051288697931155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM3,Paralemmin-3,18884,64,0.73 [0.45-1.18],0.2054743627508251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAM,Peptidyl-glycine alpha-amidating monooxygenase,22623,79,1.18 [0.57-2.43],0.6574715386273049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAMR1,Inactive serine protease PAMR1,22481,80,0.98 [0.47-2.05],0.9674916868034124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAPPA,Pappalysin-1,22021,77,0.78 [0.51-1.20],0.2638546830476564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARD3,Partitioning defective 3 homolog,19201,67,1.25 [0.98-1.60],0.0724474055548636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARK7,Parkinson disease protein 7,22481,80,1.09 [0.75-1.59],0.6476516882626957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARP1,Poly [ADP-ribose] polymerase 1,22392,81,1.21 [0.94-1.57],0.1361411036105864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAXX,Protein PAXX,19150,68,1.27 [0.77-2.07],0.3499401120814087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBK,Lymphokine-activated killer T-cell-originated protein kinase,18853,65,1.34 [0.63-2.87],0.4442794718271659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBLD,Phenazine biosynthesis-like domain-containing protein,21936,76,1.27 [0.86-1.87],0.2335348643221806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19459,66,0.57 [0.24-1.38],0.2161937170822624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCARE,Photoreceptor cilium actin regulator,18910,64,1.10 [0.86-1.41],0.4583517159428901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19121,68,1.98 [1.32-2.98],0.001034051757615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBP2,Poly(rC)-binding protein 2,19512,65,0.99 [0.71-1.37],0.929221087843286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH1,Protocadherin-1,22594,79,1.83 [0.85-3.92],0.1228986733552251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH12,Protocadherin-12,19512,65,1.83 [0.74-4.53],0.1938810356769333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH17,Protocadherin-17,22453,81,1.62 [0.97-2.70],0.0631475960810074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH7,Protocadherin-7,19459,66,0.72 [0.34-1.55],0.4049777054804852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH9,Protocadherin-9,19459,66,2.40 [1.25-4.61],0.0085699275093298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDHB15,Protocadherin beta-15,19460,68,0.73 [0.40-1.33],0.3014135403535094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCNA,Proliferating cell nuclear antigen,18853,65,1.04 [0.72-1.51],0.8356727422788217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCSK7,Proprotein convertase subtilisin/kexin type 7,19460,68,1.36 [0.94-1.98],0.1065531191088579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCSK9,Proprotein convertase subtilisin/kexin type 9,22732,79,1.38 [0.84-2.26],0.2030763876415731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCYT2,Ethanolamine-phosphate cytidylyltransferase,19459,66,1.13 [0.83-1.55],0.4230303118521833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDAP1,28 kDa heat- and acid-stable phosphoprotein,19554,67,0.99 [0.78-1.26],0.9198887555093528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD1,Programmed cell death protein 1,22590,81,1.08 [0.69-1.67],0.7454735377522045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD1LG2,Programmed cell death 1 ligand 2,22343,78,0.83 [0.44-1.56],0.5538587514195408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD5,Programmed cell death protein 5,22637,81,1.24 [0.89-1.72],0.1982049107245481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD6,Programmed cell death protein 6,22453,81,1.00 [0.76-1.33],0.9956216448470518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCL2,Phosducin-like protein 2,18853,65,1.18 [0.81-1.71],0.3794164294280142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",18853,65,1.17 [0.80-1.70],0.4178008039540013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",18884,64,1.14 [0.80-1.63],0.4738870882607583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19150,68,1.22 [0.96-1.54],0.0975206796273113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFA,Platelet-derived growth factor subunit A,22732,79,1.15 [0.88-1.52],0.3051788840293079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFB,Platelet-derived growth factor subunit B,22549,81,1.20 [0.95-1.51],0.1242160682786136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFC,Platelet-derived growth factor C,21953,75,1.31 [0.65-2.63],0.4506342029751086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFRA,Platelet-derived growth factor receptor alpha,22453,81,1.08 [0.54-2.13],0.8314221441989815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFRB,Platelet-derived growth factor receptor beta,22732,79,0.89 [0.50-1.57],0.6812647630064457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA2,Protein disulfide-isomerase A2,18853,65,1.09 [0.62-1.90],0.7602113199125392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA3,Protein disulfide-isomerase A3,19150,68,2.36 [1.17-4.77],0.0167939105470709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA4,Protein disulfide-isomerase A4,19568,68,1.06 [0.73-1.56],0.7512029108584097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA5,Protein disulfide-isomerase A5,18853,65,1.05 [0.72-1.54],0.7907469844737409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDLIM5,PDZ and LIM domain protein 5,19512,65,1.03 [0.84-1.26],0.7905855578939156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDLIM7,PDZ and LIM domain protein 7,22549,81,1.02 [0.87-1.19],0.829381958794505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",21953,75,1.32 [0.96-1.81],0.0898265331072788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDRG1,p53 and DNA damage-regulated protein 1,19029,66,0.93 [0.58-1.50],0.7790961083634039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,18853,65,0.82 [0.49-1.38],0.4619545397840985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZD2,PDZ domain-containing protein 2,18884,64,1.10 [0.74-1.62],0.6428887329904185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,18976,67,1.91 [1.25-2.89],0.0024814898118437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEAR1,Platelet endothelial aggregation receptor 1,22732,79,1.64 [0.68-3.95],0.2717931264662001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEBP1,Phosphatidylethanolamine-binding protein 1,22481,80,1.19 [0.85-1.66],0.310404322728628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PECAM1,Platelet endothelial cell adhesion molecule,22481,80,1.52 [0.81-2.86],0.1911917062046703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PECR,Peroxisomal trans-2-enoyl-CoA reductase,19070,67,0.38 [0.14-1.01],0.0515164236642226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PENK,Proenkephalin-A,19150,68,1.66 [0.96-2.89],0.070730493911772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEPD,Xaa-Pro dipeptidase,19567,68,1.56 [0.64-3.77],0.3271617845833134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PER3,Period circadian protein homolog 3,18976,67,1.08 [0.89-1.30],0.4486776225202551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PF4,Platelet factor 4,19442,69,1.22 [0.97-1.54],0.0889736018994207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN2,Prefoldin subunit 2,21936,76,1.16 [0.81-1.67],0.4113357743421801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN4,Prefoldin subunit 4,18853,65,0.59 [0.34-1.03],0.0650700279819502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN6,Prefoldin subunit 6,19029,66,1.09 [0.79-1.51],0.5814822209767156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22299,77,1.01 [0.78-1.31],0.948970269746266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGA4,Pepsin A-4,19567,68,1.11 [0.83-1.49],0.4680314690330978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19554,67,1.28 [0.84-1.97],0.2541829044883575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGF,Placenta growth factor,22669,80,1.25 [0.60-2.63],0.5532079697051395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP1,Peptidoglycan recognition protein 1,22638,79,1.36 [0.89-2.08],0.1490743014510459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19347,69,1.07 [0.49-2.32],0.8631502841217906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP4,Peptidoglycan recognition protein 4,18884,64,0.98 [0.64-1.48],0.9056661867599914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGM2,Phosphoglucomutase-2,19029,66,1.11 [0.78-1.59],0.5530769384350944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGR,Progesterone receptor,18976,67,0.84 [0.61-1.17],0.2988002909587148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHACTR2,Phosphatase and actin regulator 2,19512,65,1.09 [0.89-1.35],0.396319147040802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHLDB1,Pleckstrin homology-like domain family B member 1,19459,66,1.31 [0.85-2.02],0.2157460698424957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHLDB2,Pleckstrin homology-like domain family B member 2,18853,65,1.04 [0.82-1.33],0.7188259090092075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22257,80,1.24 [0.64-2.39],0.5233828194605941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19150,68,1.98 [1.15-3.43],0.0141689375694566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PI16,Peptidase inhibitor 16,19567,68,0.99 [0.39-2.46],0.9751747010274624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PI3,Elafin,22180,78,0.82 [0.57-1.20],0.306400172246048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19512,65,0.98 [0.72-1.33],0.8735979637970184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIGR,Polymeric immunoglobulin receptor,22182,80,1.72 [1.03-2.89],0.0397487618478204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22392,81,1.24 [0.92-1.68],0.1631951755315177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22481,80,1.12 [0.57-2.20],0.7335119631506846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,18976,67,0.77 [0.47-1.25],0.2935482316922013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRA,Paired immunoglobulin-like type 2 receptor alpha,22481,80,1.28 [0.80-2.05],0.2973214728751721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRB,Paired immunoglobulin-like type 2 receptor beta,22453,81,1.19 [0.83-1.69],0.3430582531874086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19150,68,1.07 [0.77-1.50],0.6786388388210766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PITHD1,PITH domain-containing protein 1,18823,65,0.97 [0.71-1.32],0.83854818280622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKD1,Polycystin-1,19554,67,2.44 [1.00-5.92],0.0497279368955026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKD2,Polycystin-2,18884,64,1.23 [0.84-1.80],0.2847043782124653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKLR,Pyruvate kinase PKLR,22481,81,1.18 [0.89-1.56],0.242042329574386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKN3,Serine/threonine-protein kinase N3,19201,67,1.02 [0.75-1.40],0.8785653097259758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G10,Group 10 secretory phospholipase A2,22257,80,0.93 [0.66-1.30],0.670703705416875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G15,Phospholipase A2 group XV,22542,79,2.62 [1.33-5.14],0.0052049561736242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G1B,Phospholipase A2,22702,79,0.96 [0.62-1.47],0.8370200647456978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G2A,"Phospholipase A2, membrane associated",22416,78,1.36 [1.03-1.80],0.0278275839658464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G4A,Cytosolic phospholipase A2,22549,81,1.12 [0.90-1.41],0.3055759232798729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G7,Platelet-activating factor acetylhydrolase,22481,80,0.99 [0.55-1.78],0.9821754716020412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAT,Tissue-type plasminogen activator,22666,79,1.07 [0.73-1.59],0.7190029360145558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAU,Urokinase-type plasminogen activator,22481,80,1.11 [0.59-2.08],0.7528843465976981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAUR,Urokinase plasminogen activator surface receptor,22302,81,1.77 [0.91-3.44],0.0897895769518491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLB1,"Phospholipase B1, membrane-associated",19518,67,0.92 [0.62-1.36],0.6628619725111988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",18976,67,1.17 [0.70-1.96],0.5577938981366821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19518,67,1.01 [0.79-1.28],0.9477867896853638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLEKHO1,Pleckstrin homology domain-containing family O member 1,19518,67,1.03 [0.73-1.44],0.8748124611379068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLG,Plasminogen,19099,69,0.84 [0.28-2.49],0.7563452918384942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLIN1,Perilipin-1,21936,76,1.18 [0.68-2.07],0.5508600153857703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLIN3,Perilipin-3,22453,81,1.13 [0.72-1.78],0.5992143114671837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLPBP,Pyridoxal phosphate homeostasis protein,22453,81,1.15 [0.86-1.54],0.3308359455582574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLSCR3,Phospholipid scramblase 3,19478,67,1.12 [0.75-1.68],0.567207801359665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLTP,Phospholipid transfer protein,22669,79,0.70 [0.41-1.20],0.1927174636736876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXDC1,Plexin domain-containing protein 1,21953,75,0.58 [0.27-1.24],0.1616548894952271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXDC2,Plexin domain-containing protein 2,19518,67,0.81 [0.33-1.96],0.6363091763608912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNA4,Plexin-A4,22392,81,1.04 [0.82-1.32],0.7366665598922335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB2,Plexin-B2,22617,79,2.64 [1.23-5.63],0.0122323380280997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB3,Plexin-B3,22391,81,1.23 [0.81-1.85],0.3319861598247865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22323,80,1.05 [0.94-1.17],0.3758387000067505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMCH,Pro-MCH,18884,64,1.06 [0.82-1.38],0.6421213655280914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMM2,Phosphomannomutase 2,18884,64,1.03 [0.68-1.54],0.9006048923842151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMS1,PMS1 protein homolog 1,19029,66,1.09 [0.70-1.69],0.698445805777522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMVK,Phosphomevalonate kinase,21898,75,1.06 [0.88-1.29],0.5411810821565166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIP,Pancreatic triacylglycerol lipase,19567,68,0.86 [0.60-1.22],0.3857995595462478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIPRP1,Inactive pancreatic lipase-related protein 1,19518,67,0.86 [0.65-1.15],0.3184629282861891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIPRP2,Pancreatic lipase-related protein 2,22445,81,0.99 [0.93-1.06],0.8673169878474943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNMA1,Paraneoplastic antigen Ma1,19070,67,1.01 [0.66-1.54],0.9722395257086692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNMA2,Paraneoplastic antigen Ma2,18910,64,1.14 [0.70-1.88],0.5949036316682974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22021,77,1.01 [0.84-1.20],0.9371334670632306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PODXL,Podocalyxin,22343,78,0.34 [0.09-1.24],0.1017232435311813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PODXL2,Podocalyxin-like protein 2,22542,79,1.97 [1.01-3.84],0.0477858884538641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POF1B,Protein POF1B,18976,67,1.06 [0.65-1.74],0.8198592385495573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POLR2A,DNA-directed RNA polymerase II subunit RPB1,18976,67,0.66 [0.28-1.58],0.3518884488524326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22343,78,1.39 [0.88-2.18],0.1550348455591013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POMC,Pro-opiomelanocortin,19070,67,0.78 [0.56-1.09],0.1481803338053083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON1,Serum paraoxonase/arylesterase 1,19567,68,1.18 [0.51-2.72],0.7049545197728051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON2,Serum paraoxonase/arylesterase 2,22040,77,1.03 [0.58-1.83],0.9189080263294488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON3,Serum paraoxonase/lactonase 3,22549,81,0.68 [0.46-1.01],0.0586599075136883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POSTN,Periostin,19568,68,1.13 [0.61-2.07],0.7021711951473372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPBP,Platelet basic protein,19454,69,1.16 [0.88-1.53],0.2936432321894979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPCDC,Phosphopantothenoylcysteine decarboxylase,22637,81,1.26 [0.84-1.90],0.2680287388027911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIB,Peptidyl-prolyl cis-trans isomerase B,22497,78,1.06 [0.86-1.31],0.5908079188471167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIE,Peptidyl-prolyl cis-trans isomerase E,19201,67,1.09 [0.77-1.54],0.6299388957457703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19568,68,0.96 [0.65-1.40],0.8127077309768609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPL,Periplakin,18976,67,1.18 [0.59-2.36],0.6429774876043366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1A,Protein phosphatase 1A,21953,75,0.83 [0.42-1.62],0.5797725144752075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1B,Protein phosphatase 1B,18976,67,0.84 [0.52-1.36],0.48059213831338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1F,Protein phosphatase 1F,19554,67,1.06 [0.68-1.66],0.7925287959835603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPME1,Protein phosphatase methylesterase 1,22343,78,1.17 [0.84-1.62],0.3532790988564793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19460,68,1.03 [0.78-1.36],0.846446124320942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22542,79,1.18 [0.97-1.45],0.103797703406407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19201,67,0.98 [0.71-1.37],0.9192184692567934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19512,65,0.93 [0.68-1.26],0.6374376114587067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19512,65,1.45 [0.88-2.39],0.1400638649812253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R2,Protein phosphatase inhibitor 2,22453,81,1.07 [0.84-1.37],0.5725132338067465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R9B,Neurabin-2,22669,80,1.07 [0.87-1.32],0.5205942132737595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19459,66,1.02 [0.84-1.24],0.847157772050773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP3R1,Calcineurin subunit B type 1,22257,80,1.22 [0.75-1.97],0.4248146115129417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPT1,Palmitoyl-protein thioesterase 1,19029,66,1.05 [0.78-1.41],0.7544953411506355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPY,Pancreatic prohormone,22447,78,1.08 [0.89-1.30],0.436605216678572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PQBP1,Polyglutamine-binding protein 1,21953,75,1.13 [0.83-1.54],0.4303585018183389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRAME,Melanoma antigen preferentially expressed in tumors,18853,65,0.72 [0.28-1.88],0.5061763764099326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRAP1,Proline-rich acidic protein 1,19568,68,1.02 [0.58-1.81],0.9430413405756428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRC1,Protein regulator of cytokinesis 1,19460,68,1.05 [0.62-1.75],0.8658056455274337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRCP,Lysosomal Pro-X carboxypeptidase,22611,78,1.42 [0.79-2.53],0.2397185679892096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX1,Peroxiredoxin-1,21792,77,0.95 [0.75-1.20],0.6660132345892352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX2,Peroxiredoxin-2,19225,67,0.93 [0.64-1.35],0.7008869446105526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22021,77,1.24 [0.94-1.63],0.1242286708581855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX5,"Peroxiredoxin-5, mitochondrial",22669,80,1.04 [0.77-1.40],0.814443254545167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX6,Peroxiredoxin-6,22632,81,1.05 [0.76-1.43],0.778206060580259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PREB,Prolactin regulatory element-binding protein,22021,77,1.96 [1.29-2.97],0.0016154919566451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRELP,Prolargin,22445,81,0.91 [0.40-2.04],0.8118951875400717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRG2,Bone marrow proteoglycan,19568,68,1.27 [0.83-1.94],0.2774778180793924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRG3,Proteoglycan 3,19568,68,0.97 [0.62-1.52],0.8933768794291733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22021,77,1.07 [0.74-1.56],0.7152402180669475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19029,66,0.73 [0.32-1.65],0.4484901549955505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22453,81,1.02 [0.81-1.29],0.85399689111991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19482,67,1.00 [0.75-1.34],0.9841498144062872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKCQ,Protein kinase C theta type,22021,77,0.98 [0.62-1.56],0.9353136791735196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKD2,Serine/threonine-protein kinase D2,18884,64,0.84 [0.45-1.55],0.572848507223598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKG1,cGMP-dependent protein kinase 1,19150,68,1.07 [0.89-1.29],0.4818971304289124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,21953,75,1.29 [0.97-1.73],0.0821215726849314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRL,Prolactin,22637,81,1.08 [0.83-1.40],0.5709806662788455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRND,Prion-like protein doppel,19518,67,1.11 [0.71-1.73],0.641039140077375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROC,Vitamin K-dependent protein C,22527,80,1.46 [0.67-3.22],0.341378003789234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROCR,Endothelial protein C receptor,18884,64,1.12 [0.59-2.13],0.7291305641451897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROK1,Prokineticin-1,22392,81,0.87 [0.61-1.25],0.4491395254770602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROS1,Vitamin K-dependent protein S,19587,69,0.74 [0.30-1.84],0.5231301388088787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRR4,Proline-rich protein 4,18994,68,1.18 [0.86-1.62],0.3098888694641488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRR5,Proline-rich protein 5,18976,67,0.77 [0.43-1.36],0.3658311120996894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRRT3,Proline-rich transmembrane protein 3,19070,67,1.00 [0.55-1.82],0.9900838132541826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS2,Trypsin-2,22574,80,1.24 [0.89-1.74],0.2038398601493309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS22,Brain-specific serine protease 4,18976,67,1.09 [0.58-2.03],0.7917070970502078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS27,Serine protease 27,22389,81,0.97 [0.60-1.58],0.9067756947197918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS53,Serine protease 53,19518,67,0.92 [0.51-1.66],0.7782758366554015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS8,Prostasin,22365,81,1.25 [0.79-1.98],0.3374125075844869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,21936,76,1.06 [0.88-1.28],0.514197496798958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTG,Protogenin,22632,81,1.09 [0.49-2.44],0.8266012300799358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTN3,Myeloblastin,21885,77,1.09 [0.74-1.61],0.6693876413416668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRUNE2,Protein prune homolog 2,19201,67,1.18 [0.55-2.50],0.6732722314047237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAP,Prosaposin,19374,68,2.50 [1.58-3.98],9.827205896099337e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAPL1,Proactivator polypeptide-like 1,19459,66,0.75 [0.47-1.21],0.2425068947341563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSCA,Prostate stem cell antigen,19459,66,1.06 [0.96-1.16],0.2424584630877899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSG1,Pregnancy-specific beta-1-glycoprotein 1,22257,80,1.10 [0.92-1.32],0.2958402614034682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSIP1,PC4 and SFRS1-interacting protein,22392,81,1.26 [1.00-1.60],0.052090705827458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMA1,Proteasome subunit alpha type-1,21953,75,0.68 [0.41-1.13],0.134621150051805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMC3,26S proteasome regulatory subunit 6A,18853,65,0.76 [0.34-1.68],0.4907852819583926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD1,26S proteasome non-ATPase regulatory subunit 1,19512,65,0.85 [0.52-1.40],0.5357157149271962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD5,26S proteasome non-ATPase regulatory subunit 5,19029,66,1.32 [0.99-1.78],0.0626884086388095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD9,26S proteasome non-ATPase regulatory subunit 9,22343,78,1.25 [0.90-1.74],0.1854796169147591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSME1,Proteasome activator complex subunit 1,22207,80,1.59 [0.95-2.65],0.0770116340532651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSME2,Proteasome activator complex subunit 2,22144,80,1.50 [0.89-2.54],0.129150200670197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMG3,Proteasome assembly chaperone 3,22392,81,1.30 [0.91-1.88],0.1518209614364182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMG4,Proteasome assembly chaperone 4,18976,67,0.98 [0.65-1.46],0.9051428316474788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSPN,Persephin,22392,81,1.13 [0.92-1.40],0.2501765574899575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSRC1,Proline/serine-rich coiled-coil protein 1,21953,75,1.21 [0.88-1.67],0.2368800418267032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18488,65,1.10 [0.88-1.39],0.4063148946631364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",21936,76,1.25 [0.64-2.43],0.5143269158290544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGDS,Prostaglandin-H2 D-isomerase,22298,80,1.61 [0.91-2.84],0.1026228106050536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGES2,Prostaglandin E synthase 2,18833,67,1.04 [0.67-1.61],0.8588814766832042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGR1,Prostaglandin reductase 1,19554,67,1.26 [0.97-1.65],0.0836519279164162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTH,Parathyroid hormone,19029,66,0.86 [0.63-1.15],0.3075711204273474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22392,81,1.22 [0.80-1.87],0.3531520030490702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTK7,Inactive tyrosine-protein kinase 7,21936,76,0.92 [0.54-1.59],0.7763939760205631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTN,Pleiotrophin,22040,77,1.46 [0.99-2.15],0.0554621830361794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTP4A3,Protein tyrosine phosphatase type IVA 3,18976,67,1.23 [0.84-1.80],0.2861505585529538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22257,80,1.13 [0.88-1.44],0.3423774598330388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22511,81,1.05 [0.84-1.31],0.6955529912543268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,18947,67,1.59 [1.02-2.47],0.039282217316037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRB,Receptor-type tyrosine-protein phosphatase beta,19554,67,2.53 [1.16-5.48],0.0190547087278074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRC,Receptor-type tyrosine-protein phosphatase C,19568,68,2.31 [1.01-5.29],0.0474696805974274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRF,Receptor-type tyrosine-protein phosphatase F,22732,79,0.79 [0.40-1.57],0.5054581682884927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRH,Receptor-type tyrosine-protein phosphatase H,19459,66,1.48 [0.92-2.37],0.1054350253392258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19459,66,1.83 [0.74-4.48],0.1890436349692162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRM,Receptor-type tyrosine-protein phosphatase mu,22362,81,0.90 [0.40-2.00],0.7964779410058016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22191,80,1.36 [0.76-2.43],0.2957902467303275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRR,Receptor-type tyrosine-protein phosphatase R,19518,67,1.20 [0.65-2.20],0.5664731488732375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRS,Receptor-type tyrosine-protein phosphatase S,22732,79,1.18 [0.54-2.60],0.6795177712569982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19554,67,1.55 [0.76-3.15],0.2247271389227874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19150,68,1.09 [0.74-1.61],0.6719163977040689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTS,6-pyruvoyl tetrahydrobiopterin synthase,21826,76,1.68 [1.23-2.29],0.0009866476188279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTTG1,Securin,19201,67,0.73 [0.39-1.36],0.3227098839932263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTX3,Pentraxin-related protein PTX3,22392,81,1.80 [1.12-2.89],0.0146874093120286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PVALB,Parvalbumin alpha,22511,79,1.09 [0.91-1.31],0.3584896577199042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PVR,Poliovirus receptor,22637,81,1.21 [0.72-2.03],0.4781645946439734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PXDNL,Peroxidasin-like protein,19460,68,1.22 [0.89-1.66],0.2180187172101635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PXN,Paxillin,21936,76,1.16 [0.80-1.68],0.4234004825202886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PYDC1,Pyrin domain-containing protein 1,19070,67,0.88 [0.49-1.59],0.671681283359279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PYY,Peptide YY,18884,64,1.12 [0.90-1.41],0.3150453320078411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PZP,Pregnancy zone protein,19587,69,0.92 [0.58-1.48],0.7447319014751941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QDPR,Dihydropteridine reductase,22344,80,1.25 [0.79-1.97],0.3443055736704112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QPCT,Glutaminyl-peptide cyclotransferase,22510,78,2.27 [1.18-4.34],0.0134341210741814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QSOX1,Sulfhydryl oxidase 1,19198,68,1.09 [0.65-1.84],0.748504441779394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB10,Ras-related protein Rab-10,19554,67,0.96 [0.61-1.49],0.8405048446769904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB11FIP3,Rab11 family-interacting protein 3,19554,67,1.05 [0.85-1.31],0.6347025932131574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB27B,Ras-related protein Rab-27B,19554,67,1.18 [0.88-1.58],0.2822285458388173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB2B,Ras-related protein Rab-2B,19460,68,1.00 [0.68-1.46],0.980509655182134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB33A,Ras-related protein Rab-33A,18884,64,0.94 [0.64-1.36],0.7232881314445463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB37,Ras-related protein Rab-37,22021,77,1.22 [0.99-1.50],0.0571207700822705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB39B,Ras-related protein Rab-39B,18884,64,1.16 [0.94-1.43],0.1579396324997414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,18910,64,1.39 [1.05-1.83],0.019407440303049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB44,Ras-related protein Rab-44,19460,68,1.15 [0.72-1.83],0.5520803379615734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB6A,Ras-related protein Rab-6A,22392,81,1.02 [0.67-1.56],0.9238963479946584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB6B,Ras-related protein Rab-6B,21936,76,0.95 [0.62-1.47],0.8175602780724092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEP1,Rab GTPase-binding effector protein 1,19150,68,1.08 [0.80-1.46],0.6095261069774547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEPK,Rab9 effector protein with kelch motifs,21953,75,1.38 [1.05-1.83],0.0229556602093156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABGAP1L,Rab GTPase-activating protein 1-like,22021,77,1.36 [1.00-1.86],0.0516005384470413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAC3,Ras-related C3 botulinum toxin substrate 3,19029,66,1.09 [0.80-1.50],0.5722588354936553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAD23B,UV excision repair protein RAD23 homolog B,21953,75,0.94 [0.60-1.48],0.7821913283586288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAD51,DNA repair protein RAD51 homolog 1,19201,67,1.07 [0.70-1.62],0.762691643025841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RALB,Ras-related protein Ral-B,18976,67,1.02 [0.46-2.25],0.9669765252880156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RALY,RNA-binding protein Raly,19460,68,1.45 [1.03-2.05],0.0336867008118445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANBP1,Ran-specific GTPase-activating protein,19070,67,0.84 [0.54-1.32],0.4574742739414517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANBP2,E3 SUMO-protein ligase RanBP2,18910,64,1.32 [0.65-2.67],0.4403737703164591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANGAP1,Ran GTPase-activating protein 1,21953,75,0.60 [0.35-1.01],0.0564869895723695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAP1A,Ras-related protein Rap-1A,18976,67,1.02 [0.73-1.43],0.8964625452957034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAPGEF2,Rap guanine nucleotide exchange factor 2,19201,67,0.76 [0.47-1.24],0.2756441007396428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES1,Retinoic acid receptor responder protein 1,21953,75,1.57 [1.07-2.31],0.0208706902068351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES2,Retinoic acid receptor responder protein 2,22603,80,1.38 [0.94-2.01],0.0964214929033899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASA1,Ras GTPase-activating protein 1,21936,76,0.74 [0.39-1.42],0.3681801915533959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,18853,65,1.20 [0.72-2.00],0.4892000991204113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASSF2,Ras association domain-containing protein 2,21953,75,1.24 [0.93-1.64],0.1444645053710044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBFOX3,RNA binding protein fox-1 homolog 3,19512,65,1.74 [1.14-2.65],0.01091984687717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBKS,Ribokinase,21920,79,1.18 [0.80-1.74],0.3963021471116024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM17,Splicing factor 45,19512,65,1.00 [0.73-1.37],0.9826851049035376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM19,Probable RNA-binding protein 19,18884,64,0.88 [0.50-1.57],0.67333143120177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM25,RNA-binding protein 25,18853,65,1.20 [0.74-1.95],0.4546529670846575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP1,Retinol-binding protein 1,19029,66,0.78 [0.49-1.22],0.2764850382638505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP2,Retinol-binding protein 2,22343,78,1.16 [0.91-1.49],0.2349063998323573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP5,Retinol-binding protein 5,22343,78,1.45 [1.04-2.02],0.0286661037729963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP7,Retinoid-binding protein 7,19459,66,0.90 [0.60-1.35],0.6189365261122809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBPMS,RNA-binding protein with multiple splicing,18976,67,0.88 [0.58-1.35],0.5568229040722111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBPMS2,RNA-binding protein with multiple splicing 2,19070,67,0.96 [0.77-1.21],0.7589963170947178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCC1,Regulator of chromosome condensation,19460,68,1.41 [1.01-1.97],0.0450861352817857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCOR1,REST corepressor 1,22040,77,1.05 [0.68-1.64],0.8255139178077797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19070,67,1.10 [0.35-3.46],0.8642764116750666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REEP4,Receptor expression-enhancing protein 4,19512,65,0.96 [0.65-1.42],0.8386067600090992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG1A,Lithostathine-1-alpha,22331,80,1.28 [0.90-1.83],0.1726528257470924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG1B,Lithostathine-1-beta,22732,79,1.12 [0.80-1.56],0.5111792890817417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG3A,Regenerating islet-derived protein 3-alpha,22732,79,1.16 [0.86-1.55],0.3298333141431195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG3G,Regenerating islet-derived protein 3-gamma,19460,68,1.16 [0.68-2.00],0.5885127721830434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG4,Regenerating islet-derived protein 4,22479,81,1.37 [0.96-1.96],0.0793301964858321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RELB,Transcription factor RelB,18976,67,0.93 [0.56-1.53],0.7717215437465736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RELT,Tumor necrosis factor receptor superfamily member 19L,22481,80,1.65 [0.89-3.06],0.1153221644855272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REN,Renin,22453,81,0.95 [0.74-1.20],0.6519446512098113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REPS1,RalBP1-associated Eps domain-containing protein 1,18976,67,0.78 [0.41-1.50],0.4605731309641506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REST,RE1-silencing transcription factor,18853,65,1.74 [1.04-2.91],0.034878183503376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22343,78,0.83 [0.50-1.39],0.4764290944698328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RETN,Resistin,22415,78,1.28 [0.83-1.98],0.2657241360026114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REXO2,"Oligoribonuclease, mitochondrial",18884,64,1.09 [0.69-1.71],0.7110233485835699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RFC4,Replication factor C subunit 4,19460,68,0.79 [0.25-2.49],0.6886903117551428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGCC,Regulator of cell cycle RGCC,19512,65,0.93 [0.68-1.27],0.6561656462661725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19201,67,1.33 [1.03-1.70],0.0264402505249049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGMA,Repulsive guidance molecule A,22637,81,0.85 [0.46-1.58],0.6180934614280669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGMB,RGM domain family member B,22637,81,0.69 [0.34-1.42],0.3116516576176734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGS10,Regulator of G-protein signaling 10,19512,65,0.91 [0.61-1.36],0.6429473449738058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGS8,Regulator of G-protein signaling 8,22021,77,1.08 [0.82-1.43],0.5811628016188131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RHOC,Rho-related GTP-binding protein RhoC,22128,79,1.08 [0.90-1.28],0.4110038109578245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RICTOR,Rapamycin-insensitive companion of mTOR,18976,67,1.05 [0.66-1.67],0.8530210284703494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19150,68,1.59 [1.05-2.41],0.0276702110563707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RILP,Rab-interacting lysosomal protein,22558,80,1.43 [1.04-1.97],0.0277535839031174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RILPL2,RILP-like protein 2,19554,67,1.10 [0.87-1.40],0.4264105884597643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,18884,64,0.99 [0.70-1.41],0.9734636966863048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RLN1,Prorelaxin H1,19512,65,1.30 [0.93-1.83],0.1291421284281308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RLN2,Prorelaxin H2,19113,68,1.03 [0.65-1.65],0.8930632711116141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE1,Ribonuclease pancreatic,19567,68,2.21 [1.26-3.88],0.0058925222940178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE10,Inactive ribonuclease-like protein 10,19070,67,0.74 [0.45-1.23],0.2451586966192766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE3,Eosinophil cationic protein,22350,81,0.98 [0.83-1.17],0.8424897587180425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE4,Ribonuclease 4,18887,64,1.82 [0.90-3.69],0.0946140757001694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE6,Ribonuclease K6,19424,67,1.86 [1.27-2.74],0.0016273923900105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASEH2A,Ribonuclease H2 subunit A,19512,65,0.99 [0.61-1.61],0.9661466866145926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASET2,Ribonuclease T2,22640,78,2.05 [1.13-3.74],0.018713084343478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF149,E3 ubiquitin-protein ligase RNF149,19070,67,1.43 [0.73-2.80],0.3017299131654722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF168,E3 ubiquitin-protein ligase RNF168,18976,67,0.78 [0.40-1.51],0.4545208332169183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF31,E3 ubiquitin-protein ligase RNF31,18976,67,1.16 [0.63-2.12],0.6343051387497058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF4,E3 ubiquitin-protein ligase RNF4,19201,67,0.97 [0.68-1.40],0.8835183654669077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF41,E3 ubiquitin-protein ligase NRDP1,21953,75,1.07 [0.79-1.46],0.6678085538172454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF43,E3 ubiquitin-protein ligase RNF43,19201,67,0.64 [0.36-1.13],0.1237279669096908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF5,E3 ubiquitin-protein ligase RNF5,19070,67,1.10 [0.80-1.54],0.5522437046933241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO1,Roundabout homolog 1,22479,81,2.03 [0.95-4.34],0.0664692740857057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO2,Roundabout homolog 2,22637,81,0.64 [0.27-1.52],0.3118740757909778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO4,Roundabout homolog 4,19070,67,0.77 [0.21-2.87],0.6959195438074474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22453,81,0.93 [0.51-1.69],0.8049932400860651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RP2,Protein XRP2,22343,78,1.27 [0.81-2.00],0.2960419546228243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPA2,Replication protein A 32 kDa subunit,18976,67,0.84 [0.38-1.90],0.6815348821546734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPE,Ribulose-phosphate 3-epimerase,19201,67,0.94 [0.67-1.34],0.7442366690589954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPGR,X-linked retinitis pigmentosa GTPase regulator,19029,66,0.93 [0.51-1.68],0.797773895696588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPL14,60S ribosomal protein L14,19070,67,0.87 [0.46-1.65],0.6701208602526902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPS10,40S ribosomal protein S10,18884,64,0.81 [0.42-1.55],0.5202427994936305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRAS,Ras-related protein R-Ras,19029,66,1.01 [0.84-1.22],0.8957815597219289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRM2,Ribonucleoside-diphosphate reductase subunit M2,21953,75,1.30 [0.98-1.71],0.0673755580140355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,21953,75,0.95 [0.70-1.29],0.7439711817607805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRP15,RRP15-like protein,18910,64,1.08 [0.84-1.39],0.5485244039566759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RSPO1,R-spondin-1,22257,80,1.27 [0.71-2.24],0.4213933000587812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RSPO3,R-spondin-3,22632,81,1.16 [0.59-2.27],0.6666473700429445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTBDN,Retbindin,22343,78,1.44 [0.86-2.43],0.1660982741221853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTKN2,Rhotekin-2,18884,64,1.46 [1.09-1.96],0.0121747295608432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19512,65,1.01 [0.78-1.30],0.9609550002211696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTN4R,Reticulon-4 receptor,22632,81,1.46 [0.85-2.49],0.1675572495676022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RUVBL1,RuvB-like 1,21953,75,1.07 [0.90-1.29],0.4381324056850103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RWDD1,RWD domain-containing protein 1,22637,81,1.16 [0.85-1.58],0.3401444433212516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RYR1,Ryanodine receptor 1,18884,64,1.26 [0.71-2.23],0.4355552786428331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A11,Protein S100-A11,22281,81,1.07 [0.72-1.58],0.731050804786519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A12,Protein S100-A12,22126,77,1.06 [0.81-1.39],0.6582593817090752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A13,Protein S100-A13,18976,67,1.22 [0.66-2.26],0.5253454792633698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A14,Protein S100-A14,19512,65,1.32 [0.88-1.97],0.1799591300481457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A16,Protein S100-A16,21902,76,0.91 [0.64-1.28],0.5813586782120708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A3,Protein S100-A3,19460,68,0.41 [0.17-0.97],0.0424460485273027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A4,Protein S100-A4,22542,79,0.99 [0.69-1.40],0.9411286879122668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100G,Protein S100-G,19512,65,1.38 [0.89-2.12],0.1491128645000202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100P,Protein S100-P,22040,77,1.18 [0.86-1.62],0.3179911341842264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAA4,Serum amyloid A-4 protein,19587,69,1.51 [0.98-2.33],0.0610387728000906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAFB2,Scaffold attachment factor B2,19512,65,0.84 [0.34-2.09],0.710468808881628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAG,S-arrestin,18910,64,1.10 [0.70-1.72],0.6813362514624405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAMD9L,Sterile alpha motif domain-containing protein 9-like,22392,81,1.10 [0.84-1.44],0.5034063237653851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAP18,Histone deacetylase complex subunit SAP18,19201,67,0.72 [0.52-0.99],0.0427849162688713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SARG,Specifically androgen-regulated gene protein,19465,67,1.07 [0.86-1.32],0.563943201970878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SART1,U4/U6.U5 tri-snRNP-associated protein 1,18884,64,1.35 [0.84-2.15],0.2112073893012472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAT1,Diamine acetyltransferase 1,18884,64,0.83 [0.48-1.43],0.4937446811273169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAT2,Thialysine N-epsilon-acetyltransferase,19201,67,0.66 [0.43-1.01],0.0561882428596412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SATB1,DNA-binding protein SATB1,19512,65,1.03 [0.46-2.33],0.9368177390512834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SBSN,Suprabasin,19530,68,0.76 [0.39-1.48],0.4170749640972403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCAMP3,Secretory carrier-associated membrane protein 3,22343,78,1.14 [0.90-1.44],0.267918228265104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARA5,Scavenger receptor class A member 5,22637,81,0.98 [0.51-1.89],0.9465094032569128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB1,Scavenger receptor class B member 1,21936,76,1.08 [0.76-1.51],0.6748520600604092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB2,Lysosome membrane protein 2,21832,77,1.74 [1.02-2.96],0.0416778873014201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARF1,Scavenger receptor class F member 1,22732,79,1.36 [0.86-2.15],0.1932981973911202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARF2,Scavenger receptor class F member 2,22637,81,1.29 [0.66-2.51],0.4565280288507447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCG2,Secretogranin-2,22514,80,1.60 [0.90-2.84],0.1078353528677142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCG3,Secretogranin-3,22479,81,1.49 [0.84-2.64],0.1708036222624231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB1A1,Uteroglobin,22458,80,1.08 [0.77-1.53],0.6527314739059976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB2A2,Mammaglobin-A,18884,64,1.52 [0.83-2.79],0.1788445279551258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB3A1,Secretoglobin family 3A member 1,19150,68,0.67 [0.28-1.63],0.3788805125763672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB3A2,Secretoglobin family 3A member 2,22511,81,0.83 [0.64-1.07],0.1519298440925638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGN,Secretagogin,22021,77,1.26 [0.82-1.92],0.2867100346929753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCIN,Adseverin,18910,64,0.98 [0.70-1.37],0.9227970690587518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCLY,Selenocysteine lyase,22558,80,2.00 [1.38-2.91],0.0002535700471255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN2A,Sodium channel protein type 2 subunit alpha,18910,64,1.49 [1.05-2.10],0.0240255856137091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN2B,Sodium channel subunit beta-2,19029,66,1.01 [0.44-2.29],0.9888331197176105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN3A,Sodium channel protein type 3 subunit alpha,19029,66,1.01 [0.52-1.97],0.979025651856911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN3B,Sodium channel subunit beta-3,18910,64,0.96 [0.58-1.59],0.8710646261393103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN4B,Sodium channel subunit beta-4,19070,67,0.87 [0.50-1.51],0.625859289521646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCP2,Non-specific lipid-transfer protein,21953,75,1.13 [0.88-1.45],0.348922201687683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCPEP1,Retinoid-inducible serine carboxypeptidase,18994,67,1.01 [0.62-1.63],0.977134651907991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRG1,Scrapie-responsive protein 1,19554,67,1.27 [0.56-2.88],0.5640451705267828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRIB,Protein scribble homolog,19070,67,1.00 [0.77-1.30],0.9782489658401828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRN1,Secernin-1,22392,81,1.05 [0.74-1.48],0.7932577564866352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCT,Secretin,19029,66,0.81 [0.49-1.33],0.4051523979637469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC1,Syndecan-1,22453,81,1.66 [1.06-2.58],0.0252480556533008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC4,Syndecan-4,22453,81,0.99 [0.65-1.51],0.9774755486681612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDCCAG8,Serologically defined colon cancer antigen 8,19460,68,1.03 [0.84-1.27],0.7624835220012804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDHB,Succinate dehydrogenase,19459,66,1.24 [0.89-1.72],0.2028783454532622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDK2,Protein sidekick-2,19150,68,1.15 [0.64-2.05],0.642967552512035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEC31A,Protein transport protein Sec31A,19070,67,1.10 [0.81-1.50],0.55655689980204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEL1L,Protein sel-1 homolog 1,19070,67,1.24 [0.66-2.34],0.5014684993545773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELE,E-selectin,22732,79,1.16 [0.78-1.72],0.4545200971014801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELENOP,Selenoprotein P,19587,69,1.19 [0.45-3.16],0.7220851281342975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELL,L-selectin,19587,69,1.60 [0.61-4.22],0.3413257466084691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELP,P-selectin,22574,80,1.15 [0.81-1.62],0.437541357494838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELPLG,P-selectin glycoprotein ligand 1,22392,81,0.64 [0.37-1.09],0.1019332838999706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA3F,Semaphorin-3F,22453,81,1.54 [0.75-3.17],0.2417018250041545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA3G,Semaphorin-3G,19150,68,1.52 [0.95-2.43],0.0791306335420213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA4C,Semaphorin-4C,22343,78,0.82 [0.38-1.76],0.6131501981338965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA4D,Semaphorin-4D,22637,81,1.18 [0.61-2.28],0.618242972289459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA6C,Semaphorin-6C,18976,67,1.07 [0.44-2.58],0.8845487271500121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA7A,Semaphorin-7A,22666,79,1.94 [1.15-3.25],0.0126534566853992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN3,Neuronal-specific septin-3,19512,65,0.92 [0.66-1.27],0.6092533447241011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN7,Septin-7,19201,67,0.76 [0.44-1.31],0.3241445665458997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN8,Septin-8,19489,67,1.67 [0.91-3.06],0.0947207356680655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN9,Septin-9,22343,78,0.92 [0.45-1.86],0.8151685019582491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA1,Alpha-1-antitrypsin,19202,68,2.36 [0.19-29.43],0.5059646257074533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA11,Serpin A11,22732,79,1.65 [1.01-2.71],0.0472820504550886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA12,Serpin A12,21777,78,1.05 [0.88-1.25],0.5828419640732393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA3,Alpha-1-antichymotrypsin,19502,69,1.75 [0.44-6.91],0.4230712476618302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA4,Kallistatin,19221,69,0.85 [0.32-2.25],0.7397654622554208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA5,Plasma serine protease inhibitor,19299,69,0.45 [0.19-1.03],0.0576510774230472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA6,Corticosteroid-binding globulin,19587,69,2.53 [0.61-10.52],0.2003998591051488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA7,Thyroxine-binding globulin,19587,69,1.22 [0.36-4.17],0.746645244421458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA9,Serpin A9,22236,78,1.14 [0.87-1.50],0.336158039564949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB1,Leukocyte elastase inhibitor,22401,80,1.07 [0.86-1.33],0.5546483844620309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB5,Serpin B5,22040,77,0.83 [0.56-1.23],0.3596597420724278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB6,Serpin B6,22566,81,1.03 [0.73-1.45],0.8640871450034996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB8,Serpin B8,22669,80,1.08 [0.79-1.47],0.6415801288836037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB9,Serpin B9,22257,80,1.54 [0.85-2.80],0.1569683460942502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINC1,Antithrombin-III,19555,69,1.57 [0.34-7.33],0.5665017623906377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPIND1,Heparin cofactor 2,19555,69,1.31 [0.58-2.96],0.5090995073567224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINE1,Plasminogen activator inhibitor 1,22732,79,1.08 [0.80-1.46],0.5955265921668536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINE2,Glia-derived nexin,19554,67,1.11 [0.78-1.60],0.5569562350774038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINF1,Pigment epithelium-derived factor,19290,68,0.66 [0.27-1.60],0.3574855885492725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINF2,Alpha-2-antiplasmin,19221,69,2.40 [0.46-12.44],0.2955233036499052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPING1,Plasma protease C1 inhibitor,19555,69,1.15 [0.33-4.01],0.8232331899530876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINH1,Serpin H1,19201,67,1.03 [0.86-1.23],0.7817880875361588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINI1,Neuroserpin,19122,68,0.98 [0.45-2.14],0.9563404141148198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINI2,Serpin I2,19459,66,1.15 [0.77-1.72],0.4797713890332177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,21936,76,1.22 [0.91-1.64],0.1834702393385782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SETMAR,Histone-lysine N-methyltransferase SETMAR,22181,80,2.07 [1.22-3.51],0.0068595062321279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6,Seizure protein 6 homolog,19029,66,0.92 [0.42-2.01],0.8289333254460978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6L,Seizure 6-like protein,22542,79,1.72 [0.87-3.40],0.1215823958799014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6L2,Seizure 6-like protein 2,22343,78,2.19 [1.03-4.64],0.0410705527037618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SF3B4,Splicing factor 3B subunit 4,22343,78,1.04 [0.79-1.36],0.7795887582868722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFRP1,Secreted frizzled-related protein 1,22192,80,1.30 [0.84-2.00],0.2342443697820675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFRP4,Secreted frizzled-related protein 4,19150,68,1.59 [0.88-2.87],0.124273340931556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPA1,Pulmonary surfactant-associated protein A1,21953,75,1.10 [0.79-1.53],0.5738293356905001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPA2,Pulmonary surfactant-associated protein A2,21953,75,1.31 [0.92-1.87],0.1303214506880188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPD,Pulmonary surfactant-associated protein D,22453,81,1.18 [0.89-1.58],0.2572538499986909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SGSH,N-sulphoglucosamine sulphohydrolase,19200,67,1.10 [0.73-1.65],0.6615699911046462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH2B3,SH2B adapter protein 3,21953,75,1.13 [0.91-1.39],0.2712269475193615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH2D1A,SH2 domain-containing protein 1A,22392,81,1.23 [0.93-1.63],0.1435830471151565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,18910,64,0.97 [0.64-1.46],0.8795129869412189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3BP1,SH3 domain-binding protein 1,19459,66,1.12 [0.71-1.78],0.6170921646325094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3GL3,Endophilin-A3,19107,67,0.92 [0.70-1.21],0.5710042058292399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3GLB2,Endophilin-B2,19518,67,0.97 [0.69-1.37],0.8831486747197613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHBG,Sex hormone-binding globulin,19567,68,0.98 [0.61-1.57],0.9253244520410278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHC1,SHC-transforming protein 1,18853,65,1.15 [0.96-1.37],0.1208960005476681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHD,SH2 domain-containing adapter protein D,18839,64,1.08 [0.84-1.38],0.5472665972134589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHH,Sonic hedgehog protein,18976,67,1.08 [0.62-1.87],0.790050053077181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHISA5,Protein shisa-5,19568,68,1.94 [1.07-3.53],0.0290194468768959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHMT1,"Serine hydroxymethyltransferase, cytosolic",22511,81,1.26 [1.00-1.59],0.0477560300461258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHPK,Sedoheptulokinase,19201,67,0.57 [0.27-1.18],0.1294283281752285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIAE,Sialate O-acetylesterase,22507,79,1.75 [1.16-2.63],0.0074187448297948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC1,Sialoadhesin,22549,81,1.63 [1.05-2.52],0.0287550858887526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC10,Sialic acid-binding Ig-like lectin 10,22392,81,1.75 [1.08-2.85],0.0236133606633882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC15,Sialic acid-binding Ig-like lectin 15,21936,76,0.91 [0.68-1.21],0.5228892230503994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC5,Sialic acid-binding Ig-like lectin 5,22481,80,0.97 [0.83-1.14],0.7230086480488499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC6,Sialic acid-binding Ig-like lectin 6,22632,81,1.44 [0.82-2.53],0.2011609613280411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC7,Sialic acid-binding Ig-like lectin 7,22453,81,1.32 [0.65-2.67],0.4373989721528231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19070,67,1.66 [1.02-2.73],0.043081746976393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC9,Sialic acid-binding Ig-like lectin 9,22595,80,0.84 [0.44-1.61],0.5946345416178911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIL1,Nucleotide exchange factor SIL1,19070,67,1.25 [0.67-2.31],0.4822324895002268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22519,78,1.20 [0.83-1.72],0.3359278553080432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRPB1,Signal-regulatory protein beta-1,22415,81,1.13 [0.75-1.69],0.5692320509159741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT1,NAD-dependent protein deacetylase sirtuin-1,18976,67,0.78 [0.52-1.17],0.2254413144347213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT2,NAD-dependent protein deacetylase sirtuin-2,22343,78,1.07 [0.85-1.34],0.5628352278280231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",21936,76,1.10 [0.77-1.57],0.5974637787493828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIT1,Signaling threshold-regulating transmembrane adapter 1,22021,77,1.16 [0.81-1.66],0.4058662028565418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKAP1,Src kinase-associated phosphoprotein 1,22222,80,1.09 [0.84-1.43],0.509647785232018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKAP2,Src kinase-associated phosphoprotein 2,22549,81,1.01 [0.84-1.22],0.9010597582554716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKIV2L,Helicase SKI2W,18884,64,1.30 [0.79-2.17],0.3033085560940057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLA2,Src-like-adapter 2,19512,65,1.00 [0.80-1.26],0.9906678664569392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF1,Signaling lymphocytic activation molecule,22021,77,1.42 [1.01-1.98],0.0420483904603589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF6,SLAM family member 6,21953,75,1.69 [1.04-2.73],0.0323694683580324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF7,SLAM family member 7,22392,81,1.25 [0.90-1.72],0.181111583200144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF8,SLAM family member 8,21953,75,1.27 [0.87-1.86],0.2090603579886801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC12A2,Solute carrier family 12 member 2,18884,64,1.35 [0.66-2.78],0.4123189736546515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC13A1,Solute carrier family 13 member 1,19460,68,1.14 [0.82-1.58],0.4256968901870122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC16A1,Monocarboxylate transporter 1,21936,76,1.38 [1.06-1.79],0.0172466833984303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC1A4,Neutral amino acid transporter A,19029,66,1.02 [0.64-1.64],0.9196757381848144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC27A4,Long-chain fatty acid transport protein 4,21936,76,1.01 [0.74-1.38],0.9503222320572872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC28A1,Sodium/nucleoside cotransporter 1,18853,65,0.83 [0.51-1.32],0.4256873525146628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC34A3,Sodium-dependent phosphate transport protein 2C,18853,65,1.11 [0.71-1.75],0.649837336569791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC39A14,Zinc transporter ZIP14,21936,76,1.20 [0.70-2.06],0.518375334655659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC39A5,Zinc transporter ZIP5,22392,81,0.78 [0.54-1.14],0.2026392392564753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC44A4,Choline transporter-like protein 4,19029,66,1.09 [0.79-1.49],0.6061653092282824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC4A1,Band 3 anion transport protein,19568,68,0.93 [0.57-1.51],0.7610558766458486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC51B,Organic solute transporter subunit beta,18884,64,1.18 [0.88-1.57],0.2642266481551268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19150,68,1.05 [0.80-1.39],0.7072340532360721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19459,66,1.06 [0.68-1.66],0.7879074296888124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",18853,65,1.12 [0.76-1.65],0.566011943553475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLIT2,Slit homolog 2 protein,21936,76,1.04 [0.71-1.52],0.8377597622289819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK1,SLIT and NTRK-like protein 1,18976,67,1.03 [0.50-2.13],0.9284191019566136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK2,SLIT and NTRK-like protein 2,22632,81,1.13 [0.69-1.83],0.6302581563949545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK6,SLIT and NTRK-like protein 6,22040,77,0.74 [0.41-1.33],0.316541730331041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLK,STE20-like serine/threonine-protein kinase,19201,67,1.02 [0.76-1.37],0.8793648802931543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLMAP,Sarcolemmal membrane-associated protein,19459,66,1.05 [0.79-1.39],0.7476867091684898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLURP1,Secreted Ly-6/uPAR-related protein 1,19427,68,1.47 [0.90-2.41],0.1275332537387067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD1,Mothers against decapentaplegic homolog 1,21953,75,1.14 [0.89-1.45],0.3084420334729177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD2,Mothers against decapentaplegic homolog 2,19460,68,1.07 [0.76-1.49],0.7068439886042646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD3,Mothers against decapentaplegic homolog 3,19460,68,1.04 [0.66-1.63],0.8735570143011018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD5,Mothers against decapentaplegic homolog 5,22343,78,0.65 [0.24-1.75],0.3939869146968661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMARCA2,Probable global transcription activator SNF2L2,21936,76,0.98 [0.73-1.31],0.9029218939498608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMC3,Structural maintenance of chromosomes protein 3,18853,65,0.88 [0.55-1.42],0.6055987809767653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMNDC1,Survival of motor neuron-related-splicing factor 30,19459,66,1.09 [0.76-1.56],0.6411929256019213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMOC1,SPARC-related modular calcium-binding protein 1,22632,81,1.55 [0.88-2.72],0.127491945114052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMOC2,SPARC-related modular calcium-binding protein 2,22549,81,1.40 [0.86-2.30],0.1804186381559475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPD1,Sphingomyelin phosphodiesterase,22527,81,1.04 [0.71-1.54],0.8262863668458635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPD3,Sphingomyelin phosphodiesterase 3,18976,67,0.68 [0.37-1.26],0.2167371258173025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22519,81,1.02 [0.76-1.37],0.8937578309280322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19460,68,1.03 [0.77-1.37],0.8417789833859151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMS,Spermine synthase,18910,64,0.87 [0.57-1.33],0.5202425922255371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMTN,Smoothelin,19489,67,1.03 [0.81-1.33],0.7912514785315754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP23,Synaptosomal-associated protein 23,22453,81,1.13 [0.90-1.43],0.2992580933009295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP25,Synaptosomal-associated protein 25,18910,64,1.33 [0.81-2.17],0.2630228678431671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP29,Synaptosomal-associated protein 29,22542,79,1.15 [0.92-1.43],0.2104906877678124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAPIN,SNARE-associated protein Snapin,19512,65,0.90 [0.59-1.37],0.6180211216618001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNCA,Alpha-synuclein,19150,68,1.02 [0.84-1.25],0.8186251928529509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNCG,Gamma-synuclein,22257,80,1.15 [0.86-1.55],0.3505202195340671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19070,67,1.45 [0.77-2.71],0.2460363155188333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNRPB2,U2 small nuclear ribonucleoprotein B'',19518,67,1.06 [0.65-1.74],0.8128978968753795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNU13,NHP2-like protein 1,18884,64,0.55 [0.30-0.98],0.0423327567210612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX15,Sorting nexin-15,19150,68,1.12 [0.73-1.71],0.5942826406983721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX18,Sorting nexin-18,19459,66,1.20 [0.74-1.96],0.4540708787050788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX2,Sorting nexin-2,19460,68,0.85 [0.63-1.15],0.2954954193190062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX5,Sorting nexin-5,19070,67,0.32 [0.12-0.84],0.0201287936648479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX9,Sorting nexin-9,22453,81,1.23 [0.93-1.63],0.1454525252433832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD1,Superoxide dismutase [Cu-Zn],22044,78,1.41 [0.95-2.09],0.0839903218269728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD2,"Superoxide dismutase [Mn], mitochondrial",22481,80,1.74 [1.12-2.70],0.0136109558308121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD3,Extracellular superoxide dismutase,19567,68,0.73 [0.43-1.24],0.2410977940717308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORBS1,Sorbin and SH3 domain-containing protein 1,19512,65,0.97 [0.52-1.79],0.9149222237937304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORCS2,VPS10 domain-containing receptor SorCS2,21953,75,1.64 [0.97-2.78],0.0654764408672882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORD,Sorbitol dehydrogenase,22527,80,1.34 [0.99-1.81],0.0597381445468775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORT1,Sortilin,22410,81,1.57 [0.94-2.63],0.0844512297134287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOST,Sclerostin,22410,81,1.31 [0.80-2.15],0.2879335007702633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19029,66,1.07 [0.70-1.66],0.7470641733044765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOX2,Transcription factor SOX-2,19471,65,1.42 [0.56-3.60],0.455604269608173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOX9,Transcription factor SOX-9,19029,66,1.00 [0.42-2.40],0.9996525528997114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19512,65,1.74 [1.00-3.04],0.0519192977108908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPAG1,Sperm-associated antigen 1,19512,65,0.90 [0.58-1.39],0.620553199936565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPARC,SPARC,22542,79,1.20 [0.90-1.62],0.2176972188338979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPARCL1,SPARC-like protein 1,22496,80,1.35 [0.72-2.55],0.3534019048799259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPART,Spartin,19150,68,1.10 [0.81-1.49],0.5391112658824115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPESP1,Sperm equatorial segment protein 1,19554,67,1.11 [0.54-2.28],0.7662299642727504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK1,Serine protease inhibitor Kazal-type 1,22481,80,1.31 [0.86-1.99],0.2110862955086837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK2,Serine protease inhibitor Kazal-type 2,19150,68,1.30 [0.74-2.28],0.3605320236811504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK4,Serine protease inhibitor Kazal-type 4,22392,81,1.19 [0.91-1.57],0.2115586104111503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK5,Serine protease inhibitor Kazal-type 5,22481,80,0.58 [0.32-1.06],0.074673464536601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK6,Serine protease inhibitor Kazal-type 6,22632,81,1.18 [0.81-1.71],0.3991508234367872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK8,Serine protease inhibitor Kazal-type 8,18884,64,1.28 [0.76-2.17],0.3574479647941611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT1,Kunitz-type protease inhibitor 1,22414,80,0.79 [0.36-1.76],0.5669881174087983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT2,Kunitz-type protease inhibitor 2,22549,81,1.72 [1.05-2.80],0.0303819131475103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT3,Kunitz-type protease inhibitor 3,19459,66,0.98 [0.84-1.15],0.7883347857242415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPOCK1,Testican-1,22257,80,1.67 [0.79-3.54],0.1807224265072766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPON1,Spondin-1,22479,81,1.70 [1.03-2.81],0.0397661072287982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPON2,Spondin-2,22347,81,1.26 [0.72-2.19],0.4197455550791497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPP1,Osteopontin,22704,79,1.12 [0.74-1.71],0.5882617117278303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",18976,67,0.87 [0.48-1.56],0.6404535735994843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRING1,SREBP regulating gene protein,18853,65,0.77 [0.45-1.29],0.3165769061407216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRR1B,Cornifin-B,19201,67,1.07 [0.82-1.40],0.6372104341446635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRR3,Small proline-rich protein 3,19518,67,0.89 [0.63-1.26],0.5023205412777021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRY2,Protein sprouty homolog 2,22021,77,1.09 [0.87-1.35],0.4582468323287938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",18910,64,0.90 [0.41-1.98],0.8007903851382012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPTLC1,Serine palmitoyltransferase 1,19518,67,1.09 [0.61-1.96],0.7708492654879903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRC,Proto-oncogene tyrosine-protein kinase Src,22501,79,1.04 [0.88-1.23],0.6317208122261062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRP14,Signal recognition particle 14 kDa protein,22343,78,1.20 [0.88-1.65],0.2496831523221145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRPK2,SRSF protein kinase 2,22392,81,1.08 [0.86-1.36],0.4967928928131317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRPX,Sushi repeat-containing protein SRPX,19554,67,1.69 [0.90-3.16],0.1008520255748045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSB,Lupus La protein,21936,76,1.07 [0.80-1.44],0.6434804780557646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",18976,67,1.10 [0.57-2.13],0.7685895964476814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22410,81,0.95 [0.80-1.13],0.5388821792297236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22574,80,1.18 [0.74-1.87],0.4925762173318465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSH3,Protein phosphatase Slingshot homolog 3,18853,65,0.84 [0.36-2.00],0.7004790211999823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSNA1,Sjoegren syndrome nuclear autoantigen 1,19459,66,0.97 [0.61-1.52],0.8891553436505397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST13,Hsc70-interacting protein,19150,68,1.05 [0.70-1.59],0.8046973774817838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22343,78,1.31 [0.86-2.00],0.2137632343314623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22732,79,2.12 [1.38-3.25],0.0006219966407914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",18976,67,0.97 [0.58-1.61],0.9026678372732932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAB2,Stabilin-2,19568,68,1.17 [0.51-2.69],0.7154364462380389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAM,Signal transducing adapter molecule 1,19460,68,1.18 [0.66-2.10],0.5830643676356073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAMBP,STAM-binding protein,22222,80,1.15 [0.84-1.56],0.3908155820888489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAT2,Signal transducer and activator of transcription 2,18976,67,1.19 [0.88-1.61],0.2602250888668541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAT5B,Signal transducer and activator of transcription 5B,22343,78,1.07 [0.92-1.23],0.3955075475396076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,18853,65,0.95 [0.65-1.41],0.8131053738477265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STC1,Stanniocalcin-1,22637,81,1.09 [0.70-1.68],0.7116139995723634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STC2,Stanniocalcin-2,22451,80,1.75 [0.77-3.98],0.180511959657906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STEAP4,Metalloreductase STEAP4,18910,64,0.85 [0.57-1.25],0.4001661793267972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STIP1,Stress-induced-phosphoprotein 1,22446,80,1.09 [0.81-1.46],0.5894676049652589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK11,Serine/threonine-protein kinase STK11,22040,77,1.16 [0.88-1.52],0.3010540733716734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK24,Serine/threonine-protein kinase 24,21936,76,0.98 [0.70-1.36],0.8837623105652659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK4,Serine/threonine-protein kinase 4,22453,81,1.12 [0.89-1.40],0.3286947539031098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STOML2,"Stomatin-like protein 2, mitochondrial",18853,65,0.91 [0.68-1.22],0.5354186279089825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX16,Syntaxin-16,21953,75,0.84 [0.57-1.25],0.3887927017364641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX1B,Syntaxin-1B,19029,66,0.74 [0.37-1.47],0.3936166910123897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX3,Syntaxin-3,19518,67,1.16 [0.68-1.99],0.5843896724877873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX4,Syntaxin-4,22343,78,1.13 [0.83-1.54],0.4302149594549247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX5,Syntaxin-5,18976,67,1.25 [0.77-2.05],0.3679325728590846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX6,Syntaxin-6,21953,75,0.85 [0.60-1.21],0.3616840429040577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX7,Syntaxin-7,18976,67,0.94 [0.58-1.51],0.7874929356418423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX8,Syntaxin-8,22392,81,1.08 [0.72-1.62],0.7035640307836659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STXBP1,Syntaxin-binding protein 1,19512,65,1.00 [0.73-1.36],0.9883265243058718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STXBP3,Syntaxin-binding protein 3,21953,75,0.99 [0.61-1.60],0.9526096106907492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUGP1,SURP and G-patch domain-containing protein 1,19459,66,1.11 [0.62-1.99],0.7147784843684859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUGT1,Protein SGT1 homolog,21953,75,1.07 [0.83-1.39],0.5820809737194812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SULT1A1,Sulfotransferase 1A1,22637,81,1.00 [0.86-1.17],0.9501456205684974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SULT2A1,Bile salt sulfotransferase,22392,81,1.35 [1.00-1.80],0.0467834465261286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUMF1,Formylglycine-generating enzyme,18976,67,1.22 [0.92-1.61],0.1671563602901374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22637,81,1.20 [0.81-1.76],0.3624465333690648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUOX,"Sulfite oxidase, mitochondrial",19512,65,1.25 [0.88-1.78],0.2148886641109064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD1,Sushi domain-containing protein 1,22040,77,1.24 [0.82-1.87],0.303663488597566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD2,Sushi domain-containing protein 2,22481,80,0.79 [0.39-1.58],0.5031399357353431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD4,Sushi domain-containing protein 4,19460,68,1.10 [0.64-1.90],0.7243493357077242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD5,Sushi domain-containing protein 5,19036,67,1.48 [0.75-2.90],0.2561839918299377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SV2A,Synaptic vesicle glycoprotein 2A,19029,66,1.25 [0.90-1.74],0.1744731035654273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SWAP70,Switch-associated protein 70,19459,66,1.40 [0.80-2.48],0.2412443125993402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYAP1,Synapse-associated protein 1,19150,68,1.01 [0.67-1.53],0.9475818500682311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,18910,64,1.07 [0.73-1.58],0.7224616254886681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYT1,Synaptotagmin-1,19518,67,1.27 [0.82-1.98],0.2840746966592267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYTL4,Synaptotagmin-like protein 4,19554,67,0.97 [0.70-1.33],0.8336042915737626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19201,67,1.00 [0.80-1.25],0.9724256896968132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TACC3,Transforming acidic coiled-coil-containing protein 3,22343,78,1.01 [0.85-1.19],0.9458586039053176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TACSTD2,Tumor-associated calcium signal transducer 2,19826,75,0.65 [0.32-1.34],0.2434333317369277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TADA3,Transcriptional adapter 3,19460,68,1.47 [0.84-2.57],0.1744232613037994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAFA5,Chemokine-like protein TAFA-5,22343,78,1.10 [0.65-1.88],0.7126061749643275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAGLN3,Transgelin-3,18853,65,0.98 [0.66-1.47],0.9269973479898412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TALDO1,Transaldolase,19484,68,1.24 [0.74-2.07],0.4112916632187693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TANK,TRAF family member-associated NF-kappa-B activator,22021,77,0.99 [0.74-1.33],0.9474872779995815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAP1,Antigen peptide transporter 1,19201,67,1.11 [0.79-1.57],0.54164081925866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARBP2,RISC-loading complex subunit TARBP2,21936,76,1.11 [0.86-1.43],0.4394778717557278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19029,66,1.01 [0.75-1.36],0.93826300252588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19460,68,1.09 [0.59-1.99],0.7814613206644827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAX1BP1,Tax1-binding protein 1,19518,67,0.94 [0.64-1.38],0.7632626362679349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D17,TBC1 domain family member 17,21936,76,1.41 [0.99-2.02],0.0579975031373466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D23,TBC1 domain family member 23,22343,78,1.00 [0.80-1.25],0.9850514629979076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D5,TBC1 domain family member 5,22392,81,1.08 [0.85-1.37],0.5363690008451243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCA,Tubulin-specific chaperone A,19150,68,1.03 [0.78-1.35],0.8495208736547664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCB,Tubulin-folding cofactor B,22257,80,1.09 [0.89-1.33],0.409483269117208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCC,Tubulin-specific chaperone C,22257,80,1.14 [0.89-1.46],0.3028682522085884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBL1X,F-box-like/WD repeat-containing protein TBL1X,21953,75,1.16 [0.91-1.48],0.2223637446896999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBR1,T-box brain protein 1,19029,66,0.92 [0.55-1.55],0.7542067068445163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCL1A,T-cell leukemia/lymphoma protein 1A,22235,80,1.16 [0.96-1.40],0.1234213545212989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCL1B,T-cell leukemia/lymphoma protein 1B,22040,77,0.90 [0.67-1.21],0.4874128206125053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCN1,Transcobalamin-1,19158,66,1.45 [0.77-2.72],0.2483104103088743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCN2,Transcobalamin-2,22704,79,1.43 [0.80-2.54],0.222546623738296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCOF1,Treacle protein,19554,67,1.31 [0.68-2.55],0.4213944328153779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCP11,T-complex protein 11 homolog,19201,67,0.67 [0.37-1.20],0.1766972762632197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCTN3,Tectonic-3,19554,67,0.86 [0.39-1.88],0.6985783423166825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDGF1,Teratocarcinoma-derived growth factor 1,21936,76,0.99 [0.86-1.14],0.8646989708238513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDO2,"Tryptophan 2,3-dioxygenase",19029,66,1.01 [0.54-1.89],0.9658414439976626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDP1,Tyrosyl-DNA phosphodiesterase 1,19460,68,1.09 [0.79-1.49],0.5964051598133283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDRKH,Tudor and KH domain-containing protein,21936,76,1.16 [0.92-1.47],0.1990559368073403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEF,Thyrotroph embryonic factor,18884,64,1.10 [0.66-1.84],0.7176524009607911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEK,Angiopoietin-1 receptor,22542,79,3.61 [1.52-8.56],0.0036409873036645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TERF1,Telomeric repeat-binding factor 1,18976,67,0.90 [0.39-2.07],0.7990616541930299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TET2,Methylcytosine dioxygenase TET2,19154,67,1.12 [0.93-1.36],0.2320543382072192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX101,Testis-expressed protein 101,19029,66,1.28 [0.83-1.96],0.2608075315018436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX33,Testis-expressed protein 33,19201,67,1.49 [1.07-2.06],0.0174628197436199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TF,Serotransferrin,19587,69,2.31 [0.82-6.51],0.1124492892352095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFAP2A,Transcription factor AP-2-alpha,18910,64,0.84 [0.54-1.31],0.4504034688985092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF1,Trefoil factor 1,22363,80,1.27 [1.03-1.57],0.0254116234730025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF2,Trefoil factor 2,22511,81,1.47 [1.08-2.00],0.0132734514930609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF3,Trefoil factor 3,22448,80,1.27 [0.84-1.92],0.2604140743121117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI,Tissue factor pathway inhibitor,22425,80,1.13 [0.60-2.12],0.7039361730594648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI2,Tissue factor pathway inhibitor 2,22485,79,1.46 [1.09-1.94],0.010058639729665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFRC,Transferrin receptor protein 1,22561,80,1.71 [1.06-2.76],0.0291981428809179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TG,Thyroglobulin,19460,68,1.11 [0.92-1.34],0.2713465536622237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFA,Protransforming growth factor alpha,22392,81,1.15 [0.76-1.73],0.5035994061442712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFB1,Transforming growth factor beta-1 proprotein,22635,79,1.49 [0.92-2.42],0.109217068944104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFB2,Transforming growth factor beta-2 proprotein,19460,68,1.40 [0.95-2.05],0.089175140060397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBI,Transforming growth factor-beta-induced protein ig-h3,22350,80,1.96 [0.97-3.97],0.0601276253702786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR1,TGF-beta receptor type-1,18976,67,0.72 [0.23-2.24],0.5746165896991597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR2,TGF-beta receptor type-2,22542,79,1.22 [0.70-2.13],0.4771744421343834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR3,Transforming growth factor beta receptor type 3,22732,79,1.02 [0.55-1.91],0.9424488075288132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGM2,Protein-glutamine gamma-glutamyltransferase 2,22425,81,1.21 [0.94-1.56],0.1381630155021359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGOLN2,Trans-Golgi network integral membrane protein 2,19567,68,1.01 [0.43-2.38],0.9766230773651712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THAP12,52 kDa repressor of the inhibitor of the protein kinase,18823,65,1.16 [0.91-1.46],0.2328456584481513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBD,Thrombomodulin,22453,81,1.27 [0.66-2.45],0.4733651067719467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS2,Thrombospondin-2,22481,80,1.80 [1.15-2.83],0.0108472100411554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS4,Thrombospondin-4,22491,80,1.57 [1.02-2.41],0.0395714796736485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THOP1,Thimet oligopeptidase,22331,80,1.56 [0.87-2.81],0.1342704325709188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THPO,Thrombopoietin,22040,77,0.98 [0.59-1.65],0.9525661215395856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THRAP3,Thyroid hormone receptor-associated protein 3,18884,64,1.22 [1.03-1.44],0.0181439307312171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THSD1,Thrombospondin type-1 domain-containing protein 1,18829,67,1.16 [0.58-2.29],0.679485153642214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THTPA,Thiamine-triphosphatase,19429,68,1.04 [0.80-1.35],0.783699888847152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THY1,Thy-1 membrane glycoprotein,22637,81,1.09 [0.56-2.13],0.7921298382357517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIA1,Nucleolysin TIA-1 isoform p40,21792,75,1.03 [0.87-1.22],0.7629562195885708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIE1,Tyrosine-protein kinase receptor Tie-1,22732,79,1.83 [1.01-3.34],0.0470851943313598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",21901,76,1.09 [0.71-1.68],0.6861287722265974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19201,67,1.09 [0.59-2.00],0.7942686216076348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22574,80,1.24 [0.79-1.92],0.3499679748660481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19554,67,1.04 [0.58-1.86],0.8947374056479633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19518,67,0.97 [0.73-1.27],0.8145777349223398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP1,Metalloproteinase inhibitor 1,22238,80,2.54 [1.45-4.44],0.001053377066851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP2,Metalloproteinase inhibitor 2,19554,67,0.79 [0.29-2.19],0.6521330932240719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP3,Metalloproteinase inhibitor 3,22549,81,1.13 [0.98-1.30],0.1023034506431822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP4,Metalloproteinase inhibitor 4,22481,80,0.92 [0.56-1.49],0.7227311391618777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TINAGL1,Tubulointerstitial nephritis antigen-like,22378,81,2.11 [0.88-5.07],0.0938770088204252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TJAP1,Tight junction-associated protein 1,22542,79,1.10 [0.87-1.40],0.4300040951079187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TJP3,Tight junction protein ZO-3,18910,64,1.54 [1.01-2.33],0.0429572158276979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TK1,"Thymidine kinase, cytosolic",19201,67,0.52 [0.28-0.99],0.0463451804724697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR1,Toll-like receptor 1,18976,67,1.12 [0.47-2.69],0.7988061435875969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR2,Toll-like receptor 2,19201,67,0.70 [0.26-1.95],0.4998552393754613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR3,Toll-like receptor 3,22669,80,1.13 [0.81-1.58],0.4695158055127815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR4,Toll-like receptor 4,18976,67,0.83 [0.36-1.93],0.6636158925350543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19029,66,1.12 [0.74-1.70],0.5834309966115748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED1,Transmembrane emp24 domain-containing protein 1,19201,67,0.78 [0.49-1.25],0.3059027231198933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED10,Transmembrane emp24 domain-containing protein 10,18884,64,0.48 [0.20-1.15],0.1017991428520001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED4,Transmembrane emp24 domain-containing protein 4,18884,64,0.98 [0.64-1.50],0.9190159877743924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED8,Protein TMED8,19459,66,1.04 [0.83-1.31],0.7167380395017857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM106A,Transmembrane protein 106A,19460,68,1.17 [0.85-1.59],0.3346771278228049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM132A,Transmembrane protein 132A,19070,67,1.11 [0.77-1.62],0.5737929811665681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM25,Transmembrane protein 25,19512,65,0.94 [0.55-1.63],0.8338187341415763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMOD4,Tropomodulin-4,18853,65,0.74 [0.40-1.39],0.350065540818392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS11B,Transmembrane protease serine 11B,18910,64,0.91 [0.64-1.29],0.5964539717603909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS11D,Transmembrane protease serine 11D,19489,67,1.43 [0.87-2.36],0.1566463169216121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS15,Enteropeptidase,22343,78,1.20 [0.96-1.49],0.1034589847738489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS5,Transmembrane protease serine 5,22161,80,1.10 [0.66-1.86],0.7110812749249896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMSB10,Thymosin beta-10,22481,80,1.13 [0.86-1.47],0.3739255168580228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNC,Tenascin,22574,80,1.51 [1.02-2.25],0.0406529492505785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNF,Tumor necrosis factor,22012,77,1.57 [1.14-2.16],0.0061513790352205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19459,66,1.35 [0.87-2.11],0.1787446758036595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22021,77,0.96 [0.56-1.66],0.8802707227930641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19150,68,0.93 [0.63-1.35],0.6915583991381704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22257,80,1.67 [1.01-2.76],0.0460063757521337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22257,80,1.17 [0.80-1.72],0.4278449592171698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22529,78,0.75 [0.51-1.11],0.1446356323160791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22669,80,1.48 [0.93-2.35],0.0970011446489183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22445,81,1.19 [0.61-2.31],0.6111711771580726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22542,79,1.18 [0.68-2.06],0.5490370983392672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22479,81,1.85 [1.30-2.64],0.0006538443583766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22021,77,1.25 [0.79-1.99],0.3331626443397606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22479,81,1.62 [0.90-2.91],0.1113975080322441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19150,68,1.55 [0.91-2.64],0.1048358256908693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22632,81,1.29 [0.74-2.25],0.3717516368293219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22481,80,1.39 [0.76-2.54],0.2853462665499145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22481,80,1.53 [1.07-2.18],0.0184371582955207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22637,81,0.91 [0.45-1.83],0.7856167549416594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22635,79,1.14 [0.69-1.87],0.6113980329130255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22257,80,1.36 [1.00-1.85],0.0471383828702972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22637,81,1.22 [0.81-1.83],0.3499404923808041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22257,80,1.11 [0.71-1.74],0.6398933709886705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF10,Tumor necrosis factor ligand superfamily member 10,22669,80,0.72 [0.34-1.56],0.4069466606155608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF11,Tumor necrosis factor ligand superfamily member 11,22392,81,0.99 [0.72-1.37],0.96250067628978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF12,Tumor necrosis factor ligand superfamily member 12,22669,80,1.06 [0.53-2.14],0.868781324128381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13,Tumor necrosis factor ligand superfamily member 13,22549,81,2.42 [1.22-4.82],0.0116952995024733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22703,79,1.53 [0.80-2.92],0.2014365329196498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF14,Tumor necrosis factor ligand superfamily member 14,22257,80,1.23 [0.88-1.71],0.2236655382586487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF8,Tumor necrosis factor ligand superfamily member 8,19568,68,1.23 [0.66-2.31],0.5173632140988145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNIP1,TNFAIP3-interacting protein 1,19518,67,1.02 [0.78-1.32],0.9056511127349598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNN,Tenascin-N,19568,68,1.64 [0.97-2.76],0.063944242752913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNNI3,"Troponin I, cardiac muscle",22040,77,1.19 [0.92-1.54],0.1767545815344721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNPO1,Transportin-1,19201,67,0.50 [0.25-1.00],0.0512523227513506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNR,Tenascin-R,22257,80,1.04 [0.65-1.65],0.8694246979435263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNXB,Tenascin-X,22481,80,1.12 [0.52-2.42],0.7750647284754075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19554,67,1.18 [0.88-1.57],0.2719623704015424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP1,DNA topoisomerase 1,19459,66,1.03 [0.84-1.27],0.7500881300026282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP1MT,"DNA topoisomerase I, mitochondrial",18853,65,1.12 [0.72-1.73],0.6168221275063746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP2B,DNA topoisomerase 2-beta,18976,67,1.13 [0.85-1.51],0.4026878088338798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOR1AIP1,Torsin-1A-interacting protein 1,19070,67,0.86 [0.53-1.39],0.5337025946086372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53,Cellular tumor antigen p53,21953,75,0.98 [0.61-1.59],0.939960217382644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53BP1,TP53-binding protein 1,18976,67,0.99 [0.74-1.31],0.9296671571686272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53I3,Quinone oxidoreductase PIG3,18733,67,1.34 [0.87-2.06],0.1868045964825215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53INP1,Tumor protein p53-inducible nuclear protein 1,22040,77,1.22 [0.70-2.14],0.4895626186660461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP73,Tumor protein p73,19029,66,1.34 [0.67-2.65],0.4065515537222419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPBGL,Trophoblast glycoprotein-like,19029,66,0.80 [0.43-1.51],0.4921113053264759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPD52L2,Tumor protein D54,19150,68,1.10 [0.88-1.37],0.4005707405219397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPK1,Thiamin pyrophosphokinase 1,19554,67,1.18 [0.51-2.75],0.6985852449680368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPM3,Tropomyosin alpha-3 chain,18884,64,0.97 [0.56-1.69],0.9130210986688824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPMT,Thiopurine S-methyltransferase,21953,75,1.30 [1.02-1.68],0.037481869496672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPP1,Tripeptidyl-peptidase 1,22290,80,1.60 [1.15-2.24],0.0057326485150218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPPP2,Tubulin polymerization-promoting protein family member 2,19201,67,1.12 [0.86-1.45],0.3914647488199888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPPP3,Tubulin polymerization-promoting protein family member 3,21936,76,1.43 [0.97-2.12],0.074445485760224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPR,Nucleoprotein TPR,18884,64,0.97 [0.59-1.61],0.9147709378350256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPRKB,EKC/KEOPS complex subunit TPRKB,18853,65,0.91 [0.60-1.37],0.6488029215275838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSAB1,Tryptase alpha/beta-1,22637,80,0.82 [0.57-1.20],0.3115643506149539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSD1,Tryptase delta,19512,65,0.85 [0.43-1.68],0.6415373309828076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSG1,Tryptase gamma,18976,67,0.74 [0.29-1.88],0.5230193983834713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPT1,Translationally-controlled tumor protein,22021,77,0.83 [0.57-1.21],0.3345938031013022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF2,TNF receptor-associated factor 2,22392,81,1.07 [0.81-1.42],0.6112569735668163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF3,"TNF receptor-associated factor 3, Isoform 2",18976,67,0.90 [0.46-1.76],0.7568928659246111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,18884,64,1.22 [0.80-1.86],0.3453549837071711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19201,67,1.02 [0.79-1.33],0.8559588081270066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREH,Trehalase,19568,68,1.03 [0.75-1.42],0.8494982921395633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREM2,Triggering receptor expressed on myeloid cells 2,22445,81,1.11 [0.77-1.60],0.573376103269151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREML1,Trem-like transcript 1 protein,19567,68,1.22 [0.79-1.87],0.3756784954673847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREML2,Trem-like transcript 2 protein,22481,80,1.14 [0.65-2.01],0.6395393840055746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIAP1,TP53-regulated inhibitor of apoptosis 1,22632,81,1.17 [0.85-1.59],0.3362241344710504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM21,E3 ubiquitin-protein ligase TRIM21,22392,81,0.83 [0.66-1.04],0.1005009736156919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM24,Transcription intermediary factor 1-alpha,19169,67,1.17 [0.83-1.65],0.3586335368390704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19459,66,1.09 [0.88-1.36],0.4229533966234565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM26,Tripartite motif-containing protein 26,18853,65,0.96 [0.62-1.49],0.8500074923875016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM40,E3 ubiquitin ligase TRIM40,19029,66,1.04 [0.75-1.45],0.7958926449232899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM5,Tripartite motif-containing protein 5,22392,81,1.13 [0.90-1.43],0.2837647825909596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM58,E3 ubiquitin-protein ligase TRIM58,19460,68,0.91 [0.70-1.19],0.5097450949760871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRPV3,Transient receptor potential cation channel subfamily V member 3,18884,64,0.77 [0.44-1.37],0.3777531327406872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSC1,Hamartin,18976,67,0.86 [0.58-1.27],0.4464235525381353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSC22D1,TSC22 domain family protein 1,19512,65,1.15 [0.81-1.63],0.4259990191076297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSHB,Thyrotropin subunit beta,22453,81,1.00 [0.78-1.29],0.9797396865746556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSLP,Thymic stromal lymphopoietin,22040,77,0.94 [0.66-1.33],0.7146153482280692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSNAX,Translin-associated protein X,18884,64,0.79 [0.42-1.47],0.4541101965304469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN1,Tetraspanin-1,22040,77,0.94 [0.71-1.26],0.6944923490202035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN15,Tetraspanin-15,18884,64,0.82 [0.49-1.38],0.4609914698713779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN7,Tetraspanin-7,18910,64,0.84 [0.61-1.16],0.2877970374163069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN8,Tetraspanin-8,19459,66,1.16 [0.93-1.46],0.1919225339369365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPYL1,Testis-specific Y-encoded-like protein 1,18976,67,0.99 [0.55-1.79],0.9775984523083312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TST,Thiosulfate sulfurtransferase,21894,76,1.00 [0.76-1.31],0.9936565032523016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTF2,Transcription termination factor 2,19029,66,0.96 [0.59-1.57],0.8758513443439249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTN,Titin,18884,64,0.84 [0.55-1.29],0.4293121700857226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTR,Transthyretin,19375,69,0.51 [0.21-1.24],0.1365537424264664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TUBB3,Tubulin beta-3 chain,18910,64,1.24 [0.53-2.89],0.6207736818683092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TWF2,Twinfilin-2,19568,68,1.03 [0.78-1.35],0.8596862739247773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXK,Tyrosine-protein kinase TXK,19201,67,0.94 [0.67-1.32],0.7101379400377941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXLNA,Alpha-taxilin,22257,80,1.15 [0.92-1.44],0.2300247118194986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXN,Thioredoxin,19235,66,1.20 [0.75-1.93],0.4472579869681529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC15,Thioredoxin domain-containing protein 15,22542,79,1.16 [0.57-2.38],0.6847330911892631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC5,Thioredoxin domain-containing protein 5,22637,81,1.22 [0.92-1.62],0.1619498941506358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC9,Thioredoxin domain-containing protein 9,19518,67,1.02 [0.65-1.59],0.944427892714658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNL1,Thioredoxin-like protein 1,18872,64,0.77 [0.55-1.08],0.1245254918538832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22481,80,1.40 [0.93-2.12],0.109270613620958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYMP,Thymidine phosphorylase,22301,80,1.15 [0.85-1.56],0.3523157709247845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYRO3,Tyrosine-protein kinase receptor TYRO3,22453,81,0.95 [0.47-1.90],0.8855400217302636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",18976,67,0.86 [0.60-1.24],0.4250781526352687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBAC1,Ubiquitin-associated domain-containing protein 1,22343,78,1.32 [0.75-2.32],0.3418790408838632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2B,Ubiquitin-conjugating enzyme E2 B,19460,68,0.78 [0.34-1.81],0.5637277435640626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19554,67,1.22 [0.84-1.78],0.3010635038011979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,18976,67,0.94 [0.61-1.45],0.7895344416541912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBQLN3,Ubiquilin-3,18884,64,1.34 [0.96-1.87],0.0858289918458989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBXN1,UBX domain-containing protein 1,19150,68,1.06 [0.76-1.49],0.7170667195737672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19459,66,1.03 [0.87-1.22],0.732167725157868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UGDH,UDP-glucose 6-dehydrogenase,18884,64,0.97 [0.75-1.26],0.8224307638714228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UHRF2,E3 ubiquitin-protein ligase UHRF2,18884,64,0.91 [0.44-1.89],0.7999667394090623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ULBP2,UL16-binding protein 2,22257,80,1.38 [0.85-2.23],0.1926023074798621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UMOD,Uromodulin,22667,79,0.74 [0.53-1.04],0.0871341243718697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNC5D,Netrin receptor UNC5D,18976,67,1.01 [0.41-2.49],0.98459480618356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNC79,Protein unc-79 homolog,18853,65,0.79 [0.50-1.27],0.3347942164195563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNG,Uracil-DNA glycosylase,19460,68,1.14 [0.59-2.20],0.6911986862577468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPB1,Beta-ureidopropionase,19554,67,1.29 [1.01-1.64],0.0399291564068666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPK3A,Uroplakin-3a,18910,64,1.14 [0.72-1.79],0.5803102756225242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPK3BL1,Uroplakin-3b-like protein 1,19159,67,1.04 [0.68-1.58],0.8690629925304675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UROD,Uroporphyrinogen decarboxylase,19150,68,1.00 [0.71-1.40],0.9994573934911776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UROS,Uroporphyrinogen-III synthase,19029,66,0.98 [0.69-1.40],0.9300899742657012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USO1,General vesicular transport factor p115,22343,78,1.17 [0.94-1.47],0.1574897584323808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP25,Ubiquitin carboxyl-terminal hydrolase 25,19460,68,1.05 [0.76-1.46],0.7552086542346059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP28,Ubiquitin carboxyl-terminal hydrolase 28,19518,67,1.46 [0.89-2.39],0.1297800271912128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP47,Ubiquitin carboxyl-terminal hydrolase 47,18884,64,0.88 [0.64-1.21],0.4290939467409213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP8,Ubiquitin carboxyl-terminal hydrolase 8,22040,77,1.06 [0.86-1.31],0.5809514879538824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UXS1,UDP-glucuronic acid decarboxylase 1,21953,75,0.97 [0.66-1.44],0.8907631612897743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAMP5,Vesicle-associated membrane protein 5,22040,77,1.25 [0.92-1.69],0.1562154295304936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAMP8,Vesicle-associated membrane protein 8,18976,67,1.02 [0.78-1.34],0.8868264540840487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASH1,Tubulinyl-Tyr carboxypeptidase 1,22392,81,1.02 [0.80-1.29],0.8829973650351152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASN,Vasorin,22118,77,1.59 [0.77-3.27],0.2087196129110737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASP,Vasodilator-stimulated phosphoprotein,19567,68,1.10 [0.80-1.51],0.567879757001903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22343,78,0.56 [0.20-1.59],0.2772716968275446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAV3,Guanine nucleotide exchange factor VAV3,18910,64,1.03 [0.81-1.31],0.8205714286187173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAM1,Vascular cell adhesion protein 1,22527,80,2.62 [1.37-4.99],0.0034138683866257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAN,Versican core protein,22637,81,1.89 [1.03-3.47],0.038707952845368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCPKMT,Protein-lysine methyltransferase METTL21D,18853,65,0.94 [0.69-1.27],0.6886800127531362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFA,Vascular endothelial growth factor A,22596,80,1.41 [1.03-1.93],0.0325606826625818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFB,Vascular endothelial growth factor B,18976,67,1.15 [0.51-2.57],0.7398363333322021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFC,Vascular endothelial growth factor C,22542,79,1.45 [1.02-2.07],0.0395239603837317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFD,Vascular endothelial growth factor D,22633,80,1.01 [0.59-1.75],0.966715497033709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VGF,Neurosecretory protein VGF,19512,65,1.69 [0.82-3.48],0.1552722866684052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIM,Vimentin,22040,77,1.25 [1.03-1.52],0.0220228906728664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIPR1,Vasoactive intestinal polypeptide receptor 1,19070,67,0.71 [0.25-2.03],0.5258211759802176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIT,Vitrin,19554,67,0.81 [0.44-1.49],0.4923226698386305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VMO1,Vitelline membrane outer layer protein 1 homolog,22343,78,1.33 [0.97-1.82],0.0759543303391713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN1,Pantetheinase,19567,68,1.09 [0.79-1.51],0.6085859541270048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN2,Vascular non-inflammatory molecule 2,22343,78,1.43 [0.91-2.25],0.1255256875287986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS28,Vacuolar protein sorting-associated protein 28 homolog,19201,67,1.08 [0.76-1.54],0.6545562960212495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS37A,Vacuolar protein sorting-associated protein 37A,22343,78,1.00 [0.78-1.28],0.9849623953021938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS4B,Vacuolar protein sorting-associated protein 4B,19460,68,1.05 [0.82-1.34],0.7042861735281978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS53,Vacuolar protein sorting-associated protein 53 homolog,22343,78,1.06 [0.82-1.36],0.6812352552463411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG10,V-set and immunoglobulin domain-containing protein 10,19460,68,1.43 [0.82-2.48],0.2047188917374464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,18884,64,1.49 [0.77-2.87],0.2324834537702079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG2,V-set and immunoglobulin domain-containing protein 2,19460,68,1.18 [0.85-1.64],0.3229364193765616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG4,V-set and immunoglobulin domain-containing protein 4,22451,80,1.16 [0.74-1.83],0.5193678616907882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22414,81,1.34 [1.00-1.79],0.0501786593588957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSNL1,Visinin-like protein 1,19518,67,1.61 [0.95-2.73],0.074941310941602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM1,V-set and transmembrane domain-containing protein 1,21936,76,1.04 [0.69-1.55],0.861412154182573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM2B,V-set and transmembrane domain-containing protein 2B,19201,67,0.55 [0.25-1.20],0.1353038157898158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22040,77,1.32 [1.02-1.72],0.0346336454178735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22637,81,1.22 [0.93-1.60],0.1449606464125459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTCN1,V-set domain-containing T-cell activation inhibitor 1,21953,75,0.93 [0.48-1.82],0.8409918791658026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19150,68,1.10 [0.74-1.64],0.6279414128216863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWA1,von Willebrand factor A domain-containing protein 1,22595,81,1.22 [0.76-1.95],0.4162486736881865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWA5A,von Willebrand factor A domain-containing protein 5A,18853,65,1.11 [0.85-1.46],0.4511476498627887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWC2,Brorin,22188,80,1.17 [0.72-1.89],0.5342297648793206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWC2L,von Willebrand factor C domain-containing protein 2-like,19512,65,0.82 [0.45-1.52],0.531009138928291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWF,von Willebrand factor,22732,79,1.28 [0.98-1.68],0.0653978117135685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WARS,"Tryptophan--tRNA ligase, cytoplasmic",22481,80,1.50 [0.90-2.51],0.1189368833111837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WAS,Wiskott-Aldrich syndrome protein,22021,77,0.93 [0.69-1.27],0.6546375004907274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASF1,Wiskott-Aldrich syndrome protein family member 1,22040,77,0.99 [0.80-1.23],0.929390710885576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASF3,Wiskott-Aldrich syndrome protein family member 3,21936,76,0.99 [0.77-1.26],0.9152336855002442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASHC3,WASH complex subunit 3,19518,67,0.87 [0.63-1.21],0.4085377358084804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASL,Neural Wiskott-Aldrich syndrome protein,18976,67,1.04 [0.70-1.53],0.8569615709793943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WDR46,WD repeat-containing protein 46,19460,68,1.23 [0.70-2.16],0.4784490387839009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC1,WAP four-disulfide core domain protein 1,19053,65,0.76 [0.44-1.31],0.3209996794606381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC12,WAP four-disulfide core domain protein 12,22600,81,1.15 [0.85-1.54],0.3617909985752828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC2,WAP four-disulfide core domain protein 2,21337,75,1.36 [0.86-2.15],0.1895243721348324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22181,80,0.86 [0.54-1.39],0.5431259086203892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22479,81,0.94 [0.53-1.67],0.8323513764411845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WIF1,Wnt inhibitory factor 1,22632,81,1.30 [0.74-2.27],0.3567149598271615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WNT9A,Protein Wnt-9a,22021,77,1.78 [0.98-3.24],0.0581806675059519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22257,80,1.15 [0.80-1.65],0.4644739834090811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XCL1,Lymphotactin,22632,81,1.27 [0.93-1.74],0.1395539790262053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XG,Glycoprotein Xg,22635,79,1.25 [0.70-2.24],0.4499994004111498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XIAP,E3 ubiquitin-protein ligase XIAP,18976,67,1.03 [0.68-1.56],0.8916788864975488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XPNPEP2,Xaa-Pro aminopeptidase 2,22542,79,0.99 [0.81-1.20],0.9057907406957264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XRCC4,DNA repair protein XRCC4,21936,76,1.00 [0.58-1.73],0.9997294009108572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YAP1,Transcriptional coactivator YAP1,19518,67,2.00 [0.97-4.10],0.0599970094301609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19459,66,1.06 [0.90-1.25],0.4519442033301257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YES1,Tyrosine-protein kinase Yes,22343,78,1.09 [0.92-1.30],0.3234384242346476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YJU2,Splicing factor YJU2,19460,68,1.13 [0.57-2.26],0.7293891655315381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YOD1,Ubiquitin thioesterase OTU1,18884,64,1.01 [0.69-1.47],0.95947967794811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YTHDF3,YTH domain-containing family protein 3,22021,77,1.24 [0.99-1.57],0.0624510697571653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YWHAQ,14-3-3 protein theta,19150,68,1.17 [0.85-1.59],0.3353720487692212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YY1,Transcriptional repressor protein YY1,18976,67,0.95 [0.41-2.20],0.9003712963407873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBP1,Z-DNA-binding protein 1,18976,67,1.36 [0.84-2.21],0.2140262746380807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB16,Zinc finger and BTB domain-containing protein 16,21953,75,1.01 [0.76-1.35],0.9239229179237868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB17,Zinc finger and BTB domain-containing protein 17,22040,77,1.47 [1.04-2.07],0.0274275273324862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZCCHC8,Zinc finger CCHC domain-containing protein 8,18884,64,0.98 [0.65-1.46],0.908458753515776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZFYVE19,Abscission/NoCut checkpoint regulator,19459,66,1.06 [0.82-1.38],0.6468914857729529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZHX2,Zinc fingers and homeoboxes protein 2,19518,67,0.92 [0.43-1.97],0.8338330606345327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF174,Zinc finger protein 174,18976,67,1.15 [0.65-2.03],0.6408490275821033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF75D,Zinc finger protein 75D,19201,67,1.23 [0.90-1.68],0.1865176197830517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF830,Zinc finger protein 830,19460,68,1.05 [0.78-1.41],0.7573033169559612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNRD2,Protein ZNRD2,19459,66,0.92 [0.65-1.30],0.6483010323990833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19460,68,1.40 [0.98-2.01],0.0669179803269654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZP3,Zona pellucida sperm-binding protein 3,19070,67,1.01 [0.93-1.11],0.750028224939468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZP4,Zona pellucida sperm-binding protein 4,18853,65,0.75 [0.32-1.75],0.5120644959400265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZPR1,Zinc finger protein ZPR1,18910,64,1.21 [1.00-1.46],0.0553624871022297
